Table of Contents

 

As filed with the Securities and Exchange Commission on April 6, 2012May 11, 2018

Registration No. 333-

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON,Washington, D.C. 20549

 


 

FORM S-3

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 


 

MACKINAC FINANCIAL CORPORATION

(Exact name of registrantRegistrant as specified in its charter)

 


Michigan

(State or other jurisdiction

of incorporation or organization)

6022

(Primary Standard Industrial
Classification Code Number)

38-2062816

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer

Identification No.)employer
identification number)

 

130 South Cedar Street
Manistique, Michigan 49854


(888) 343-8147

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)


 

Ernie R. Krueger

Jesse Deering
Executive Vice President/Chief Financial Officer


Mackinac Financial Corporation


130 South Cedar Street


Manistique, Michigan 49854

(906) 341-7158
(248) 290-5900

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 


CopiesCopy to:

Phillip D. Torrence,Jeffrey H. Kuras, Esq.


Jessica M. Herron, Esq.
Honigman Miller Schwartz and Cohn LLP
660 Woodward Avenue
2290 First National Building
Detroit, Michigan 48226
(313) 465-7446

350 East Michigan Avenue, Suite 300

Kalamazoo, Michigan 49007

(269) 337-7702


 

Approximate Datedate of Commencementcommencement of Proposed Saleproposed sale to the Public:public:

As soon as practicableFrom time to time after the effective date of this registration statement.

 

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box:box.  o

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box:box.  ox

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, of 1933, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:offering.  o

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering:offering.  o

 

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.  o

 

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”,filer,” “accelerated filer”filer,” “smaller reporting company” and “smaller reporting“emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filero

o

Accelerated filer o

 

Non-accelerated filer o

 

Non-accelerated filer

o (Do not check if a smaller reporting company)

Smaller reporting company x

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  o

 

CALCULATION OF REGISTRATION FEE

Title of Each Class of Securities to be
Registered

 

Amount to be
Registered

 

Proposed
Maximum
Offering Price
Per
Share(2)

 

Proposed
Maximum
Aggregate
Offering
Price(2)

 

Amount of
Registration
Fee

 

Subscription Rights, each to purchase one (1) Common Share, no par value per share(1)

 

 

 

 

(2)

Common Shares, no par value per share (1)

 

 

 

 

 

$

7,000,000

 

$

802.20

(3)

(1)This registration statement relates to (a) the subscription rights to purchase our Common Shares, and (b) Common Shares deliverable upon the exercise of the subscription rights.

(2)The subscription rights are being issued without consideration. Pursuant to Rule 457(g), no separate registration fee is payable with respect to the subscription rights being offered hereby since the subscription rights are being registered in the same registration statement as the securities to be offered pursuant thereto.

(3)Calculated pursuant to Rule 457(o) based on an estimate of the proposed maximum offering price.

 

 

 

 

 

 

 

 

 

 

Title of Each Class of
Securities to be Registered

 

Amount
to be
Registered (1)(2)(3)

 

Proposed
Maximum
Offering
Price
Per Unit
(3)

 

Proposed
Maximum
Aggregate
Offering Price (3)(4)(5)

 

Amount of
Registration Fee (3)(4)

 

Common Stock, no par value

 

 

 

 

 

 

 

 

 

Preferred Stock

 

 

 

 

 

 

 

 

 

Debt Securities (6)

 

 

 

 

 

 

 

 

 

Warrants(7)

 

 

 

 

 

 

 

 

 

Rights(8)

 

 

 

 

 

 

 

 

 

Units (9)

 

 

 

 

 

 

 

 

 

TOTAL

 

 

 

 

 

$

75,000,000

 

$

9,337.50

 

(1)

Also includes an indeterminate number of shares of each identified class as may be issued by the Registrant upon exercise, conversion or exchange of any securities that provide for such issuance. In no event will the aggregate offering price of all types of securities issued by the Registrant pursuant to this registration statement exceed $75,000,000.

(2)

Pursuant to Rule 416 under the Securities Act, this registration statement also covers any additional securities that may be offered or issued in connection with any stock split, stock dividend or similar transaction.

(3)

Pursuant to General Instruction II.D. of Form S-3, the table lists each of the classes of securities being registered and the aggregate proceeds to be raised, but does not specify by each class information as to the amount to be registered, proposed maximum offering price per unit, and proposed maximum aggregate offering price.

(4)

The proposed maximum aggregate offering price has been estimated solely to calculate the registration fee in accordance with Rule 457(o) under the Securities Act.

(5)

Includes consideration received by us, if applicable, for registered securities that are issuable upon exercise, conversion or exchange of other registered securities.

(6)

May consist of one or more series of senior or subordinated debt. If any debt securities are issued at an original issue discount, then such greater amount as may be sold for an initial aggregate offering price up to the proposed maximum aggregate offering price.

(7)

Warrants may be sold separately or together with common stock, preferred stock or debt securities of the Registrant.

(8)

Each right will represent rights to purchase shares of common stock or other securities covered by this registration statement.

(9)

Each unit will be issued under a unit agreement or indenture and will represent an interest in two or more securities, which may or may not be separable from one another.

 

The registrant hereby amends this Registration Statementregistration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statementregistration statement shall thereafter become effective in accordance with Sectionsection 8(a) of the Securities Act of 1933 or until this Registration Statementthe registration statement shall become effective on such date as the Securities and Exchange Commission acting pursuant to such Sectionsaid section 8(a), may determine.

 

 

 



Table of Contents

 

The information contained in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities, and we areit is not soliciting offersan offer to buy these securities in any jurisdictionstate where the offer or sale is not permitted.

 


Preliminary and Subject to Completion, dated , 2012May 11, 2018

PROSPECTUS

 

of$75,000,000

 

Common Stock ·  Preferred Stock ·  Debt Securities ·  Warrants ·  Rights  ·  Units

We may offer and sell from time to time, together or separately, in one or more offerings, any combination of the securities listed above. The securities we may offer may be convertible into or exchangeable for other securities. The maximum aggregate initial public offering price of the securities offered through this prospectus is $75,000,000.

This prospectus describes the general terms that may apply to the securities offered. The specific terms of our securities to be offered will be described in one or more supplements to this prospectus. This prospectus may not be used to sell securities unless accompanied by a prospectus supplement. The prospectus supplement and any related free writing prospectus also may add, update or change information contained in this prospectus. Before you invest in any of our securities, please carefully read this prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as any documents incorporated by reference in this prospectus or any prospectus supplement.

Our common stock is quoted on the Nasdaq Capital Market, under the symbol “MFNC.” On May 10, 2018, the closing price of our common stock was $15.35 per share. You are urged to obtain current market quotations for the common stock. None of the other securities that we may offer is currently traded on any securities exchange.

We may offer and sell the securities on a continuous or delayed basis, through agents, dealers or underwriters, or directly to purchasers. The prospectus supplement for each offering of securities will describe in detail the plan of distribution for that offering. If agents or any dealers or underwriters are involved in the sale of the securities, the applicable prospectus supplement will set forth the names of the agents, dealers or underwriters and any applicable commissions or discounts. The price to the public of such securities and the net proceeds that we expect to receive from such sale will also be set forth in a prospectus supplement. For general information about the distribution of securities offered, please see ���Plan of Distribution” in this prospectus.

Investing in our securities involves risks. Before making any decision to invest in our securities, you should carefully consider the risk factors beginning on page 3 as well as those contained or incorporated by reference into this prospectus and in the applicable prospectus supplement or free writing prospectus.

 

MACKINAC FINANCIAL CORPORATIONNeither the Securities and Exchange Commission nor any state securities commission or regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

$7,000,000The securities are not savings accounts, deposits or obligations of any bank and are not insured by the Federal Deposit Insurance Company or any other governmental agency.

 

Subscription Rights to Purchase up to The date of this Prospectus is               , 20181,217,391 Common Shares

at $5.75 per Share


We are distributing, at no charge, to holders of our Common Shares (the “Common Shares”), non-transferable subscription rights to purchase up to 1,217,391 of our Common Shares. You will receive approximately three hundred fifty-six thousandths (0.356) of a subscription right for each Common Share owned at 5:00 p.m., Eastern Time, on April 6, 2012 (the “Record Date”).

Each whole subscription right will entitle you to purchase one (1) of our Common Shares at a subscription price of $5.75 per share (the “Subscription Price”), which we refer to as the basic subscription privilege. The Subscription Price is equal to the same per share price for which we agreed to sell Common Shares to Steinhardt Capital Investors, LLLP (“SCI”) pursuant to the terms and conditions of the securities purchase agreement entered into with SCI.  Subscription rights may only be exercised in whole numbers; we will not issue fractional shares and will round all of the subscription rights down to the nearest whole number. If you fully exercise your basic subscription privilege and other shareholders do not fully exercise their basic subscription privileges, you will be entitled to exercise an over-subscription privilege to purchase a portion of the unsubscribed common shares at the same Subscription Price of $5.75 per share, subject to proration and subject, further, to reduction by us under certain circumstances.  Funds we receive from subscribers in the rights offering will be held in escrow by the subscription agent until the rights offering is completed or canceled. To the extent you properly exercise your over-subscription privilege for an amount of shares that exceeds the number of the unsubscribed shares available to you, any excess subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable.

The subscription rights will expire if they are not exercised by 5:00 p.m., Eastern Time, on [    ·    ], 2012, unless we extend the rights offering period in our sole discretion.  If any subscription rights (including any over-subscriptions) remain unexercised after the expiration of the rights offering, they will expire and have no value.

Pursuant to the securities purchase agreement, SCI has agreed to purchase, upon completion of the rights offering, between $5,000,000 and $11,000,000 of varying types and amounts of our securities (the “SCI Investment”) depending on (i) the outcome of the rights offering and (ii) SCI receiving approval from the Board of Governors of the Federal Reserve System to hold more than 9.9% of the total number of our Common Shares then issued and outstanding (the “Federal Reserve Approval”).  If SCI receives the Federal Reserve Approval by the completion of the rights offering, then SCI has agreed to purchase an amount of our Common Shares (which will include some or all of the Common Shares not purchased by our shareholders in the rights offering) that SCI can purchase without SCI owning more than 19.9% of our Common Shares then issued and outstanding and an 8.0% senior promissory note in the principal amount to be determined based on the amount of proceeds derived from the rights offering and the sale to SCI of the Common Shares with the 19.9% limitation for no more than an aggregate of $11,000,000.  If SCI does not receive the Federal Reserve Approval by the completion of the rights offering, then SCI has agreed to purchase an amount of our Common Shares (which will include some or all of the Common Shares not purchased by our shareholders in the rights offering) that SCI can purchase without SCI owning more than 9.9% of our Common Shares then issued and outstanding, an amount of shares of our Mandatorily Convertible Cumulative Participating Series B Preferred Stock (the “Series B Preferred”) determined by dividing the amount of investment that SCI could not make in 19.9% of our Common Shares then issued and outstanding due to the 9.9% limitation by a per Series B Preferred share price of $1,000, and a senior promissory note in the principal amount to be determined based on the amount of proceeds derived from the rights offering, the sale to SCI of the Common Shares with the 9.9% limitation and the sale to SCI of the Series B Preferred for no more than an aggregate of $11,000,000.

The proceeds from the sale of securities derived from the SCI Investment and the rights offering will be used exclusively to repurchase the Corporation’s outstanding Fixed Rate Cumulative Perpetual Preferred Stock and the related warrants (collectively, the “TARP Securities”) that were issued by the Corporation to the U.S. Department of the Treasury (“Treasury”) under the Troubled Asset Relief Capital Purchase Program in 2009.

 



Table of Contents

 

Assuming Federal Reserve Approval, the aggregate maximum number of Common Shares that may be sold to SCI, if no current shareholder exercises its subscription rights or over-subscription rights, is 728,498.TABLE OF CONTENTS

 

You should carefully consider whether to exercise your subscription rights prior to the expiration of the rights offering. All exercises of subscription rights are irrevocable.  Our board of directors is not making a recommendation regarding your exercise of the subscription rights.  The subscription rights may not be sold, transferred or assigned and will not be listed for trading on any stock exchange or market or on any over-the-counter or bulletin board market.

ABOUT THIS PROSPECTUS

1

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

1

MACKINAC FINANCIAL CORPORATION

3

RISK FACTORS

3

REGULATORY CONSIDERATIONS

10

USE OF PROCEEDS

11

RATIOS OF EARNINGS TO FIXED CHARGES AND PREFERRED STOCK DIVIDENDS

12

SECURITIES WE MAY OFFER

12

DESCRIPTION OF COMMON STOCK

13

DESCRIPTION OF PREFERRED STOCK

15

DESCRIPTION OF DEBT SECURITIES

17

DESCRIPTION OF WARRANTS

25

DESCRIPTION OF RIGHTS

26

DESCRIPTION OF UNITS

27

PLAN OF DISTRIBUTION

28

LEGAL MATTERS

31

EXPERTS

31

WHERE YOU CAN FIND ADDITIONAL INFORMATION

31

INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

31

 

This is not an underwritten offering. Our Common Shares are being offered directly by us without the services of an underwriterNo dealer, salesperson or selling agent. We have engaged River Branch Capital LLC as our financial and marketing advisorother person has been authorized to give any information or to make any representations in connection with the rights offering. River Branch Capital LLC is not obligated to sell or to acquire for its own account or with a view to distribution any Common Shares that are being offered in the rights offering.

We have engaged Registrar and Transfer Companyto serve as the subscription agent for the rights offering. The subscription agent will hold in escrow the funds received from subscribers until we complete or cancel the rights offering. For further information about this offering please contact our Executive Vice President/Chief Financial Officer, Ernie R. Krueger, at: Mackinac Financial Corporation, 130 South Cedar Street, Manistique, Michigan 49854, (906) 341-7158.

Our board of directors may cancel the rights offering at any time prior to the expiration of the rights offering for any reason. In the event the rights offering is cancelled, the subscription agent will return all subscription payments it has received, without interest or penalty, as soon as practicable.

Our Common Shares are traded on the NASDAQ Capital Market under the ticker symbol “MFNC.” On [    ·    ], 2012, the closing sales price for our Common Shares was $[    ·    ] per share. The Common Shares issued in this rights offering will also be listed on the NASDAQ Capital Market under the same ticker symbol.

The exercise of your subscription rights for our Common Shares involves risks. See “Risk Factors” beginning on page [   ·   ] ofoffer made by this prospectus and the documentsor any prospectus supplement or any free writing prospectus other than those contained in, or incorporated by reference in, this prospectus or any prospectus supplement or related free writing prospectus, and if given or made, such information or representations must not be relied upon as having been authorized by us or any agent, underwriter or dealer. This prospectus, any prospectus supplement or any free writing prospectus does not constitute an offer to read about important factors you should consider before exercising your subscription rights.

Neither the Securities and Exchange Commission (the “SEC”), the Board of Governors of the Federal Reserve, the Michigan Office of Financial and Insurance Regulation nor any state securities commission has approvedsell or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

These securities are not savings accounts, deposits or other obligationssolicitation of any bank and are not insuredoffer to buy any securities in any jurisdiction to any person to whom it is unlawful to make an offer or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency.

solicitation in such jurisdiction. The datedelivery of this prospectus, any prospectus supplement or any free writing prospectus or any sale of a security at any time does not imply that the information contained herein or therein is [    ·    ], 2012.



Tablecorrect as of Contentsany time subsequent to their respective dates.

 

iTABLE OF CONTENTS

PROSPECTUS

ABOUT THIS PROSPECTUS

1

FORWARD-LOOKING STATEMENTS

1

PROSPECTUS SUMMARY

3

QUESTIONS AND ANSWERS RELATING TO THE RIGHTS OFFERING

8

RISK FACTORS

14

OUR BUSINESS

21

USE OF PROCEEDS

22

DETERMINATION OF OFFERING PRICE

22

MARKET FOR OUR COMMON SHARES AND DIVIDEND INFORMATION

23

CAPITALIZATION

24

PLAN OF DISTRIBUTION

25

DESCRIPTION OF OUR CAPITAL STOCK

26

DESCRIPTION OF THE SUBSCRIPTION RIGHTS

32

CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONS

49

LEGAL MATTERS

52

EXPERTS

52

INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

52

WHERE YOU CAN FIND MORE INFORMATION

53

COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

53



Table of Contents

 

ABOUT THIS PROSPECTUS

 

This prospectus is part of a registration statement on Form S-3 that we have filed with the U.S. Securities and Exchange Commission which(the “SEC”) using a “shelf” registration process. Under this shelf registration process, we refer to asmay sell any combination of the “SEC.” Insecurities described in this prospectus we provideas being offered, from time to time in one or more offerings, up to a total dollar amount of $75,000,000.

This prospectus provides you with a general description of the securities we may offer. Each time we sell securities, we will provide a prospectus supplement that will contain specific information about all of the subscription rightsterms of that offering. We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to that offering. The applicable prospectus supplement (and any related free writing prospectus that we are distributingmay authorize to you in this rights offering. This prospectus includes importantbe provided to you) may also add, update or change information about us, the subscription rights, our Common Shares and other information you should know before exercising your subscription rights.

The exhibits to our registration statement contain the text of certain contracts and other important documents we have summarizedcontained in this prospectus or in the documents that we have incorporated by reference in this prospectus. Since these summaries mayreference. This prospectus does not contain all of the information that you may find importantset forth in deciding whether to purchase the securities we offer, you should review the full text of these documents. The registration statement and the exhibits to the registration statement. You should read this prospectus and the documents incorporated by reference can be obtainedapplicable prospectus supplement and any related free writing prospectus together with additional information from the SEC as indicated under the headingsources described in “Where You Can Find More Information.”

We are sellingAdditional Information” and “Incorporation of Certain Documents by Reference” in this prospectus. You should not assume that the securities directly to one or more purchasers. We and our agents reserveinformation in this prospectus, the sole right to accept and to reject in whole or in part any proposed purchase of securities. See “Description of the Subscription Rights” and “Plan of Distribution” below.

This prospectus together with any accompanying prospectus supplement,supplements, any free writing prospectus that we may provide you and the informationor any document incorporated by reference in these documents, includes all material information relating to this offering. We have not authorizedis accurate as of any underwriter, agent, dealer, salesman or other person to give any information or to make any representationdate other than those containedthe date of the applicable document.

You should rely only on the information provided or incorporated by reference in this prospectus, any free writing prospectus and the applicableany prospectus supplement, or any free-writing prospectus that we may authorize to be delivered to you. We take no responsibility for, and can provide no assurances as to the reliability of, any other information that others may give you.if applicable. We have not authorized anyone to provide you with different or additional information. You should not assume that the information appearing in this prospectus, any accompanying prospectus supplement, any free writing prospectus that we may provide you

References to “we,” “us,” “our,” “Mackinac” or the documents incorporated by reference herein or therein is accurate as of any date other than their respective dates, regardless of the time of delivery of this prospectus or any sale of a security. Our business, financial condition, results of operations and prospects may have changed since those dates. Neither the delivery of this prospectus, any accompanying prospectus supplement or any free writing prospectus nor any distribution of securities pursuant to such documents shall, under any circumstances, create any implication that there has been no change in the information set forth in such documents or in our affairs since the date of such documents.

This prospectus and the applicable prospectus supplement do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor do this prospectus and the applicable prospectus supplement constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.

You should carefully read this prospectus, any accompanying prospectus supplement, any free writing prospectus that we may provide you and the information incorporated by reference in these documents, together with the additional information described under “Incorporation of Certain Information by Reference” and “Where You Can Find More Information,” before exercising your subscription rights.

References in this prospectus to the “Corporation,” “Company,” “registrant,” “we,” “us” and “our” are“Company” refer to Mackinac Financial Corporation and its subsidiaries, unless the context otherwise requires. The term “you” refers to a Michigan corporation, and our wholly owned subsidiary, mBank, a Michigan state chartered commercial bank.prospective investor.

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

From timeCertain of the statements made in this prospectus, including information incorporated in this prospectus by reference to time,other documents, are “forward-looking statements” within the Corporationmeaning and its senior managers have madeprotections of Section 27A of the Securities Act of 1933, as amended (referred to as the Securities Act), and will makeSection 21E of the Securities Exchange Act of 1934, as amended (referred to as the Exchange Act). All statements other than statements of historical fact, including statements regarding our financial position, business strategy and the plans and objectives of our management for future operations, are forward-looking statements. You can identify these forward-looking statements that are not historical facts and that are intended to be covered by the safe harbor for “forward-looking statements” provided by the Private Securities Litigation Reform Actthrough our use of 1995. These forward-looking statements may include, but are not limited to, statements about the Corporation’s plans, objectives, expectations and intentions and other statements contained in this release that are not historical facts and pertain to the Corporation’s future operating results. When used in this report, forward-looking terminologywords such as “may,” “will,” “anticipate,” “assume,” “should,” “potential,“indicate,“intend,“would,“expect,“believe,“endeavor,” “seek,” “anticipate,“contemplate,” “expect,” “estimate,” “overestimate,“continue,“underestimate,“plan,“believe,“point to,” “project,” “could,” “can,“intend,“plan,“target,“project,” “predict,” “continue,” “trend,” “opportunity,” “pipeline,” “comfortable,” “current,” “position,” “assume,” “outlook,” “remain,” “maintain,” “sustain,” “achieve,” “would” orand other similar words orand expressions andrelating to the negative of such words are generally intended to identify forward-looking statements. We make forward-looking statements regarding projected sources of funds, use of proceeds, availability of acquisition and growth opportunities, ability to repay government funds, payment of dividends, adequacy of our allowance for loan and lease losses and provision for loan and lease losses,

1



Table of Contents

and subsequent charge-offs. Such statements may be contained in this report and in other documents that we file with the SEC. Such statements may also be made by the Corporation and its senior managers in oral or written presentations to analysts, investors, the media and others.future.

 

Actual results may differ materially, and adversely or positively, from the expectations of the Company that are expressed or implied by any forward-looking statement. Risks, uncertainties, and factors that could cause the Company’s actual results discussed in theseto vary materially from those expressed or implied by any forward-looking statements because such statements are inherently subject to significant assumptions, risks and uncertainties, many of which are difficult to predict and are generally beyond our control. Thesestatement include but are not limited to:

 

·                                          our ability to effectively manage interest rate risk and other market risk, credit risk and operational risk;the use of proceeds of future offerings of securities;

 

·                                          possiblethe unknown future direction of interest rates and the timing and magnitude of any changes in the quality or composition of our loans or investment portfolios, including adverse developments in the real estate markets, the borrowers’ industries or in the repayment ability of individual borrowers or issuers;interest rates;

 

·                                          our ability to manage fluctuationschanges in the value of assets and liabilities and off-balance sheet exposure so as to maintain sufficient capital and liquidity to support our business;competitive conditions;

 

·                                          our ability to expand into new markets;the introduction, withdrawal, success and timing of asset/liability management strategies or of mergers and acquisitions and other business initiatives and strategies;

 

·                                          possible changes in general economic and business conditions, including real estate and economic markets, in the United States in general and in the larger region and local communities we serve in particular may lead to a deterioration in credit quality, thereby requiring increases in our provision for credit losses or a reduced demand for credit, thereby reducing earning assets;

·the cost and other effects of material contingencies;

·our ability to keep pace with technological changes;

·our ability to develop competitive new products and services in a timely manner and the acceptance of such products and services by our customers and potential customers;

·further easing of restrictions on participants in the financial services industry, such as banks, securities brokers and dealers,customer borrowing, repayment, investment companies, credit unions and finance companies, may increase competitive pressures and affect our ability to preserve our customer relationships and margins;

·the costs of integrating our operations with the various banks we may acquire, which could be greater than we expect;

·potential customer loss and deposit attrition as a result of any merger or acquisition of additional banks and the failure to achieve expected gains, revenue growth and/or expense savings from such a transaction;practices;

 

·the threat or occurrence of war or acts of terrorism and the existence or exacerbation of general geopolitical instability and uncertainty;

·possible changes in trade, monetary and fiscal policies, laws and regulations and other activities of governments, agencies and similar organizations, including changes in accounting standards; and

·Management’s inability to develop and execute plans to effectively respond to unexpected changes.

Other factors that could cause actual conditions, events or results to differ significantly from those described in the forward-looking statements may be found under the heading “Risk Factors” below and under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K, as updated periodically in our filings with the SEC. Unless legally required, we disclaim any obligation to update any forward-looking statement. You should consider any forward-looking statement in light of this explanation, and we caution you about relying on forward-looking statements.

2



Table of Contents

PROSPECTUS SUMMARY

This prospectus summary contains basic information about us and this offering. Because it is a summary, it does not contain all of the information that you should consider before deciding whether or not you should exercise your subscription rights. You should carefully read this prospectus, including the “Risk Factors” section, and the information included or incorporated by reference herein, including our audited consolidated financial statements and the accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2010, and our unaudited consolidated financial statements on Form 10-Q for the quarters ended March 31, 2011, June 30, 2011, and September 30, 2011, before you decide to exercise your subscription rights.

Company Information

Mackinac Financial Corporation (the “Corporation”) was incorporated under the laws of the state of Michigan on December 16, 1974. The Corporation changed its name from “First Manistique Corporation” to “North Country Financial Corporation” on April 14, 1998. On December 16, 2004, the Corporation changed its name from North Country Financial Corporation to Mackinac Financial Corporation. The Corporation owns all of the outstanding stock of its banking subsidiary, mBank (the “Bank”). The Corporation also owns three (3) non-bank subsidiaries: First Manistique Agency, presently inactive; First Rural Relending Company, a relending company for nonprofit organizations; and North Country Capital Trust, a statutory business trust which was formed solely for the issuance of trust preferred securities. The Bank represents the principal asset of the Corporation. The Corporation and its subsidiary Bank are engaged in a single industry segment, commercial banking, broadly defined to include commercial and retail banking activities, along with other permitted activities closely related to banking.

Our principal executive offices are located at 130 South Cedar Street, Manistique, Michigan 49854, and our telephone number is (906) 341-8401.

For additional information about our business, see our annual and quarterly reports and the other documents we file with the SEC, which are incorporated into this registration statement by reference. See “Where You Can Find More Information” on page [    ·    ].

The Rights Offering

The following summary describes the principal terms of the rights offering, but is not intended to be complete. See the information under the heading “Description of the Subscription Rights” in this prospectus for a more detailed description of the terms and conditions of the rights offering.

Basic Subscription Privilege:

For each whole right that you own, you will have a basic subscription privilege to buy from us one (1) of our Common Shares (our “Common Shares”) at a Subscription Price of $5.75 per share (the “Subscription Price”). The Subscription Price is equal to the same per share price for which we agreed to sell Common Shares to Steinhardt Capital Investors, LLLP (“SCI”) pursuant to the terms and conditions of the securities purchase agreement entered into with SCI. You may exercise your basic subscription privilege for some or all of your rights, or you may choose not to exercise your rights.

Over-Subscription Privilege:

In the event that you purchase all of our Common Shares available to you pursuant to your basic subscription privilege, you may also choose to purchase a portion of any of our Common Shares that are not purchased by our other shareholders through the exercise of their basic subscription privileges.

If holders exercise their over-subscription privileges for more shares than are available to be purchased pursuant to the over-subscription privileges, we will allocate our Common Shares to be issued pursuant to the exercise of over-subscription privileges in accordance with the procedures summarized under “Description of the Subscription Rights — Over-Subscription Rights.” If you are not allocated the full amount of shares for which you oversubscribe, you will receive a refund of the Subscription Price, without interest or penalty, which you delivered for those of our Common Shares that are not allocated to you. The subscription agent will mail such refunds as soon as practicable after the completion of the offering.

Limitations on the Purchase of Common Shares:

We will not issue Common Shares pursuant to the exercise of basic subscription privileges or over-subscription privileges to any shareholder who, in our sole opinion, could be required to obtain prior clearance or approval from or submit a notice to any state or federal regulatory

3



Table of Contents

authority, including the Board of Governors of the Federal Reserve System (the “Federal Reserve Board”), to acquire, own or control such Common Shares if, as of the closing of the rights offering, such clearance or approval has not already been obtained or any applicable waiting period has not expired.

Certain Defined Terms:

For purposes of this prospectus:

·    the Common Shares subscribed for by the Corporation’s shareholders in the rights offering (including any amount subscribed for pursuant to the shareholders’ over-subscription privileges) shall be referred to as the “Subscribed Shares”;

·    the Common Shares, if any, that are not subscribed for by the Corporation’s shareholders in the rights offering shall be referred to as the “Unsubscribed Shares”;

·    the aggregate purchase price of the Subscribed Shares, which equals the number of Subscribed Shares multiplied by the Subscription Price, shall be referred to as the “Aggregate Subscription Price”;

·    shares of our Mandatorily Convertible Cumulative Participating Series B Preferred Stock shall be referred to as the “Series B Preferred Shares”;

·    the per share price of the Series B Preferred Shares shall be $1,000 and shall be referred to as the “Series B Preferred Per Share Price”;

·    the Series B Preferred Per Share Price divided by the Subscription Price shall be referred to as the “Series B Preferred Conversion Rate.”

SCI Investment:

We have separately entered into a securities purchase agreement with SCI in connection with the rights offering. Pursuant to the securities purchase agreement, SCI has agreed to purchase, upon completion of the rights offering, between $5,000,000 and $11,000,000 of our securities, comprised of varying types and amounts of securities (the “SCI Investment”), depending on (i) the outcome of the rights offering and (ii) SCI receiving approval from the Board of Governors of the Federal Reserve Board to hold more than 9.9%, but no more than 19.9%, of the total number of our Common Shares then issued and outstanding (the “Federal Reserve Approval”).

If SCI receives the Federal Reserve Approval by the completion of the rights offering, then SCI has agreed to purchase:

·    an amount of our Common Shares (which will include some or all of the Unsubscribed Shares) that SCI can purchase without SCI owning more than 19.9% of our Common Shares then issued and outstanding at a per share price equal to the Subscription Price (such shares, the “Approval Common Shares,” and the amount of Approval Common Shares multiplied by the Subscription Price shall be referred to in this prospectus as the “Approval Aggregate Common Purchase Price”); and

·    a senior promissory note in the principal amount to be determined based upon the number of Unsubscribed Shares remaining after the issuance to SCI of the Approval Common Shares (the “Approval Note”).

If SCI does not receive the Federal Reserve Approval by the completion of the rights offering, then SCI has agreed to purchase:

·    an amount of our Common Shares (which will include some or all of the Unsubscribed Shares) that SCI can purchase without SCI owning more than 9.9% of our Common Shares then issued and outstanding at a per share price equal to the Subscription Price (such shares, the “No Approval Common Shares,” and the amount of No Approval Common Shares multiplied by the Subscription Price shall be

4



Table of Contents

referred to in this prospectus as the “No Approval Aggregate Common Purchase Price”);

·    an amount of our Series B Preferred Shares determined by dividing (1) the difference between (x) the Approval Aggregate Common Purchase Price that SCI would have paid if it had received Federal Reserve Approval by the completion of the rights offering and (y) the No Approval Aggregate Common Purchase Price (such difference being referred to herein as the “No Approval Aggregate Preferred Purchase Price”) by (2) the Series B Preferred Per Share Price (such shares, the “No Approval Preferred Shares”); and

·    an 8% senior promissory note in the principal amount to be determined based upon the number of Unsubscribed Shares remaining after the issuance to SCI of the No Approval Common Shares and the No Approval Preferred Shares (the “No Approval Note”).

The Approval Note or the No Approval Note (as applicable, the “Note”) would (i) be senior to all current and future indebtedness of the Corporation, (ii) bear interest at a per annum rate of 8% calculated on the basis of a 360-day year consisting of twelve (12) thirty (30)-day months, (iii) be unsecured, (iv) require monthly interest-only payments, (v) mature on the third anniversary of the Closing and (vi) permit prepayment without penalty.

If issued, upon receipt by SCI of the Federal Reserve Approval, the No Approval Preferred Shares would automatically convert into that number of Common Shares equal to the amount of No Approval Preferred Shares multiplied by the Series B Preferred Conversion Rate. The rights and preferences of the No Approval Preferred Shares are summarized under “The SCI Investment Transaction — Mandatorily Convertible Cumulative Preferred Stock, Series B” on page [ ] of this prospectus.

The closing of the SCI Investment would occur upon the satisfaction of the following closing conditions (the “Closing”):

·    receiving any other necessary approvals from the Federal Reserve Board, the Michigan Office of Financial and Insurance Regulation (“OFIR”), the Federal Deposit Insurance Corporation (the “FDIC”) and any other applicable governmental or regulatory body;

·    the Corporation must have entered into a definitive agreement with the Treasury to redeem all of the TARP Securities (each as defined below);

·    the closing or expiration of the rights offering; and

·    other standard conditions to closing.

The proceeds from the sale of securities derived from the SCI Investment and the rights offering would be used exclusively to repurchase the Corporation’s outstanding Fixed Rate Cumulative Perpetual Preferred Stock and the related warrants (collectively, the “TARP Securities”) that were issued by the Corporation to the U.S. Department of the Treasury (the “Treasury”) under the Troubled Asset Relief Capital Purchase Program. The aggregate maximum number of Common Shares that may be sold to SCI, if no current shareholder exercises its subscription rights or over-subscription rights and SCI receives the Federal Reserve Approval, is 728,498.

For so long as SCI holds a specified amount of our Common Shares, we have agreed to take all action necessary to cause one (1) person designated by SCI to be elected to our board of directors and, so long as such person is appropriately qualified, to recommend to our shareholders that they elect such designee to our board of directors. SCI has indicated that its designee to our board of directors will initially be David R. Steinhardt.

5



Table of Contents

More information regarding our transaction with SCI can be found in our Current Report on Form 8-K, filed with the SEC on March 28, 2012, which is incorporated into the registration statement in which this prospectus is a part by reference.

Subscription Price:

$5.75 per Common Share, payable in cash, which represents the same price at which the Common Shares were sold to SCI under the securities purchase agreement. To be effective, any payment related to the exercise of a right must clear prior to the expiration of the rights offering.

Record Date:

5:00 p.m., Eastern Time, on April 6, 2012.

Expiration of the Rights Offering:

5:00 p.m., Eastern Time, on [    ·    ], 2012, unless the expiration date is extended. We reserve the right to extend the rights offering at our sole discretion.

Use of Proceeds:

We intend to use the proceeds of the rights offering and the SCI Investment exclusively to repurchase the Corporation’s TARP Securities that were issued by the Corporation to the Treasury.

Non-Transferability of Rights:

The subscription rights may not be sold, transferred or assigned and will not be listed for trading on any stock exchange or market or on any over-the-counter or bulletin board market.

No Board Recommendation:

Our board of directors is making no recommendation regarding your exercise of the subscription rights. You are urged to make your decision based on your own assessment of our business and the rights offering. Please see “Risk Factors” on page [    ·    ] for a discussion of some of the risks involved in investing in our Common Shares.

No Revocation:

Any exercise of subscription rights is irrevocable, even if you later learn information about us that you consider to be unfavorable. You should not exercise your subscription rights unless you are certain that you wish to purchase additional Common Shares offered pursuant to this rights offering.

Federal Income Tax Considerations:

The receipt and exercise of subscription rights pursuant to the basic subscription privilege or subscription for shares pursuant to the over-subscription privilege will generally not be taxable for U.S. federal income tax purposes. You should, however, seek specific tax advice from your tax advisor in light of your particular circumstances and as to the applicability and effect of any other tax laws. See “Certain U.S. Federal Income Tax Considerations” on page [    ·    ].

Extension, Cancellation and Amendment:

We have the option to extend the rights offering and the period for exercising your subscription rights for a period or successive periods in our discretion, although we do not presently intend to do so. Our board of directors may cancel the rights offering at any time prior to the expiration of the rights offering for any reason. In the event that the rights offering is cancelled, all subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable. We also reserve the right to amend or modify the terms of the rights offering, including increasing the size of the offering, as appropriate.

Procedures for Exercising Rights:

To exercise your subscription rights, you must take the following steps:

If you are a registered holder of our Common Shares, you may deliver payment and a properly completed rights certificate to the subscription agent, Registrar and Transfer Company, before 5:00 p.m., Eastern Time, on [    ·    ], 2012, unless the expiration date is extended. You may deliver the documents and payments by mail or commercial carrier. If regular mail is used for this purpose, we recommend using registered mail, properly insured, with return receipt requested.

If you are a beneficial owner of shares that are registered in the name of a broker, dealer, custodian bank or other nominee, or if you would rather an institution conduct the transaction on your behalf, you should instruct your broker, dealer, custodian bank or other nominee to exercise your subscription rights on your behalf and deliver all documents and payments before 5:00 p.m., Eastern Time, on [    ·    ], 2012. If you wish to purchase Common Shares

6



Table of Contents

through the rights offering, please promptly contact your broker, dealer, custodian bank or other nominee as record holder of your shares. We will ask your record holder to notify you of the rights offering. You should complete and return to your record holder the form entitled “Beneficial Owner Election Form.”

Issuance of Common Shares:

If you purchase Common Shares through the rights offering, we will issue those shares to you as soon as practicable after the completion of the rights offering.

Shares Outstanding Before the Rights Offering:

3,419,736 Common Shares were outstanding as of March 30, 2012.

Shares Outstanding After Completion of the Rights Offering:

Assuming no options to acquire Common Shares are exercised prior to the expiration of the rights offering, the full $7.0 million is subscribed for and the maximum number of Common Shares are issued to SCI pursuant to the SCI Investment, we expect approximately 5,668,073 of our Common Shares will be outstanding immediately after completion of the rights offering. We reserve the right to increase the size of the offering, which would increase the number of shares outstanding.

Subscription Agent:

Registrar and Transfer Company.

Fees and Expenses:

We will pay the fees and all of our expenses related to the rights offering. We have engaged River Branch Capital LLC in connection with the rights offering. In connection with River Branch Capital LLC serving as our financial advisor, we will pay River Branch Capital LLC a fee of $100,000 (with half already paid and half payable at year-end) and reimburse its reasonable out-of-pocket expenses. We have also agreed to pay SCI’s reasonable fees and expenses in connection with the SCI Investment in an amount not to exceed $75,000.

Trading Symbol:

Our Common Shares are currently listed for quotation on the NASDAQ Capital Market under the ticker symbol “MFNC,” and the shares to be issued in connection with the rights offering will also be listed on the NASDAQ Capital Market under the same symbol.

Additional Information:

For additional information, please see the description of this offering contained in this prospectus or contact our Vice President/Chief Financial Officer, Ernie R. Krueger, at: Mackinac Financial Corporation, 130 South Cedar Street, Manistique, Michigan 49854, (906) 341-7158.

7



Table of Contents

QUESTIONS AND ANSWERS RELATING TO THE RIGHTS OFFERING

The following are examples of what we anticipate will be common questions about the rights offering.  The answers are based on selected information included elsewhere in this prospectus.  The following questions and answers do not contain all of the information that may be important to you and may not address all of the questions that you may have about the rights offering.  This prospectus and the documents incorporated by reference into this prospectus contain more detailed descriptions of the terms and conditions of the rights offering and provide additional information about us and our business, including potential risks related to the rights offering, the shares of our common stock offered in the rights offering and our business.

What is the rights offering?

We are distributing, at no charge, to holders of our Common Shares non-transferable subscription rights to purchase Common Shares. You will receive approximately three hundred fifty-six thousandths (0.356) of a subscription right for each Common Share you owned as of 5:00 p.m., Eastern Time, on April 6, 2012, the Record Date. The subscription rights will be evidenced by rights certificates. Each subscription right will entitle the holder to a basic subscription privilege and an over-subscription privilege.

What is the basic subscription privilege?

For each whole subscription right that you own, you will have a basic subscription privilege to buy from us one (1) of our Common Shares at a Subscription Price of $5.75 per share. You may exercise your basic subscription privilege for some or all of your subscription rights, or you may choose not to exercise any subscription rights.  If you exercise less than all of your subscription rights, you will not be entitled to purchase shares pursuant to your over-subscription privilege.

For example, if you owned one thousand (1,000) Common Shares as of 5:00 p.m., Eastern Time, on the Record Date, you would receive three hundred fifty-six (356) whole subscription rights and would have the right to purchase three hundred fifty-six (356) Common Shares for $5.75 per share with your basic subscription privilege.

We determined the number of Common Shares to be offered and the fractional subscription right to attach to each whole Common Share based on the total Common Shares outstanding on the Record Date and the number of Common Shares underlying this Rights Offering. Because we are offering subscription rights to purchase $7.0 million of Common Shares at $5.75 per Common Share, the subscription rights must be exercisable for 1,217,391 Common Shares ($7.0 million divided by $5.75). To determine the number of subscription rights to attach to each outstanding Common Share, we divided the number of Common Shares that we are offering (1,217,391) by the 3,419,736 currently outstanding Common Shares eligible to participate. The result, to the third decimal place, is that each shareholder will receive three hundred fifty-six thousandths (.356) of a subscription right for each whole Common Share owned by such shareholder.  Accordingly, you will need to own at least three (3) Common Shares in order to exercise a full subscription right for one (1) Common Share in this Rights Offering.

Subscription rights may only be exercised in whole numbers; we will not issue fractional shares and will round all of the subscription rights down to the nearest whole number. As a result, we may not issue the full number of shares authorized for issuance in connection with the rights offering. Any excess subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable.

What is the over-subscription privilege?

If you purchase all of the Common Shares available to you pursuant to your basic subscription privilege, you may also choose to purchase a portion of any Common Shares that our other shareholders do not purchase through the exercise of their basic subscription privileges. You should indicate on your subscription rights certificate, or the form provided by your nominee if your Common Shares are held in the name of a nominee, how many additional Common Shares you would like to purchase pursuant to your over-subscription privilege.  The Subscription Price for shares purchased pursuant to the over-subscription privilege will be the same as the Subscription Price for the basic subscription privilege.

Common Shares available to our shareholders pursuant to the over-subscription privilege will be allocated pursuant to a two-step process. The maximum number of Common Shares purchasable by a shareholder in the first step of the allocation process will be limited to the result of: (x) the total number of unsubscribed Common Shares multiplied by (y) the number of subscription rights that were distributed to such shareholder divided by (z) the number of subscription rights distributed to all holders of Common Shares as of the Record Date. Shareholders whose over-subscription requests exceed the Common Share limitation of the first step of the allocation process will proceed to the second step, where we will seek to honor over-subscription requests in full if sufficient Common Shares are available. If over-subscription requests for Common Shares in the second step of the allocation process exceed the number of Common Shares available, however, we will allocate the available Common Shares pro rata among the shareholders participating in

8



Table of Contents

the second step of the allocation process in proportion to the number of subscription rights that were distributed to each of those shareholders relative to the number of subscription rights distributed to all holders of Common Shares participating in the second step of the allocation, with the number of Common Shares rounded up or down, as applicable, to result in the allocation of whole Common Shares. If this pro rata allocation results in any shareholder receiving a greater number of Common Shares than for which the shareholder subscribed pursuant to the exercise of the over-subscription privilege, then such shareholder will be allocated only that number of Common Shares for which the shareholder oversubscribed, and the remaining Common Shares will be allocated among all other shareholders exercising the over-subscription privilege on the same pro rata basis described above. The proration process will be repeated until all Common Shares have been allocated.

For example, if: (i) there are one hundred (100) excess Common Shares available for purchase by three (3) shareholders who have timely and fully exercised their basic subscription privileges with respect to all the subscription rights they hold and (ii) shareholder A, who received 15% of the subscription rights distributed to all holders of Common Shares as of the Record Date, requests the purchase of one hundred (100) Common Shares pursuant to shareholder A’s over-subscription privilege, shareholder B, who received 10% of the subscription rights distributed to all holders of Common Shares as of the Record Date, requests the purchase of fifty (50) Common Shares pursuant to shareholder B’s over-subscription privilege and shareholder C, who received 5% of the subscription rights distributed to all holders of Common Shares as of the Record Date, requests the purchase of twenty (20) Common Shares pursuant to shareholder C’s over-subscription privilege, then, assuming the valid exercise of each of these shareholder’s basic subscription privileges and receipt of sufficient payment for the Common Shares requested pursuant to the over-subscription request, in the first step of the allocation process of the over-subscription privilege: shareholder A would receive fifteen (15) Common Shares, shareholder B would receive ten (10) Common Shares and shareholder C would receive five (5) Common Shares. In the second step of the allocation process: shareholder A would receive thirty-five (35) Common Shares, shareholder B would receive twenty-three and thirty-three hundredths (23.33) Common Shares (rounded down to twenty-three (23) Common Shares, with the total subscription payment being adjusted accordingly) and shareholder C would receive eleven and sixty-seven hundredths (11.67) Common Shares (rounded up to twelve (12) Common Shares, with the total subscription payment being adjusted accordingly).

Registrar & Transfer Company, our subscription agent for the rights offering, will determine the over-subscription allocation based on the formula described above. Any excess subscription payments received by the subscription agent will be returned as soon as practicable, without interest or penalty.

To properly exercise your over-subscription privilege, you must deliver the subscription payment related to your over-subscription privilege before the rights offering expires. Because we will not know the total number of unsubscribed Common Shares before the rights offering expires, if you wish to maximize the number of Common Shares you may purchase pursuant to your over-subscription privilege, you will need to deliver payment in an amount equal to the aggregate subscription price for the maximum number of Common Shares that may be available to you (i.e., the aggregate payment for both your basic subscription rights and for any additional shares you desire to purchase pursuant to your over-subscription privileges).

Why are we conducting the rights offering?

We are conducting the rights offering and the SCI Investment to raise sufficient capital to repurchase the Corporation’s outstanding TARP Securities that were issued by the Corporation to the Treasury by participating in the Capital Purchase Program under TARP.

How was the $5.75 per full share Subscription Price determined?

In determining the Subscription Price, we considered a number of factors, including: the price at which our shareholders might be willing to participate in the rights offering, the price at which SCI was willing to participate in the SCI Investment, historical and current trading prices for our Common Shares and the desire to provide an opportunity to our shareholders to participate in the rights offering on a pro rata basis.  The Subscription Price was established at a price of $5.75 per full share, which equals the price to be paid by SCI for our Common Shares in the SCI Investment. The Subscription Price is not necessarily related to our book value, net worth or any other established criteria of value and may or may not be considered the fair value of our Common Shares to be offered in the rights offering.  You should not consider the Subscription Price as an indication of value of the Company or our Common Shares.  You should not assume or expect that, after the rights offering, our Common Shares will trade at or above the Subscription Price in any given time period.  The market price of our Common Shares may decline during or after the rights offering, and you may not be able to sell the underlying Common Shares purchased during the rights offering at a price equal to or greater than the Subscription Price.  You should obtain a current quote for our Common Shares before exercising your subscription rights and make your own assessment of our business and financial condition, our prospects for the future and the terms of this rights offering.

9



Table of Contents

 

We retained River Branch Capital LLC to advise us with respect to an appropriate per share price range for the Subscription Price of the shares·                                          changes in this rights offering.In connection with River Branch Capital LLC serving as our financial advisor, we will pay River Branch Capital LLC a fee of $100,000 (with half already paidfiscal, monetary and half payable at year-end) and reimburse its reasonable out-of-pocket expenses.

Am I required to exercise the subscription rights I receive in the rights offering?

No. You may exercise any number of your subscription rights, or you may choose not to exercise any subscription rights. However, if you choose not to fully exercise your basic subscription privilege and other shareholders fully exercise their basic subscription privilege, the percentage of our Common Shares owned by these other shareholders will increase relative to your ownership percentage, and your voting and other rights will likewise be diluted. In addition, if you do not exercise your basic subscription privilege in full, you will not be entitled to subscribe to purchase additional shares pursuant to the over-subscription privilege and your ownership percentage in our Common Shares and related voting and other rights may be further diluted.

How soon must I act to exercise my subscription rights?tax policies;

 

·                                          changes in financial and capital markets;

·                                          deterioration in general economic conditions, either nationally or locally, resulting in, among other things, credit quality deterioration;

·                                          capital management activities, including possible future sales of new securities;

·                                          risks of expansion through acquisitions and mergers, such as unexpected credit quality problems of the acquired loans or other assets, unexpected attrition of the customer base of the acquired institution or branches, and difficulties in integration of the acquired operations;

·                                          factors that may cause the Company to incur impairment charges on its investment securities;

·                                          the impact, extent and timing of technological changes;

·                                          electronic, cyber and physical security breaches;

·                                          claims and litigation liabilities, including related costs, expenses, settlements and judgments, or the outcome of matters before regulatory agencies, whether pending or commencing in the future;

·                                          actions of the Board of Governors of the Federal Reserve System;

·                                          changes in accounting principles and interpretations;

·                                          potential increases of federal deposit insurance premium expense, and possible future special assessments of the Federal Deposit Insurance Company, either industry wide or specific to the Company’s banking subsidiary;

·                                          legislation and/or regulation affecting the financial services industry as a whole, and Mackinac and its subsidiaries in particular, including the effects resulting from the reforms enacted by the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) and the adoption of regulations by regulatory bodies under the Dodd-Frank Act;

·                                          the possible impact of whole or partial dismantling of provisions of the Dodd-Frank Act under the current presidential administration;

·                                          the potential for changes in tax laws, particularly corporate income tax reform, that may affect current returns, Mackinac’s deferred tax assets and liabilities, the ability to utilize federal and state net operating loss carryforwards, and the market’s perception on overall value;

·                                          actions of the regulatory authorities under the Consumer Financial Protection Board and the Federal Deposit Insurance Act and other possible legislative and regulatory actions and reforms;

·                                          the continued availability of earnings and excess capital sufficient for the lawful and prudent declaration and payment of cash dividends; and

·                                          other factors and risks described under “Risk Factors” in our most recent Annual Report on Form 10-K, as updated by any of our subsequent reports that we have made or make with the SEC under the Exchange Act.

Because such forward-looking statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such statements. The subscription rights may be exercised at any time beginningforegoing list of important factors is not exclusive and you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this prospectus and prior to the expiration of the rights offering, which is [    ·    ], at 5:00 p.m., Eastern Time. If you elect to exercise any rights, the subscription agent must actually receive all required documents and payments from you prior to the expiration of the rights offering. Although we have the option of extending the expiration of the rights offering, we currently do not intend to do so.

May I transfer my subscription rights?

No. You may not selldocument or, transfer your subscription rights to anyone else.

Can our board of directors extend, cancel or amend the rights offering?

Yes. We have the option to extend the rights offering and the period for exercising your subscription rights in our discretion, although we do not presently intend to do so. Our board of directors may cancel the rights offering at any time prior to the expiration of the rights offering for any reason. In the event that the rights offering is cancelled, all subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable. We also reserve the right to amend or modify the terms of the rights offering, including increasing the size of the offering, as appropriate.

Are we requiring a minimum subscription to complete the rights offering?

No. However, our board of directors reserves the right to cancel the rights offering for any reason, including if our board of directors believes that there is insufficient participation by our shareholders. If the rights offering is cancelled, all subscription proceeds received by the subscription agent will be returned, without interest or penalty, as soon as practicable.

If the rights offering is not completed, will my subscription payment be refunded to me?

Yes. The subscription agent will hold all funds it receives in a segregated bank account until completion of the rights offering. If the rights offering is not completed, the subscription agent will return all subscription payments, without interest or penalty, as soon as practicable. If you own shares in “street name,” it may take longer for you to receive payment because the subscription agent will return payments through the record holder of the shares.

Has our board of directors made a recommendation to our shareholders regarding the rights offering?

No. Our board of directors is making no recommendation regarding your exercise of the subscription rights. Shareholders who exercise subscription rights risk investment loss on new money invested. We cannot assure you that the market price for our Common Shares will be above the Subscription Price or that anyone purchasing shares at the Subscription Price will be able to sell those shares in the future at the same price or a higher price. You are urged to make your decision based on your own assessmentcase of our business and the rights offering. Among other things, you should carefully consider the risks described under the heading “Risk Factors” in this prospectus and the risks described in documents incorporated by reference, the dates of those documents. We do not undertake to update any forward-looking statements, whether written or oral, that may be made from time to time by or on behalf of us. For a detailed discussion of the risks and uncertainties that may cause our actual results or performance to differ materially from the results or performance expressed or implied by forward-looking statements, see “Risk Factors” herein and in our most recent Annual Report on Form 10-K, as updated by our subsequent filings and in all other information appearing in this prospectus.prospectus or incorporated by reference into this prospectus and any applicable prospectus supplement.

 

Will members of the board of directors and management be permitted to participate in the rights offering?MACKINAC FINANCIAL CORPORATION

 

Yes. Members of our board and executive management team have indicated an interest in purchasing an aggregate of approximately $[      ] of our shares in the offering, including pursuant to the over-subscription privilege, if available. We caution you

10



Table of Contents

that the board of directors or members of the executive management team do not make any recommendation regarding your exercise of the subscription rights.

Are there limitations on the number of Common Shares I may purchase?

AsMackinac is a bank holding company, we are subject to regulation by the Federal Reserve Board. The Federal Reserve Board has the authority to prevent individuals and entities from acquiring control of us. Under Federal Reserve Board rules and regulations, if you, directly or indirectly, or through one or more subsidiaries or acting in concert with one or more persons or entities will own 10% or more of our voting stock after giving effect to the rights offering and the SCI Investment, then you will be presumed to control us. This presumption of control is rebuttable; however, it is likely that you will need to submit materials to the Federal Reserve Board or enter into what is referred to as a passivity commitment to successfully rebut this presumption. If, after giving effect to the rights offering and the SCI Investment, you will hold 25% or more of our voting stock, you will be conclusively presumed to control us, and the Federal Reserve Board will require that an application or other notice be filed prior to obtaining this level of control.

We will not issue Common Shares pursuant to the exercise of basic subscription privileges or over-subscription privileges to any shareholder who, in our sole opinion, could be required to obtain prior clearance or approval from or submit a notice to any state or federal bank regulatory authority, including the Federal Reserve Board, to acquire, own or control such Common Shares if, as of the closing of this rights offering, such clearance or approval has not already been obtained or any applicable waiting period has not expired. If we elect not to issue Common Shares in such a case, the unissued Common Shares will become available to satisfy over-subscriptions by other shareholders.

What will happen if I choose not to exercise my subscription rights?

If you do not exercise any subscription rights, the number of Common Shares you own will not change; however, due to the fact that shares will be purchased by other shareholders, your percentage ownership of the Corporation will be diluted after the completion of the rights offering.

How do I exercise my subscription rights?

You must properly complete the enclosed subscription rights certificate and deliver it, along with the full Subscription Price (including any amounts in respect of your over-subscription privilege), to the subscription agent before 5:00 p.m., Eastern Time, on [    ·    ], 2012. If you use the mail, we recommend that you use insured, registered mail, return receipt requested.

You must timely pay the full Subscription Price for the full number of Common Shares you wish to acquireBHC, incorporated under the basic subscription privilege and any over-subscription request by delivering to the subscription agent a certified check or a personal check that clears before the expiration date of the rights offering. If you wish to use any other form of payment, then you must obtain prior approval from us and make arrangements in advance for the delivery of such payment.

If you send a payment that is insufficient to purchase the number of shares you requested, or if the number of shares you requested is not specifiedMichigan law, primarily engaged in the forms,business of planning, directing and coordinating the payment received will be appliedbusiness activities of its wholly owned banking subsidiary, mBank, a Michigan state-chartered bank. As a BHC, Mackinac’s activities are limited to exercise your subscription rightsbanking and activities that are closely related to the fullest extent possible based on the amount of the payment received, subject to the availability of shares under the over-subscription privilege and the elimination of fractional shares.

What form of payment must I use to pay the Subscription Price?

You must timely pay the full Subscription Price for the full number of Common Shares you wish to acquire under the basic subscription privilege and any over-subscription request by delivering to the subscription agent a certified check or a personal check that clears before the expiration date of the rights offering. If you wish to use any other form of payment, then you must obtain the prior approval of the subscription agent and make arrangements in advance with the subscription agent for the delivery of such payment.

What should I do if I want to participate in the rights offering, but my shares are held in the name of my broker, dealer, custodian bank or other nominee?

If you hold your Common Shares in the name of a broker, dealer, custodian bank or other nominee, then your broker, dealer, custodian bank or other nominee is the record holder of the shares you own. You will not receive a subscription rights certificate. The record holder must exercise the subscription rights on your behalf for the Common Shares you wish to purchase.

11



Table of Contents

If you wish to purchase Common Shares through the rights offering, please promptly contact your broker, dealer, custodian bank or other nominee as record holder of your shares. We will ask your record holder to notify you of the rights offering. You should complete and return to your record holder the form entitled “Beneficial Owner Election Form.” You should receive this form from your record holder with the other rights offering materials. Your broker, dealer, custodian bank or other nominee may establish a deadline prior to 5:00 p.m. Eastern Time on [    ·    ], 2012, which we established as the expiration date of the rights offering.

When will I receive my new shares?

As soon as practicable after the expiration of the rights offering period, the subscription agent will arrange for the issuance of the Common Shares purchased pursuant to the basic subscription privilege. Shares purchased pursuant to the over-subscription privilege will be issued as soon as practicable after the expiration date of the rights offering and following the completion of any pro-rations as may be necessary in the event the over-subscription requests exceed the number of shares available to satisfy such requests. Subject to state securities laws and regulations, we have the discretion to delay distribution of any shares you may have elected to purchase by exercise of your rights in order to comply with state securities laws.

After I send in my payment and rights certificate, may I cancel my exercise of subscription rights?

No. Any exercise of subscription rights is irrevocable, even if you later learn information that you consider to be unfavorable to the exercise of your subscription rights. You should not exercise your subscription rights unless you are certain that you wish to purchase additional Common Shares at a Subscription Price of $5.75 per share.

How many of our Common Shares will be outstanding after the rights offering?

As of March 30, 2012, webanking. At December 31, 2017 Mackinac had 3,419,736 Common Shares issued and outstanding. Assuming we sell the full offering amount, the rights offering and SCI Investment will result in the issuanceconsolidated total assets of approximately 2,248,337 additional shares. Accordingly, there may be 5,668,073 Common Shares outstanding after the rights offering,Common Shares outstanding. We reserve the right to increase the size$985.4 million, loans and leases receivable, net of the offering, which would increase the numberallowances, of shares outstanding.

How much money will the Corporation receive from the rights offering?

The$806.0 million and total proceeds to us from the rights offering will depend on the numberdeposits of subscription rights that are exercised. If we issue all 1,217,391shares available in the rights offering, the total proceeds to us, before expenses, will be $7.00$818.0 million.

Are there risks in exercising my subscription rights?

Yes. The exercise of your subscription rights involves risk. Exercising your subscription rights involves the purchase of additional Common Shares and should be considered as carefully as you would consider any other equity investment. Among other things, you should carefully consider the risks described under the heading “Risk Factors” on page [    ·    ] of this prospectus and the documents incorporated by reference in this prospectus.

If the rights offering is not completed, will my subscription payment be refunded to me?

Yes. The subscription agent will hold all funds it receives in a segregated bank account until completion of the rights offering. If the rights offering is not completed, all subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable. If you own shares in “street name,” it may take longer for you to receive payment because payments will be returned through the record holder of your shares.

Will the subscription rights be listed on a stock exchange or national market?

 

The subscription rights may not be sold, transferred or assigned and will not be listed for trading on any stock exchange or market or on any over-the-counter or bulletin board market.  Our Common Sharesprincipal executive offices of Mackinac are traded on the NASDAQ Capital Market under the ticker symbol “MFNC.”

How do I exercise my subscription rights if I live outside the United States?

We will not mail this prospectus or the rights certificates to shareholders whose addresses are outside the United States or who have an army post office or foreign post office address. The subscription agent will hold the rights certificates for their account.

12



Table of Contents

To exercise subscription rights, any foreign shareholders must notify the subscription agent and timely follow the procedures described in “Description of the Subscription Rights—Foreign Shareholders” on page [    ·    ].

What fees or charges apply if I purchase Common Shares?

We are not charging any fee or sales commission to issue subscription rights to you or to issue shares to you if you exercise your subscription rights. If you exercise your subscription rights through the record holder of your shares, you are responsible for paying any fees your record holder may charge you.

What are the material U.S. federal income tax consequences of exercising subscription rights?

The receipt and exercise of subscription rights pursuant to the basic subscription privilege or subscription for shares pursuant to the over-subscription privilege should generally not be taxable for U.S. federal income tax purposes. You should, however, seek specific tax advice from your tax advisor in light of your particular circumstances and as to the applicability and effect of any other tax laws. See “Certain U.S. Federal Income Tax Considerations” on page [    ·    ].

To whom should I send my forms and payment?

If your shares are held in the name of a broker, dealer or other nominee, then you should send your subscription documents, rights certificate and subscription payment to that record holder. If you are the record holder, then you should send your subscription documents, rights certificate and subscription payment by hand delivery, first class mail or courier service toRegistrar and Transfer Company, the subscription agent for the rights offering, as follows:

By Hand or Overnight Courier

(Until 5:00 p.m. Eastern Time on

By First Class Mail:

the expiration date of the rights offering):

Registrar and Transfer Company

Registrar and Transfer Company

P.O. Box 645

10 Commerce Drive

Cranford, NJ 07016

Cranford, NJ 07016

Attn: Reorg/Exchange Dept.

Attn: Reorg/Exchange Dept.

You should direct any questions, requests for assistance concerning the method of subscribing for our Common Shares or requests for additional copies of this prospectus to our Executive Vice President/Chief Financial Officer, Ernie R. Krueger, at: Mackinac Financial Corporation,located at 130 South Cedar Street, Manistique, Michigan 49854, (906) 341-7158.and its telephone number is (888) 343-8147. Mackinac’s website can be accessed at http://www.bankmbank.com. Information contained in Mackinac’s website does not constitute part of, and is not incorporated into, this prospectus. Mackinac’s common stock is traded on the Nasdaq Capital Market under the symbol “MFNC.”

 

For more information about Mackinac and its subsidiaries, see “Where You are solely responsible for completing delivery to the subscription agent of your subscription documents, rights certificate and payment. We urge you to allow sufficient time for delivery of your subscription materials to the subscription agent.

Whom should I contact if I have other questions?

If you have other questions or need assistance, please contact our Executive Vice President/Chief Financial Officer, Ernie R. Krueger, at: Mackinac Financial Corporation, 130 South Cedar Street, Manistique, Michigan 49854, (906) 341-7158.

13



Table of ContentsCan Find Additional Information.”

 

RISK FACTORS

 

Before you exercise your subscription rights to purchase our Common Shares, you should be aware that an investmentInvesting in our securities involves a high degree of risk. You should carefully consider the specific risks describedset forth in “Risk Factors” below and in the risks that we have highlightedapplicable prospectus supplement and any related free writing prospectus and under the captions “Risk Factors” in other sectionsany of this prospectus, togetherour filings with the other information included or incorporated by reference in this prospectus,SEC, including the risks describedheading captioned “Risk Factors” in the section entitled“Management’sManagement Discussion and Analysis of Financial Condition and Results of Operations”item included in our most recent Annual Report on Form 10-K, for the period ended December 31, 2010, as updated periodicallyby our subsequent filings and in our filings withall other information appearing in this prospectus or incorporated by reference into this prospectus and any applicable prospectus supplement. For additional information, please see the SEC, before making an investment decision. Thesources described in “Where You Can Find Additional Information.”

These risks described below are not the only risks we face. TheAdditional risks and uncertainties not presently known to us, or that we currently deemview as immaterial, may also may impair our business, operations. Ifif any of the followingrisks described in our SEC filings or any prospectus supplement or any additional risks actually occurs,occur, our business, financial condition, results of operations and financial conditioncash flows could suffer.be materially and adversely affected. In that event,case, the trading pricevalue of our Common Sharessecurities could decline substantially and you maycould lose all or part of your investment in our Common Shares. The risks discussed below include forward-looking statements, and our actual results may differ substantially from those discussed in these forward-looking statements.investment.

 

RisksRisk Factors Related to the Rights OfferingBusiness of Mackinac

 

TheMackinac’s net interest income could be negatively affected by interest rate adjustments by the Federal Reserve, as well as by competition in its primary market price of our Common Shares is volatile and may decline before or after the subscription rights expire.area.

 

TheAs a financial institution, Mackinac’s earnings are significantly dependent upon its net interest income, which is the difference between the interest income that is earned on interest-earning assets, such as investment securities and loans, and the interest expense that we pay on interest-bearing liabilities, such as deposits and borrowings. Therefore, any change in general market price of our Common Shares could be subject to wide fluctuations in response to numerous factors, some of which are beyond our control. These factors include, among other things, actual or anticipated variations in our costs of doing business, operating results and cash flow, the nature and content of our earnings releases and our competitors’ earnings releases,interest rates, including changes resulting from changes in financial estimates by securities analysts, businessthe Federal Reserve’s fiscal and monetary policies, affects it more than non-financial institutions and can have a significant effect on net interest income and total income. Mackinac’s assets and liabilities may react differently to

changes in overall market rates or conditions in our markets andbecause there may be mismatches between the general staterepricing or maturity characteristics of the securities marketsassets and theliabilities. As a result, an increase or decrease in market for other financial stocks, changes in capital markets that affect the perceived availability of capital to companies in our industry, governmental legislation or regulation, currency and exchange rate fluctuations, as well as general economic and market conditions, such as downturns in our economy and recessions.

Once you exercise your subscription rights, you may not revoke them. We cannot assure you that the market price of our Common Shares will not decline after you elect to exercise your subscription rights. If you exercise your subscription rights and, afterwards, the public trading market price of our Common Shares decreases below the Subscription Price, you will have committed to buying our Common Shares at a price above the prevailing market price andinterest rates could have an immediate unrealized loss. Our Common Shares are tradedmaterial adverse effects on the NASDAQ Capital Market under the ticker symbol “MFNC,”net interest margin and the last reported sales priceresults of our Common Shares on the NASDAQ Capital Market on [    ·    ], 2012, was $[    ·    ] per share. Moreover, we cannot assure you that following the exercise of your subscription rights you will be able to sell your Common Shares at a price equal to or greater than the Subscription Price. Until shares are delivered upon expiration of the rights offering, you will not be able to sell the Common Shares that you purchase in the rights offering.operations.

 

If you dothe allowance for loan losses is not fully exercise your subscription rights, your ownership interest will be diluted.sufficient to cover actual loan losses, Mackinac’s earnings could decrease.

 

Assuming we sellMackinac’s success depends to a significant extent upon the full offering amount,quality of its assets, particularly loans. In originating loans, there is a substantial likelihood that credit losses will be experienced. The risk of loss will vary with, among other things, general economic conditions, the rights offeringtype of loan being made, the creditworthiness of the borrower over the term of the loan and, SCI Investment will result in our issuancethe case of approximately 2,248,337a collateralized loan, the quality of our Common Shares. If you choosethe collateral for the loan.

Mackinac’s loan customers may not to fully exercise your subscription rights priorrepay their loans according to the expirationterms of these loans, and the collateral securing the payment of these loans may be insufficient to assure repayment. As a result, Mackinac may experience significant loan losses, which could have a material adverse effect on operating results. Management makes various assumptions and judgments about the collectability of the rights offering, your relative ownership interestloan portfolio, including the creditworthiness of borrowers and the value of the real estate and other assets serving as collateral for the repayment of many of Mackinac’s loans. An allowance for loan losses is maintained in our Common Shares willan attempt to cover any loan losses that may occur. In determining the size of the allowance, management relies on an analysis of the loan portfolio based on historical loss experience, volume and types of loans, trends in classification, volume and trends in delinquencies and non-accruals, national and local economic conditions and other pertinent information. The determination of the size of the allowance could be diluted.understated due to deviations in one or more of these factors.

If assumptions are wrong, the current allowance may not be sufficient to cover future loan losses, and adjustments may be necessary to allow for different economic conditions or adverse developments in Mackinac’s loan portfolio. Material additions to the allowance would materially decrease net income.

In addition, federal and state regulators periodically review the allowance for loan losses and may require Mackinac to increase its provision for loan losses or recognize further loan charge-offs, based on judgments different than those of management. Any increase in the allowance for loan losses or loan charge-offs as required by these regulatory agencies could have a negative effect on Mackinac’s operating results.

 

The subscription rights areMackinac may need to raise additional capital in the future, but that capital may not transferable, and therebe available when it is no market for the subscription rights.needed.

 

YouMackinac is required by federal and state regulatory authorities to maintain adequate levels of capital to support its operations. Management may not sell, transfer or assign your subscription rights. The subscription rights are only transferable by operationat some point in the future need to raise additional capital to support its business as a result of law. Because the subscription rights are non-transferable, there is no marketgrowth losses or other meansdevelopment. Its ability to raise additional capital, if needed, will depend on conditions in the capital markets at that time, which are outside the control of management, and on Mackinac’s financial performance. Accordingly, Mackinac cannot assure you of its ability to raise additional capital if needed on terms acceptable to management. If additional capital cannot be raised when needed, Mackinac’s ability to further expand its operations through internal growth and to operate its business could be materially impaired.

If Mackinac is unable to increase its share of deposits in the markets that its banks operate within, it may accept out-of-market and brokered deposits, the costs of which may be higher than expected.

Mackinac’s management can offer no assurance that it will be able to maintain or increase Mackinac’s market share of deposits in its highly competitive service areas. If unable to do so, it may be forced to accept increased amounts of out-of-market or brokered deposits. As of December 31, 2017, Mackinac had approximately $175.3 million in out of market brokered deposits, which represented approximately 21.4% of total deposits. At times, the cost of out-of-market and brokered deposits exceeds the cost of deposits in the local market. In addition, the cost of out-of-market and brokered deposits can be volatile, and if Mackinac is unable to access these markets, or if its costs related to out of market and brokered deposits increase, its liquidity and ability to support demand for youloans could be adversely affected.

Volatility and disruptions in global capital and credit markets may adversely impact Mackinac’s business, financial condition and results of operations.

Even though Mackinac operates in a distinct geographic region in the U.S., it is impacted by global capital and credit markets, which are sometimes subject to directly realize any value associated withperiods of extreme volatility and disruption. Disruptions, uncertainty or volatility in the subscription rights. You must exercise the subscription rightscapital and acquire additional Common Sharescredit markets may limit Mackinac’s ability to realize any potential value from your subscription rights.access capital and manage liquidity, which may adversely affect Mackinac’s business, financial condition and results of operations. Further, Mackinac’s customers may be adversely impacted by such conditions, which could have a negative impact on Mackinac’s business, financial condition and results of operations.

 

The Subscription Price determined for the rights offeringMackinac is not an indication of the fair value of our Common Shares.subject to extensive regulation that could limit or restrict its activities.

 

In determiningMackinac operates in a highly regulated industry and is subject to examination, supervision and comprehensive regulation by various federal and state agencies. Compliance with these regulations is costly and restricts certain activities, including payment of dividends, mergers and acquisitions, investments, loans and interest rates charged, interest rates paid on deposits and locations of offices. Mackinac is also subject to capitalization guidelines established by its regulators, which require it to maintain adequate capital to support its growth.

Mackinac’s business also is subject to laws, rules and regulations regarding the Subscription Price,disclosure of non-public information about its customers to non-affiliated third parties. Internet operations are not currently subject to direct regulation by any government agency in the board of directors considered aUnited States beyond regulations applicable to businesses generally. A number of factors,legislative and regulatory proposals currently under consideration by federal, state and local governmental organizations may lead to laws or regulations concerning various aspects of Mackinac’s business on the Internet, including: the price at which our shareholders might be willing to participateuser privacy, taxation, content, access charges, liability for third-party activities and jurisdiction. The adoption of new laws or a change in the rights offering, historicalapplication of existing laws may decrease the use of the Internet, increase costs or otherwise adversely affect Mackinac’s business.

In particular, Congress and current trading prices for our Common Shares,other regulators have increased their focus on the price at which SCI was willing to participateregulation of the financial services industry in recent years. While recent changes in the SCI Investment, historicalexecutive branch may mitigate this impact, the effects on Mackinac of recent legislation and current trading prices for our Common Sharesregulatory actions cannot reliably be fully determined at this time. Moreover, as some of the legislation and regulatory actions previously implemented in response to the desire to provide an opportunity to our shareholders to participaterecent financial crisis expire, the impact of the conclusion of these programs on the financial sector and on the economic recovery is unknown. Any delay in the rights offeringeconomic recovery or a worsening of current financial market conditions could adversely affect Mackinac. Mackinac can neither predict when or whether future regulatory or legislative reforms will be enacted nor what their contents will be. The impact of any future legislation or regulatory actions on a pro rata basis.  Mackinac’s businesses or operations cannot be determined at this time, and such impact may adversely affect Mackinac.

The per share Subscription Price is not necessarily relatedlaws and regulations applicable to our book value, net worththe banking industry could change at any time, and management cannot predict the effects of these changes on Mackinac’s business and profitability. Additionally, Mackinac cannot predict the effect of any legislation that may be passed at the state or any other established criteriafederal level in response to the recent deterioration of fair valuethe subprime, mortgage, credit and may or may not be consideredliquidity markets. Because government regulation greatly affects the fair valuebusiness and financial results of our Common Sharesall commercial banks and bank holding companies, the cost of compliance could adversely affect Mackinac’s ability to be offered in the rights offering. After the date of this prospectus, our Common Shares may trade at prices above or below the Subscription Price.operate profitably.

 

14Mackinac’s financial condition and results of operations are reported in accordance with accounting principles generally accepted in the United States (“GAAP”). While not impacting economic results, future changes in accounting principles issued by the Financial Accounting Standards Board could impact Mackinac’s earnings as reported under GAAP. As a public company, Mackinac is also subject to the corporate governance standards set forth in the Sarbanes-Oxley Act of 2002, as well as applicable rules and regulations promulgated by the SEC. Complying with these standards, rules and regulations has and continues to impose administrative costs and burdens on the company.



TableAdditionally, political conditions could impact Mackinac’s earnings. Acts or threats of Contentswar or terrorism, as well as actions taken by the United States or other governments in response to such acts or threats, could impact the business and economic conditions in which it operates.

 

WeMackinac may cancelmake or be required to make further increases in its provision for loan losses and to charge off additional loans in the rights offering at any time prior tofuture, which could adversely affect the expirationresults of the rights offering, and neither we nor the subscription agent will have any obligation to you except to return your subscription payments.operations.

 

We may,As a result of changes in our sole discretion, decide notbalances and composition of Mackinac’s loan portfolio, changes in economic and market conditions that occur from time to continue withtime and other factors specific to a borrower’s circumstances, the rights offeringlevel of non-performing assets will fluctuate. Increased non-performing assets, credit losses or to cancel the rights offering prior to the expirationprovision for loan losses would materially adversely affect Mackinac’s financial condition and results of the rights offering. If the rights offering is cancelled, all subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable.operations.

 

If you do not act promptly and follow the subscription instructions, your exercise of subscription rights will be rejected.Mackinac’s adjustable-rate loans may expose it to increased default risks.

 

Shareholders who desireWhile adjustable-rate loans better offset the adverse effects of an increase in interest rates as compared to purchase sharesfixed-rate loans, the increased payments required of adjustable-rate loan borrowers upon an interest rate adjustment in the rights offering must act promptly to ensure that all required formsa rising interest rate environment could cause an increase in delinquencies and payments are actually received by the subscription agent prior to the expirationdefaults. The marketability of the rights offering at 5:00 p.m., Eastern Time, on [    ·    ], 2012. If you areunderlying property may also be adversely affected in a beneficial owner of shares, you must act promptlyrising interest rate environment. In addition, although adjustable-rate loans help make Mackinac’s asset base more responsive to ensure that your broker, dealer, custodian bank or other nominee acts for you, and that all required forms and payments are actually received by the subscription agent prior to the expiration of the rights offering. We are not responsible if your broker, dealer, custodian bank or nominee fails to ensure that all required forms and payments are actually received by the subscription agent prior to the expiration of the rights offering. If you fail to complete and sign the required subscription forms, send an incorrect payment amount or otherwise fail to follow the subscription procedures that apply to your exercisechanges in the rights offering prior to the expiration of the rights offering, the subscription agent may, depending on the circumstances, reject your subscription or accept it only tointerest rates, the extent of this interest sensitivity is limited by the payment received. Neither we nor the subscription agent will undertake to contact you concerning an incomplete or incorrect subscription form or payment, nor are we under any obligation to correct such forms or payment. We have the sole discretion to determine whether a subscription exercise properly complies with the subscription procedures.annual and lifetime interest rate adjustment limits.

 

As a result of the SCI Investment, SCI will become a substantial holder of our Common Shares.Changing interest rates may decrease Mackinac’s earnings and asset values.

 

UponManagement is unable to accurately predict future market interest rates, which are affected by many factors, including, but not limited to, inflation, recession, changes in employment levels, changes in the completionmoney supply and domestic and international disorder and instability in domestic and foreign financial markets. Changes in the interest rate environment may reduce Mackinac’s profits. Net interest income is a significant component of its net income and consists of the SCI Investment, SCI will become a holderdifference, or spread, between interest income generated on interest-earning assets and interest expense incurred on interest-bearing liabilities. Net interest spreads are affected by the difference between the maturities and repricing characteristics of either approximately 9.9% of our outstanding Common Shares (assuming no Federal Reserve Approval of SCI’s application to acquire in excess of 9.9% of our outstanding Common Shares) or 19.9% of our outstanding Common Sharesinterest-earning assets and will have a representative on both the Corporation’sinterest-bearing liabilities. Although certain interest-earning assets and the Bank’s board of directors. Although SCI has entered into certain passivity agreements with the Federal Reserve Board in connection with their investments in us, SCI will have a substantial influence over our corporate policy and business strategy. In pursuing its economic interests, SCIinterest-bearing liabilities may have interestssimilar maturities or periods in which they reprice, they may react in different degrees to changes in market interest rates. In addition, residential mortgage loan origination volumes are affected by market interest rates on loans; rising interest rates generally are associated with a lower volume of loan originations, while falling interest rates are usually associated with higher loan originations. Mackinac’s ability to generate gains on sales of mortgage loans is significantly dependent on the level of originations. Cash flows are affected by changes in market interest rates. Generally, in rising interest rate environments, loan prepayment rates are likely to decline, and in falling interest rate environments, loan prepayment rates are likely to increase. A majority of Mackinac’s commercial, commercial real estate and multi-family residential real estate loans are adjustable rate loans and an increase in the general level of interest rates may adversely affect the ability of some borrowers to pay the interest on and principal of their obligations, especially borrowers with loans that are different fromhave adjustable rates of interest. Changes in interest rates, prepayment speeds and other factors may also cause the interestsvalue of our other shareholders.loans held for sale to change. Accordingly, changes in levels of market interest rates could materially and adversely affect Mackinac’s net interest spread, loan volume, asset quality, value of loans held for sale and cash flows, as well as the market value of its securities portfolio and overall profitability.

 

OurMackinac faces strong competition from other financial institutions, financial services companies and other organizations offering services similar to those offered by it, which could result in Mackinac not being able to sustain or grow its loan and deposit businesses.

Mackinac conducts its business operations primarily in the State of Michigan, and more recently, Northeastern Wisconsin. Increased competition within these markets may result in reduced loan originations and deposits. Ultimately, Mackinac may not be able to compete successfully against current and future competitors. Many competitors offer the types of loans and banking services that it offers. These competitors include other savings associations, community banks, regional banks and money center banks. Mackinac also faces competition

from many other types of financial institutions, including finance companies, brokerage firms, insurance companies, credit unions, mortgage banks and other financial intermediaries. Mackinac’s competitors with greater resources may have a marketplace advantage enabling them to maintain numerous banking locations and mount extensive promotional and advertising campaigns.

Additionally, financial intermediaries not subject to bank regulatory restrictions and banks and other financial institutions with larger capitalization have larger lending limits and are thereby able to serve the credit needs of larger clients. These institutions, particularly to the extent they are more diversified than Mackinac is, may be able to offer the same loan products and services that Mackinac offers at more competitive rates and prices. If Mackinac is unable to attract and retain banking clients, it may be unable to sustain current loan and deposit levels or increase its loan and deposit levels, and its business, financial condition and future prospects may be negatively affected.

Mackinac’s ability to use net operating loss carryovers to reduce future tax payments may be limited or restricted.

 

As of December 31, 2011, we have2017, Mackinac had net operating loss (NOLs”NOL”) carry-forwardscarryforwards of approximately $26.7$7.5 million. WeMackinac is generally are able to carry NOLs forward to reduce taxable income in future years. However, ourits ability to utilize the NOLsits NOL carryforwards is subject to the rules of Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”).Code. Section 382 of the Code generally restricts the use of NOLsNOL carryforwards after an “ownership change.” An ownership change occurs if, among other things, the shareholders (or specified groups of shareholders) who own or have owned, directly or indirectly, 5% or more of a corporation’s common shares, or are otherwise treated as 5% shareholders under Section 382 of the Code and the Treasury regulations promulgated thereunder, increase their aggregate percentage ownership of that corporation’s shares by more than fifty (50) percentage points over the lowest percentage of the shares owned by these shareholders over a three (3)-year rolling period. In the event of an ownership change, Section 382 of the Code imposes an annual limitation on the amount of taxable income a corporation may offset with its pre-ownership change NOL carry forwards. This annual limitation is generally equal to the product of the value of the corporation’s shares on the date ofimmediately before the ownership change multiplied by the long-term tax-exempt rate published monthly byin effect for the United States Internal Revenue Service (“IRS”).month in which the ownership change occurs. Any unused annual limitation may be carried over to later years until the applicable expiration date for the respective NOL carry forwards.carryforwards.

 

We do not anticipate that our recapitalization, includingAs of December 31, 2017, Mackinac had tax credit carryforwards of approximately $1.7 million. Mackinac is generally able to carry tax credits forward to reduce taxes in future years. However, Mackinac’s ability to utilize the SCI Investment,tax credit carryforwards is subject to the redemption of the TARP Securities and this rights offering will cause an “ownership change” within the meaningrules of Section 382383 of the Code. However, weSection 383 of the Code imposes a comparable and related set of rules for limiting the use of capital loss and tax credit carry-forwards in the event of an ownership change.

Management cannot ensure that ourMackinac’s ability to use our NOLsits NOL carryforwards to offset taxable income or its tax credit carryforwards to offset tax will not become limited in the future. As a result, weMackinac could pay taxes earlier and in larger amounts than would be the case if our NOLsits NOL and tax credit carryforwards were available to reduce ourits federal income taxes without restriction.

 

Risks RelatedMackinac may not be able to Our Common Shares

Our abilityutilize technology to pay dividends is limited,efficiently and we may be unableeffectively develop, market, and deliver new products and services to pay future dividends without the prior written consent of the Federal Reserve.its customers.

 

Substantially allThe financial services industry experiences rapid technological change with regular introductions of our activities are conducted through the Bank,new technology-driven products and consequently, as the parent companyservices. The efficient and effective utilization of the Bank, we receive substantially all of our revenue as dividends from the Bank. Ourtechnology enables financial institutions to better serve customers and to reduce costs. Mackinac’s future success depends, in part, upon its ability to pay dividends is limitedaddress the needs of its customers by using technology to market and deliver products and services that will satisfy customer demands, meet regulatory restrictionsrequirements, and the needcreate additional efficiencies in its operations. Mackinac may not be able to maintain sufficient consolidated capital. The ability of our banking subsidiaryeffectively develop new technology-driven products and services or be successful in marketing or supporting these products and services to pay dividends to us is limited by its

15



Table of Contents

obligations to maintain sufficient capital and by other general restrictions customers, which could have a material adverse impact on its dividends that are applicable to banks that are regulated by the Federal Deposit Insurance Corporation, or FDIC. As further described below, until we repurchase the TARP Securities, we are prohibited from paying dividends on our Common Shares without prior regulatory approval.financial condition and results of operations.

We may issue additional Common Shares in the future, which would dilute your ownership if you did not,Operational difficulties, failure of technology infrastructure or were not permitted to, invest in the additional issuances.information security incidents could adversely affect Mackinac’s business and operations.

 

Our ArticlesMackinac is exposed to many types of Incorporation authorize our boardoperational risk, including reputational risk, legal and compliance risk, the risk of directors, without shareholder approval, to, among other things, issue additional Common Shares in connection with future equity offerings, convertiblefraud or debt offeringstheft by employees or outsiders, failure of its controls and acquisitions of securitiesprocedures and unauthorized transactions by employees or assets of other companies.operational errors, including clerical or recordkeeping errors or those resulting from computer or telecommunications systems malfunctions. Given the current market conditionshigh volume of transactions Mackinac processes, certain errors may be repeated or compounded before they are identified and overall economy, we expect to issue additional equityresolved. In particular, Mackinac’s operations rely on the secure processing, storage and convertible debt securities to raise additional capital to support our business. The issuancetransmission of any additional Common Sharesconfidential and other information on its technology systems and networks. Any failure, interruption or convertible securitiesbreach in security of these systems could be substantially dilutive to holders of our Common Shares if they do not investresult in future offerings. Moreover, to the extent that we issue restricted stock units, stock appreciation rights, optionsfailures or warrants to purchase our Common Sharesdisruptions in the future,its customer relationship management, general ledger, deposit, loan and those stock appreciation rights, options or warrants are exercised or as the restricted stock units vest, our shareholders may experience further dilution. Holders of our Common Shares have no preemptive rights that entitle them to purchase their pro rata share of any offering of shares of any class or series and, therefore, our shareholders may not be permitted to invest in future issuances of our Common Shares and, as a result, will be diluted.other systems.

 

Our Common SharesMackinac also faces the risk of operational disruption, failure or capacity constraints due to its dependency on third party vendors for components of its business infrastructure, including its core data processing systems which are equity and therefore are subordinate to our indebtedness and preferred shares.

Our Common Shares are equity interests in the Corporation and dolargely outsourced. While Mackinac has selected these third party vendors carefully, it does not constitute indebtedness.control their operations. As such, our Common Shares will rank junior to all indebtedness and other non-equity claimsany failure on the Corporation with respectpart of these business partners to assets available to satisfy claims on the Corporation, including in a liquidation of the Corporation. Additionally, holders of our Common Shares are subject to the prior dividendperform their various responsibilities could also adversely affect Mackinac’s business and liquidation rights of any holders of our preferred shares then outstanding.

Because of our participation in the Treasury’s Capital Purchase Program, we are subject to several restrictions, including restrictions on our ability to declare or pay dividends and repurchase our shares.

Under the terms of the preferred shares we issued to the U.S. Department of the Treasury (the “Treasury”) in connection with our participation in its Capital Purchase Program, we are required to receive prior consent from the Treasury for any increase during the three (3) year period beginning April 24, 2009, in the payment of dividends by the Corporation. During such time period, we are also restricted, with certain limited exceptions, from repurchasing our common stock.  If we are unable to repurchase the TARP Securities, such restrictions will remain in effect, and the Company will not proceed with closing the SCI Investment or issuing the Common Shares that are the subject of the Rights Offering.

We may issue debt and equity securities or securities convertible into equity securities which are senior to our Common Shares as to distributions and in liquidation, which could negatively affect the value of our Common Shares.

In the future, we may attempt to increase our capital resources by entering into debt or debt-like financing that is unsecured or secured by all or up to all of our assets, or by issuing debt or equity securities, which could include issuances of secured or unsecured commercial paper, medium-term notes, senior notes, subordinated notes, Common Shares or securities convertible into Common Shares. In the event of our liquidation, our lenders and holders of our debt securities would receive a distribution of our available assets before distributions to the holders of our Common Shares. Because our decision to incur debt and issue securities in our future offerings will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings and debt financings. Further, market conditions could require us to accept less favorable terms for the issuance of our securities in the future.

Risks Related to Our Business

We make and hold in our portfolio a significant number of loans to the hospitality and tourism industry; a downturn in these industries would disproportionately affect us versus our competitors.

On an historical basis, our highest concentration of credit risk was the hospitality and tourism industry.  Although we do not consider the current loan concentrations in hospitality and tourism to be problematic and have no intention of further reducing loans to this industry segment, a downturn in these segments would disproportionately affect our results as compared to other financial institutions.

16



Table of Contents

Our net interest income could be negatively affected by interest rate adjustments by the Federal Reserve, as well as by competition in our primary market area.

As a financial institution, our earnings are significantly dependent upon our net interest income, which is the difference between the interest income that we earn on interest-earning assets, such as investment securities and loans, and the interest expense that we pay on interest-bearing liabilities, such as deposits and borrowings. Therefore, any change in general market interest rates, including changes resulting from changes in the Federal Reserve’s fiscal and monetary policies, affects us more than non-financial institutions and can have a significant effect on our net interest income and total income. Our assets and liabilities may react differently to changes in overall market rates or conditions because there may be mismatches between the repricing or maturity characteristics of the assets and liabilities. As a result, an increase or decrease in market interest rates could have material adverse effects on our net interest margin and results of operations.

 

If our allowanceMackinac may also be subject to disruptions of its operating systems arising from events that are wholly or partially beyond its control, which may include, for loan losses is not sufficientexample, computer viruses, cyberattacks, spikes in transaction volume and/or customer activity, electrical or telecommunications outages, or natural disasters. Although Mackinac has programs in place related to cover actual loan losses, our earnings could decrease.business continuity, disaster recovery and information security to maintain the confidentiality, integrity, and availability of its systems, business applications and customer information, such disruptions may give rise to interruptions in service to customers and loss or liability to Mackinac.

 

Our success dependsThe occurrence of any failure or interruption in Mackinac’s operations or information systems, or any security breach, could cause reputational damage, jeopardize the confidentiality of customer information, result in a loss of customer business, subject Mackinac to a significant extent upon the qualityregulatory intervention or expose it to civil litigation and financial loss or liability, any of our assets, particularly loans. In originating loans, there is a substantial likelihood that credit losses will be experienced. The risk of loss will vary with, among other things, general economic conditions, the type of loan being made, the creditworthiness of the borrower over the term of the loan and, in the case of a collateralized loan, the quality of the collateral for the loan.

Our loan customers may not repay their loans according to the terms of these loans, and the collateral securing the payment of these loans may be insufficient to assure repayment. As a result, we may experience significant loan losses, which could have a material adverse effect on our operating results. Management makes various assumptionsMackinac.

Changes in customer behavior may adversely impact Mackinac’s business, financial condition and judgments about the collectabilityresults of our loan portfolio, including the creditworthinessoperations.

Mackinac uses a variety of our borrowersmethods to anticipate customer behavior as a part of its strategic planning and the value of the real estate and other assets serving as collateral for the repayment of many of our loans. We maintain an allowance for loan losses in an attempt to cover any loan losses that may occur. In determining the size of the allowance, we rely on an analysis of our loan portfolio based on historical loss experience, volume and types of loans, trends in classification, volume and trends in delinquencies and non-accruals, national and localmeet certain regulatory requirements. Individual, economic, political, industry-specific conditions and other pertinent information. Our determinationfactors outside of its control, such as fuel prices, energy costs, real estate values or other factors that affect customer income levels, could alter predicted customer borrowing, repayment, investment and deposit practices. Such a change in these practices could materially adversely affect Mackinac’s ability to anticipate business needs and meet regulatory requirements.

Further, difficult economic conditions may negatively affect consumer confidence levels. A decrease in consumer confidence levels would likely aggravate the sizeadverse effects of these difficult market conditions on Mackinac, its customers and others in the allowancefinancial institutions industry.

Mackinac’s ability to maintain and expand customer relationships may differ from expectations.

The financial services industry is very competitive. Mackinac not only vies for business opportunities with new customers, but also competes to maintain and expand the relationships it has with its existing customers. While Mackinac believes that it can continue to grow many of these relationships, Mackinac will continue to experience pressures to maintain these relationships as its competitors attempt to capture its customers. Failure to create new customer relationships and to maintain and expand existing customer relationships to the extent anticipated may adversely impact Mackinac’s earnings.

The trading price of Mackinac’s common stock may be subject to significant fluctuations and volatility.

The market price of Mackinac’s common stock could be understatedsubject to significant fluctuations due to, deviationsamong other things:

·                  variations in quarterly or annual results of operations;

·                  changes in dividends per share;

·                  deterioration in asset quality, including declining real estate values;

·                  changes in interest rates;

·                  significant acquisitions or business combinations, strategic partnerships, joint ventures, or capital commitments by or involving Mackinac or its competitors;

·                  regulatory actions, including changes to regulatory capital levels, the components of regulatory capital and how regulatory capital is calculated;

·                  new regulations that limit or significantly change Mackinac’s ability to continue to offer products or services;

·                  volatility of stock market prices and volumes;

·                  issuance of additional shares of common stock or other debt or equity securities;

·                  changes in market valuations of similar companies;

·                  changes in securities analysts’ estimates of financial performance or recommendations;

·                  perceptions in the marketplace regarding the financial services industry, Mackinac and/or its competitors; and/or

·                  the occurrence of any one or more of these factors.the risk factors described above.

 

If our assumptions are wrong, our current allowance may not be sufficient to cover future loan losses, and adjustments may be necessary to allow for different economic conditions or adverse developments in our loan portfolio. Material additions to our allowance would materially decrease our net income. In 2010 and 2011, because of the economic downturn, we incurred higher levels of charge-offs. These elevated levels of charge-offs, along with an increase in non-performing loans required us to increase our loan loss provision to restore the level of our allowance for loan losses. We expect to continue to addRisks Related to the allowance during the remainder of 2012, however, we can make no assurance that our allowance will be adequate to cover future loan losses given current and future market conditions.

In addition, federal and state regulators periodically review our allowance for loan losses and may require us to increase our provision for loan losses or recognize further loan charge-offs, based on judgments different than those of our management. Any increase in our allowance for loan losses or loan charge-offs as required by these regulatory agencies could have a negative effect on our operating results.Securities Being Offered

 

There may be no established trading market for some of the securities being offered, and this could make selling such securities difficult and also impact the price of such securities.

Other than our common stock, there may be no established trading market for the securities offered by this prospectus. Some of the securities may not be listed on any securities exchange or included in any automated quotation system. We cannot assure you that an active trading market for such securities will develop or, if such market develops, that you will be able to sell such securities. If a trading market does not develop or is not maintained, holders of the securities may experience difficulty in reselling, or an inability to sell, such securities. As a result, the liquidity of such securities may be limited and, under certain circumstances, nonexistent. If a market does develop, any such market may be discontinued at any time.

The liquidity of, pricing of and trading market for the securities, including our common stock, may be adversely affected by, among other things, changes in the overall markets for equity securities, changes in our financial performance and prospects, the prospects in general for companies in our industry, the number of holders of the various securities, the interest of securities dealers in making a market in the securities, adverse credit rating actions and prevailing interest rates.

The offering price of the securities being offered may not be an indication of the fair value of and market terms for those securities.

The price of the securities sold in any offering may not indicate the market price for those securities after the offering is completed or at any future time. The offering price of the securities will be determined by our board of directors based on a number of factors, including the price at which investors will be willing to purchase the securities, the Corporation’s operating history and prospects, the Corporation’s current performance, the prospects of the banking industry in which the Corporation competes, and the general condition of the securities market at the time of the offering. You should not consider the offering price as an indication of the fair value of the securities.

We have broad discretion in allocating the proposed net proceeds from this offering, and, in using our discretion, we may not apply them in the most effective manner.

We intend to use the net proceeds from any offering of securities to provide additional capital for general corporate purposes, including but not limited to supporting the assets and operations of our subsidiary bank. However, we will have significant flexibility in applying the net proceeds of any such offering. Our failure to apply such funds effectively could have a material adverse effect on our business and on your investment.

Mackinac may need to raise additional capital in the future but that capital may not be available when it is needed.needed or may be dilutive to our shareholders.

 

We are required by federal and state regulatory authorities to maintain adequate capital levels of capital to support our operations. Following this rights offering,In order to support our operations and comply with regulatory standards, we may at some point need to raise additional capital to support our business as a result of our losses.in the future. Our ability to raise additional capital if needed, will depend on conditions in the capital markets at that time, which are outside our control, and on our financial performance. Accordingly, we cannot assure you of our ability to raise additional capital, if needed, on terms acceptablefavorable terms. In some cases, volatility in markets has produced downward pressure on stock prices and credit availability for certain issuers without regard to us.those issuers’ underlying financial strength. If volatility increases, our ability to raise additional capital may be disrupted. If we cannot raise additional capital when needed, our abilityresults of operations and financial condition may be adversely affected, and our banking regulators may subject us to further expand our operations through internal growth and to operate our business could be materially impaired.

Our deposit insurance premium could be substantially higher in the future, which could have a material adverse effect on our future earnings.

The FDIC insures deposits at the Bank and at other financial institutions. The FDIC charges insured financial institutions premiums to maintain the Deposit Insurance Fund at a certain level. Current economic conditions have caused bank failures and expectations for additional bank failures, in which case the FDIC, through the Deposit Insurance Fund, ensures payments of customer deposits at failed banks up to insured limits.regulatory enforcement action, including receivership. In addition, deposit insurance limits on customer deposit accounts have generally increased to $250,000 from $100,000, and the FDIC adoptedissuance of additional shares of our equity securities will dilute the Temporary Liquidity Guarantee Program (the “TLGP”) for noninterest-bearing transaction deposit accounts. These developments will cause the premiums assessed by the FDIC to increase and

17



Tableeconomic ownership interest of Contents

will materially increase our noninterest expense. An increase in the risk category of the Bank would also cause our premiums to increase. Whether through adjustments to base deposit insurance assessment rates, significant special assessments or emergency assessments under the TLGP, increased deposit insurance premiums could have a material adverse effect on our earnings.common shareholders.

 

If wethere are unable to increasesales of substantial amounts of our sharecommon stock in the future, the price of deposits in our market, we may accept out of market and brokered deposits, the costs of which may be higher than expected.common stock could decline.

 

We can offer no assurance that we will be able to maintain or increaseOther than certain shares held by our market shareaffiliates, all of deposits in our highly competitive service area. If weoutstanding shares of common stock are unable to do so, we may be forced to accept increasedavailable for immediate sale. Sales of substantial amounts of out ofour common stock, or the perception that such sales could occur, could adversely affect prevailing market or brokered deposits. As of [    ·    ], we had approximately $[    ·    ] million in out of market deposits, including brokered deposits, which represented approximately [    ·    ] %prices of our total deposits. At times, the cost of out of market and brokered deposits exceeds the cost of deposits in our local market. In addition, the cost of out of market and brokered deposits can be volatile, and if we are unable to access these markets, or if our costs related to out of market and brokered deposits increases, our liquidity and ability to support demand for loans could be adversely affected.common stock.

 

We are subject to extensive regulation that could limit or restrict our activities.

We operate in a highly regulated industry and are subject to examination, supervision and comprehensive regulation by various federal and state agencies. Our compliance with these regulations is costly and restricts certain of our activities, including payment of dividends, mergers and acquisitions, investments, loans and interest rates charged, interest rates paid on deposits and locations of offices. We are also subject to capitalization guidelines established by our regulators, which require us to maintain adequate capital to support our growth.

Our business also is subject to laws, rules and regulations regarding the disclosure of non-public information about our customers to non-affiliated third parties. Our operations on the InternetMackinac’s securities are not currently subject to direct regulation by any government agency in the United States beyond regulations applicable to businesses generally. A number of legislative and regulatory proposals currently under consideration by federal, state and local governmental organizations may lead to laws or regulations concerning various aspects of our business on the Internet, including: user privacy, taxation, content, access charges, liability for third-party activities and jurisdiction. The adoption of new laws or a change in the application of existing laws may decrease the use of the Internet, increase our costs or otherwise adversely affect our business.

The laws and regulations applicable to the banking industry could change at any time, and we cannot predict the effects of these changes on our business and profitability. Additionally, we cannot predict the effect of any legislation that may be passed at the state or federal level in response to the recent deterioration of the subprime, mortgage, credit and liquidity markets. Because government regulation greatly affects the business and financial results of all commercial banks and bank holding companies, our cost of compliance could adversely affect our ability to operate profitably.

Our financial condition and results of operations are reported in accordance with accounting principles generally accepted in the United States (“GAAP”). While not impacting economic results, future changes in accounting principles issued by the Financial Accounting Standards Board could impact our earnings as reported under GAAP. As a public company, we are also subject to the corporate governance standards set forth in the Sarbanes-Oxley Act of 2002, as well as applicable rules and regulations promulgated by the SEC. Complying with these standards, rules and regulations has and continues to impose administrative costs and burdens on us.

Additionally, political conditions could impact our earnings. Acts or threats of war or terrorism, as well as actions taken by the United States or other governments in response to such acts or threats, could impact the business and economic conditions in which we operate.

We are subject to executive compensation restrictions because of our participation in the Treasury’s TARP Capital Purchase Program.

We are subject to TARP rules and standards governing executive compensation, which generally apply to our Chief Executive Officer, Chief Financial Officer and the three (3) next most highly compensated senior executive officers and, with recent amendments, apply to a number of other employees. The standards include (i) a requirement to recover any bonus payment to senior executive officers or certain other employees if payment was based on materially inaccurate financial statements or performance metric criteria; (ii) a prohibition on making any golden parachute payments to senior executive officers and certain other employees; (iii) a prohibition on paying or accruing any bonus payment to certain employees, except as otherwise permitted by the rules; (iv) a prohibition on maintaining any plan for senior executive officers that encourages such officers to take unnecessary and excessive risks that threaten the Corporation’s value; (v) a prohibition on maintaining any employee compensation plan that encourages the

18



Table of Contents

manipulation of reported earnings to enhance the compensation of any employee; and (vi) a prohibition on providing tax gross-ups to senior executive officers and certain other employees. These restrictions and standards could limit our ability to recruit and retain executives.  If we are unable to repurchase the TARP Securities, such restrictions will remain in effect.

A continuation of turmoil in the financial markets could have an adverse effect on our financial position or results of operations.

Since 2008, United States and global financial markets have experienced severe disruption and volatility, and general economic conditions have declined significantly. Adverse developments in credit quality, asset values and revenue opportunities throughout the financial services industry, as well as general uncertainty regarding the economic, industry and regulatory environment, have had a marked negative impact on the industry. Dramatic declines in the U.S. housing market, with falling home and real estate prices, increasing foreclosures and high unemployment, have negatively affected the credit performance of mortgage loans and resulted in significant write-downs of asset values by many financial institutions. The U.S. and the governments of other countries have taken steps to try to stabilize the financial system, including investing in financial institutions, and have also been working to design and implement programs to improve general economic conditions. Notwithstanding the actions of the U.S. and other governments, these efforts may not succeed in improving industry, economic or market conditions and may result in adverse unintended consequences. Factors that could continue to pressure financial services companies, including the Corporation, are numerous and include: (i) worsening credit quality, leading among other things to increases in loan losses and reserves; (ii) continued or worsening disruption and volatility in financial markets, leading to, among other things, continuing reductions in asset values; (iii) capital and liquidity concerns regarding financial institutions generally; (iv) limitations resulting from or imposed in connection with governmental actions intended to stabilize or provide additional regulation of the financial system; or (v) recessionary conditions that are deeper or last longer than currently anticipated.

The ongoing economic recession could result in increases in our level of nonperforming loans and/or reduce demand for our products and services, which would lead to lower revenue, higher loan losses and lower earnings.FDIC insured.

 

Our business activitiessecurities are not savings or deposit accounts or other obligations of our subsidiary bank, and earnings are affected by general business conditions in the U.S. and in our local market area. These conditions include short-term and long-term interest rates, inflation, unemployment levels, monetary supply, consumer confidence and spending, fluctuations in both debt and equity capital markets and the strength of the economy in the U.S. generally, and in our market area in particular. In the current low growth environment, the national economy has experienced a general economic downturn, with high unemployment levels, declines in real estate values and the erosion of consumer confidence. Our primary market area has also been negatively impactednot insured by the economic recession. In DecemberDeposit Insurance Fund, the FDIC or any other agency or private entity and are subject to investment risk, including the possible loss of 2011, the unemployment rate in Michigan was 9.3%, according to Bureausome or all of Labor Statistics data. In addition, our primary market area has also experienced a softening of the local real estate market, a reduction in local property values and a decline in the local manufacturing industry. A prolonged or more severe economic downturn, continued elevated levels of unemployment, further decline in the value of real estate or other events that affect our borrowers could impair the ability of our borrowers to repay their loans in accordance with their terms and could reduce the value of collateral securing these loans. Nearly all of our commercial real estate and consumer mortgage loans are secured by real estate located in Michigan. As a result of this concentration, a prolonged or more severe downturn in the state’s economy could result in significant increases in nonperforming loans, which would negatively impact our interest income and result in higher provisions for loan losses, which would decrease our earnings. The economic downturn could also result in reduced demand for credit or fee-based products and services, which would also decrease our revenues.your investment.

 

We may make or be required to make further increases in our provision for loan losses and to charge off additional loans in the future, which could adversely affect our results of operations.REGULATORY CONSIDERATIONS

As a result of changes in balances and composition of our loan portfolio, changes in economic and market conditions that occur from time to time and other factors specific to a borrower’s circumstances, the level of non-performing assets will fluctuate. Although we have made some progress in reducing our level of non-performing assets during 2011, we expect non-performing assets to remain at or increase to historically high levels for the immediate future. If current trends in the housing and real estate markets continue, we expect that we will continue to experience increased delinquencies and credit losses. Moreover, if the slow economy in our market continues, we expect that it would further negatively impact economic conditions, and we could experience continuing high delinquencies and credit losses. Current levels of, or an increase in, our non-performing assets, credit losses or our provision for loan losses would materially adversely affect our financial condition and results of operations. Unless and until we can increase our capital to support new lending and substantially reduce our levels of non-performing loans and other real estate owned, we do not expect to return to profitability.

Our adjustable-rate loans may expose us to increased lending risks.

While adjustable-rate loans better offset the adverse effects of an increase in interest rates as compared to fixed-rate loans, the increased payments required of adjustable-rate loan borrowers upon an interest rate adjustment in a rising interest rate environment

 

19



Table of Contents

could cause an increase in delinquencies and defaults. The marketability of the underlying property may also be adversely affected in a rising interest rate environment. In addition, although adjustable-rate loans help make our asset base more responsive to changes in interest rates, the extent of this interest sensitivity is limited by the annual and lifetime interest rate adjustment limits.

Increased and/or special FDIC assessments have and may continue to hurt our earnings.

Beginning in late 2008, the economic environment caused higher levels of bank failures, which dramatically increased FDIC resolution costs and led to a significant reduction in the deposit insurance fund. As a result, the FDIC has significantly increased the initial base assessment rates paid by financial institutions for deposit insurance. These increases in the base assessment rate have increased our deposit insurance costsregistered bank holding company, Mackinac is subject to regulation and negatively impacted our earnings.

Changing interest rates may decrease our earnings and asset values.

Management is unable to accurately predict future market interest rates, which are affected by many factors, including, but not limited to, inflation, recession, changes in employment levels, changes in the money supply and domestic and international disorder and instability in domestic and foreign financial markets. Changes in the interest rate environment may reduce our profits. Net interest income is a significant component of our net income and consists of the difference, or spread, between interest income generated on interest-earning assets and interest expense incurred on interest-bearing liabilities. Net interest spreads are affected by the difference between the maturities and repricing characteristics of interest-earning assets and interest-bearing liabilities. Although certain interest-earning assets and interest-bearing liabilities may have similar maturities or periods in which they reprice, they may react in different degrees to changes in market interest rates. In addition, residential mortgage loan origination volumes are affected by market interest rates on loans; rising interest rates generally are associated with a lower volume of loan originations, while falling interest rates are usually associated with higher loan originations. Our ability to generate gains on sales of mortgage loans is significantly dependent on the level of originations. Cash flows are affected by changes in market interest rates. Generally, in rising interest rate environments, loan prepayment rates are likely to decline, and in falling interest rate environments, loan prepayment rates are likely to increase. A majority of our commercial, commercial real estate and multi-family residential real estate loans are adjustable rate loans andan increase in the general level of interest rates may adversely affect the ability of some borrowers to pay the interest on and principal of their obligations, especially borrowers with loans that have adjustable rates of interest. Changes in interest rates, prepayment speeds and other factors may also cause the value of our loans held for sale to change. Accordingly, changes in levels of market interest rates could materially and adversely affect our net interest spread, loan volume, asset quality, value of loans held for sale and cash flows, as well as the market value of our securities portfolio and overall profitability.

Regulatory reform may have a material impact on our operations.

On July 21, 2010, President Obama signed into law the Dodd-Frank Act which could impact the performance of the Corporation and the Bank in future periods. The Dodd-Frank Act included numerous provisions intended to strengthen the financial industry, enhance consumer protection, expand disclosures and provide for transparency. Some of these provisions included changes to FDIC insurance coverage, which included a permanent increase in the coverage to $250,000 per depositor. Additional provisions created a Bureau of Consumer Financial Protection, which is authorized to write rules on all consumer financial products. Still other provisions created a Financial Stability Oversight Council, which is not only empowered to determine the entities that are systemically significant and therefore require more stringent regulations, but is also charged with reviewing, and when appropriate, submitting, comments to the SEC and Financial Accounting Standards Board with respect to existing or proposed accounting principles, standards or procedures. Further, the Dodd-Frank Act retained the thrift charter and merged the OTS, the former regulator of the Corporation and the Bank, into the Comptroller of the Currency, and the Corporation is now regulatedexamination by the Board of Governors of the Federal Reserve System. The aforementioned are only a few of the numerous provisions included in the Dodd-Frank Act. The overall impact of the entire Dodd-Frank Act will not be known until full implementation is completed, but the possibility of significant additional compliance costs exists, and the Dodd-Frank Act consequently may have a material adverse impact on our operations.

System (theWe face strong competition from other financial institutions, financial services companies and other organizations offering services similar to those offered by us, which could result in our not being able to sustain or grow our loan and deposit businesses.

We conduct our business operations primarily in the State of Michigan. Increased competition within this market may result in reduced loan originations and deposits. Ultimately, we may not be able to compete successfully against current and future competitors. Many competitors offer the types of loans and banking services that we offer. These competitors include other savings associations, community banks, regional banks and money center banks. We also face competition from many other types of financial institutions, including finance companies, brokerage firms, insurance companies, credit unions, mortgage banks and other financial intermediaries. Our competitors with greater resources may have a marketplace advantage enabling them to maintain numerous banking locations and mount extensive promotional and advertising campaigns.

20



Table of Contents

Additionally, financial intermediaries not subject to bank regulatory restrictions and banks and other financial institutions with larger capitalization have larger lending limits and are thereby able to serve the credit needs of larger clients. These institutions, particularly to the extent they are more diversified than we are, may be able to offer the same loan products and services that we offer at more competitive rates and prices. If we are unable to attract and retain banking clients, we may be unable to sustain current loan and deposit levels or increase our loan and deposit levels, and our business, financial condition and future prospects may be negatively affected.

OUR BUSINESS

General

The Corporation is a registered bank holding company formed under the Bank Holding Company Act of 1956.  The principal subsidiary of the Corporation is the Bank. Headquartered in Manistique, Michigan, the Bank has eleven (11) branch locations; seven (7) in the Upper Peninsula of the State of Michigan, three (3) in the Northern Lower Peninsula of the State of Michigan and one in Oakland County, Michigan.

Business and Operations

The principal business the Corporation is engaged in, through the Bank, is the general commercial banking business, providing a full range of loan and deposit products. These banking services include customary retail and commercial banking services, including checking and savings accounts, time deposits, interest bearing transaction accounts, safe deposit facilities, real estate mortgage lending, commercial lending, commercial and governmental lease financing, and direct and indirect consumer financing. Funds for the Bank’s operation are also provided by brokered deposits and through borrowings from the Federal Home Loan Bank (“FHLB” “Federal Reserve Board”) system, proceeds from the sale of loans and mortgage-backed and other securities, funds from repayment of outstanding loans and earnings from operations. Earnings depend primarily upon the difference between (i) revenues from loans, investments and other interest-bearing assets and (ii) expenses incurred in payment of interest on deposit accounts and borrowings, maintaining an adequate allowance for loan losses and general operating expenses.

The Bank makes mortgage, commercial and installment loans to customers throughout the State of Michigan. Fees may be charged for these services. The Bank’s most prominent concentration in its loan portfolio relates to real estate non-commercial loans to operators of nonresidential buildings. This concentration represented $75.391 million, or 24.22%, of the Bank’s commercial loan portfolio as of December 31, 2011. The Bank also supports the service industry, particularly hospitality and related businesses, as well as gaming, forestry, restaurants, farming, fishing and many other activities important to growth in Michigan. The economy of the Bank’s market areas is affected by summer and winter tourism activities.

The Bank also offers various consumer loan products including installment, mortgage and home equity loans. In addition to making consumer portfolio loans, the Bank engages in the business of making residential mortgage loans for sale to the secondary market.

The Bank’s primary source for lending, investments and other general business purposes is deposits. The Bank offers a wide range of interest bearing and non-interest bearing accounts, including commercial and retail checking accounts, negotiable order of withdrawal accounts, money market accounts with limited transactions, individual retirement accounts, regular interest bearing statement savings accounts, certificates of deposit with a range of maturity date options and accessibility to a customer’s deposit relationship through online banking. The sources of deposits are residents, businesses and employees of businesses within the Bank’s market areas, as well as those obtained through the personal solicitation of the Bank’s officers and directors, direct mail solicitation and limited advertisements published in the local media. The Bank also utilizes the wholesale deposit market for any shortfalls in loan funding. No material portion of the Bank’s deposits has been received from a single person, industry, group or geographical location.

The Bank is a member of the FHLB. The FHLB provides an additional source of liquidity and long-term funds. Membership in the FHLB has provided access to attractive rate advances, as well as advantageous lending programs. The Community Investment Program makes advances to be used for funding community-oriented mortgage lending, and the Affordable Housing Program grants advances to fund lending for long-term low and moderate income owner-occupied and affordable rental housing at subsidized interest rates.

The Bank has secondary borrowing lines of credit available to respond to deposit fluctuations and temporary loan demands. The unsecured lines totaled $27.500 million as of December 31, 2011, with an additional $1.675 million available if collateralized.

21



Table of Contents

Supervision and Regulation

As a registered bank holding company, the Corporation is subject to regulation and examination by the Federal Reserve Board under the Bank Holding Company Act, as amended (theBHCA “BHCA”).  The Bank is subject to regulation and examination by the Michigan OfficeDepartment of FinancialInsurance and InsuranceFinancial Services (theOFIS “DIFS”) and the Federal Deposit Insurance Corporation (theFDIC “FDIC”).

Under the BHCA, Mackinac is subject to periodic examination by the Federal Reserve Board, and is required to file with the Federal Reserve Board periodic reports of its operations and such additional information as the Federal Reserve Board may require.  In accordance with Federal Reserve Board policy, Mackinac is expected to act as a source of financial strength to the Bank and to commit resources to support the Bank in circumstances where Mackinac might not do so absent such policy.  In addition, there are numerous federal and state laws and regulations which regulate the activities of Mackinac, the Bank and the non-bank subsidiaries, including requirements and limitations relating to capital and reserve requirements, permissible investments and lines of business, transactions with affiliates, loan limits, mergers and acquisitions, issuances of securities, dividend payments, inter-affiliate liabilities, extensions of credit and branch banking.

Federal banking regulatory agencies have established risk-based capital guidelines for banks and bank holding companies that are designed to make regulatory capital requirements more sensitive to differences in risk

profiles among banks and bank holding companies.  The resulting capital ratios represent qualifying capital as a percentage of total risk-weighted assets and off-balance sheet items.  The guidelines are minimums, and the federal regulators have noted that banks and bank holding companies contemplating expansion programs should not allow expansion to diminish their capital ratios and should maintain all ratios well in excess of the minimums.

The Federal Deposit Insurance Corporation Improvement Act contains “prompt corrective action” provisions pursuant to which banks are to be classified into one of five categories based upon capital adequacy, ranging from “well capitalized” to “critically undercapitalized” and which require (subject to certain exceptions) the appropriate federal banking agency to take prompt corrective action with respect to an institution which becomes “significantly undercapitalized” or “critically undercapitalized”.  The CorporationFDIC also, after an opportunity for a hearing, has authority to downgrade an institution from “well capitalized” to “adequately capitalized” or to subject an “adequately capitalized” or “undercapitalized” institution to the supervisory actions applicable to the next lower category, for supervisory concerns.  Information pertaining to Mackinac’s and the Bank are also subject to various recently enacted U.S. laws, such as the Gramm-Leach-Bliley Act (the “GLBA”), the UnitingBank’s capital is contained in “Management’s Discussion and Strengthening America by Providing Appropriate Tools Required to InterceptAnalysis of Financial Condition and Obstruct Terrorism ActResults of 2001 (the “USA PATRIOT Act”), The Sarbanes-Oxley Act of 2002 (“SOX”), the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) and certain extraordinary government programs, such as TARP.  All of these laws, the various regulations promulgated under such laws and these programs significantly affect our business and how we operate.  More information on these laws and programs can be foundOperations” in our Annual Report on Form 10-K for the year ended December 31, 2017.

Current federal law provides that adequately capitalized and managed bank holding companies from any state may acquire banks and bank holding companies located in any other state, subject to certain conditions.

In 1999, Congress enacted the Gramm-Leach-Bliley Act (“GLBA”), which eliminated certain barriers to and restrictions on affiliations between banks and securities firms, insurance companies and other financial service organizations.  Among other things, GLBA repealed certain Glass-Steagall Act restrictions on affiliations between banks and securities firms, and amended the BHCA to permit bank holding companies that qualify as “financial holding companies” to engage in a broad list of “financial activities,” and any non-financial activity that the Federal Reserve Board, in consultation with the Secretary of the Treasury, determines is “complementary” to a financial activity and poses no substantial risk to the safety and soundness of depository institutions or the financial system.  GLBA treats lending, insurance underwriting, insurance company portfolio investment, financial advisory, securities underwriting, dealing and market-making, and merchant banking activities as financial in nature for this purpose.

Under GLBA, a bank holding company may become certified as a financial holding company by filing a notice with the Federal Reserve Board, together with a certification that the bank holding company meets certain criteria, including capital, management, and Community Reinvestment Act requirements.  Mackinac is not currently required to qualify as a financial holding company.

For a discussion of the material elements of the regulatory framework applicable to bank holding companies and their subsidiaries and specific information relevant to us, please refer to Item 1, “Business,” in our Annual Report on Form 10-K for the year ended December 31, 2017, and to the subsequent reports we have filed with the SEC, which are incorporated by reference in this prospectus. This regulatory framework is intended primarily for the protection of depositors and the federal deposit insurance fund and not for the protection of security holders.

USE OF PROCEEDS

We will retain broad discretion over the use of the net proceeds from the sale of the securities offered by this prospectus. Unless otherwise specified in the applicable prospectus supplement or any related free writing prospectus, we currently expect to use the net proceeds of our sale of securities for general corporate purposes.

General corporate purposes may include, among other purposes, making contributions to the capital of the Bank to support its lending, investing and other financial services activities; repayments of our debt; repurchases of our common stock; supporting or funding acquisitions of other institutions or branches if opportunities for such transactions become available; and other permitted activities. We may temporarily invest funds that we do not immediately need for these purposes in investment securities or use them to make payments on our borrowings.

RATIOS OF EARNINGS TO FIXED CHARGES

AND PREFERRED STOCK DIVIDENDS

The following table sets forth our ratios of earnings to combined fixed charges and preferred stock dividends for the periods indicated.  The results and data for the three months ended March 31, 2011,2018 are unaudited.

Ratio of Earnings to

 

For the Three Months

 

 

 

 

 

 

 

 

 

 

 

Combined Fixed Charges and

 

Ended

 

For the Years Ended December 31,

 

Preferred Stock Dividends(1):

 

March 31, 2018

 

2017

 

2016

 

2015

 

2014

 

2013

 

Excluding Interest on deposits

 

7.24

 

8.40

 

7.45

 

10.79

 

7.54

 

10.34

 

Including Interest on deposits

 

2.11

 

2.71

 

2.39

 

2.80

 

1.68

 

2.25

 


(1) Earnings have been calculated by adding combined fixed charges to consolidated income before provision for income taxes.  The earnings calculation gives effect to fixed charges in each period presented.  Combined fixed charges consist of interest expense (including/excluding interest on deposits) and preferred stock dividends.  For all periods, we computed the ratios of earnings to combined fixed charges and preferred stock dividends by dividing earnings by combined fixed charges.

SECURITIES WE MAY OFFER

The securities that may be offered from time to time through this prospectus are:

·                                          common stock;

·                                          preferred stock, which we may issue in one or more series;

·                                          debt securities, which we may issue in one or more series;

·                                          warrants entitling the holders to purchase common stock or debt securities;

·                                          rights to purchase common stock or other securities; and

·                                          units.

We will describe the terms of particular securities that we may offer in the future in the prospectus supplement we will deliver with this prospectus. This prospectus may not be used to offer or sell any securities unless accompanied by a prospectus supplement. In each prospectus supplement we will include, if relevant and material, the following information:

·                                          type and amount of securities which we propose to sell;

·                                          initial public offering price of the securities;

·                                          maturity;

·                                          original issue discount, if any;

·                                          rates and times of payment of interest, dividends or other payments, if any;

·                                          redemption, conversion, exercise, exchange, settlement or sinking fund terms, if any;

·                                          ranking;

·                                          voting or other rights, if any;

·                                          conversion, exchange or settlement prices or rates, if any, and, if applicable, any provisions for changes to or adjustments in the conversion, exchange or settlement prices or rates and in the securities or other property receivable upon conversion, exchange or settlement;

·                                          names of the underwriters, agents or dealers, if any, through or to which we or any selling securityholder will sell the securities;

·                                          compensation, if any, of those underwriters, agents or dealers;

·                                          details regarding over-allotment options, if any;

·                                          net proceeds to us;

·                                          information about any securities exchange or automated quotation system on which the securities will be listed or traded;

·                                          material United States (“U.S.”) federal income tax considerations applicable to the securities;

·                                          any material risk factors associated with the securities; and

·                                          any other material information about the offer and sale of the securities.

In addition, the applicable prospectus supplement and any related free writing prospectus may add, update or change the information contained in this prospectus or in the documents we have incorporated by reference.

DESCRIPTION OF COMMON STOCK

General

Mackinac’s authorized capital stock consists of 18,000,000 shares of common stock, no par value per share, and 500,000 shares of preferred stock, no par value per share. As of May 7, 2018, there were 6,340,560 shares of Mackinac common stock issued and outstanding, no shares of Mackinac preferred stock outstanding, and 67,262 shares of Mackinac common stock to be issued upon vesting of restricted stock awards.

Our common stock is listed on the Nasdaq Capital Market. Outstanding shares of our common stock are validly issued, fully paid and non-assessable.

Voting Rights

Each holder of Mackinac common stock is entitled to one vote per share and will not have any right to cumulate votes in the election of directors. Directors are elected by a plurality of the shares actually voting on the matter. Mackinac’s board of directors is divided into three classes, as nearly equal in number as reasonably possible, with each class of directors serving for successive three-year terms so that each year the term of only one class of directors expires.  This structure may frustrate or prevent any attempts by our shareholders to replace or remove our current management or effect a change in control by making it more difficult for shareholders to replace members of the board of directors. When an action other than the election of directors is to be taken by a vote of the shareholders, it shall be authorized by a majority of the votes cast by the holders of shares entitled to vote, unless a greater plurality is required by the articles or the Michigan Business Corporation Act (the “MBCA”). If Mackinac issues preferred stock, holders of such preferred stock may also possess voting rights.

Dividends and Repurchases

Mackinac can pay dividends if, as and when declared by Mackinac’s board of directors, subject to compliance with limitations imposed by law. The holders of Mackinac common stock are entitled to receive and share equally in these dividends as they may be declared by Mackinac’s board of directors out of funds legally

available for such purpose. If Mackinac issues any shares of its authorized preferred stock, the holders of such preferred stock may have a priority over the holders of the common stock with respect to dividends.

Rights upon Liquidation or Dissolution

In the event of liquidation, dissolution or winding up of Mackinac, whether voluntary or involuntary, the holders of Mackinac common stock would be entitled to receive, after payment or provision for payment of all its debts and liabilities, and payment or provision for payment of all required distributions with respect to outstanding shares of preferred stock, all of the assets of Mackinac available for distribution. If preferred stock is issued, the holders thereof may have a priority over the holders of the common stock in the event of liquidation or dissolution.

No Preemptive, Conversion or Redemption Rights

Under the MBCA, shareholders do not have preemptive rights unless Mackinac’s articles of incorporation provide otherwise. Mackinac’s articles of incorporation do not provide for preemptive rights. Mackinac does not have a rights plan in effect. Neither Mackinac nor holders of Mackinac common stock are parties to a shareholders’ agreement with respect to Mackinac’s capital stock.

Shareholder Liability

Mackinac’s articles of incorporation provide that directors of Mackinac will not be personally liable to Mackinac or its shareholders for money damages, except for liability (1) for any breach of the director’s duty of loyalty to Mackinac or its shareholders, (2) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (3) resulting from a violation of the MBCA, or (4) for any transaction from which the director derived an improper benefit.  Mackinac’s bylaws provide for the indemnification of directors and officers to the fullest extent authorized by law and of employees and agents to such extent as authorized by the board of directors and permitted by law.  Mackinac’s bylaws provide that Mackinac may purchase and maintain insurance on behalf of its directors, officers, employees and agents against any liability, whether or not Mackinac would have the power to indemnify such person against such liability under its articles of incorporation. Mackinac maintains such insurance.

Michigan Law

Mackinac is subject to the provisions of Chapter 7A of the MBCA. Chapter 7A contains provisions that generally require that business combinations between a corporation that is subject to Chapter 7A and a beneficial owner of 10% or more of the voting power of the corporation be approved by a very high percentage of the shareholders. The vote required is the affirmative vote of at least 90% of the votes of each class of stock entitled to be cast and not less than two-thirds of the votes of each class of stock entitled to be cast by shareholders other than the 10% owner who is a party to the combination. The high vote requirements will not apply if (i) our board of directors approves the transaction prior to the time the 10% owner becomes such or (ii) the transaction satisfies the specified fairness standards, various other conditions are met and the 10% owner has been such for at least five years.

Federal Law

The BHCA requires any “bank holding company,” as defined in the BHCA, to obtain the approval of the Board of Governors of the Federal Reserve Board  before acquiring 5% or more of our common stock. Any entity that is a holder of 25% or more of our common stock, or a holder of 5% or more if such holder otherwise exercises a “controlling influence” over us, is subject to regulation as a bank holding company under the BHCA. Any person, other than a bank holding company, is required to obtain the approval of the Federal Reserve Board before acquiring 10% or more of our common stock under the Change in Bank Control Act of 1978, as amended.

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is Broadridge Corporate Issuer Solutions, Inc., 51 Mercedes Way, Edgewood, NY 11717.

DESCRIPTION OF PREFERRED STOCK

The complete terms of the preferred stock will be contained in the prospectus supplement and in the applicable certificate of designations that amends our Articles of Incorporation creating one or more series of preferred stock that may be adopted by our board of directors in the future. You should read the applicable certificate of designations and the prospectus supplement, which will contain additional information and which may update or modify some of the information below.

General

Pursuant to our articles of incorporation, our board of directors is authorized to issue up to 500,000 shares of preferred stock in one or more series, with such designations, titles, voting powers, preferences and rights as may be fixed by Mackinac’s board of directors without any further action by Mackinac shareholders. The issuance of preferred stock could adversely affect the rights of holders of common stock.

Preferred Stock We May Offer

The terms of any series of preferred stock designated by our board of directors will be set forth in a certificate of designations that will amend our Articles of Incorporation, and we will include each certificate of designations as an exhibit to the registration statement that includes this prospectus, or as an exhibit to a filing with the SEC that is incorporated by reference into this prospectus. The description of preferred stock in any prospectus supplement will not necessarily describe all of the terms of the preferred stock in detail. You should read the applicable amendment to our Articles of Incorporation for a complete description of all of the terms. As of the date of this prospectus, none of the authorized preferred stock has been designated by our board of directors for issuance as part of any particular series of preferred stock, and all of such preferred stock is therefore available for future issuance in the discretion of our board of directors as part of one or more series of preferred stock with terms yet to be determined.

Terms

You should refer to the prospectus supplement relating to the offering of any series of preferred stock for specific terms of the shares, including the following terms:

·                                          title and stated or liquidation value;

·                                          number of shares offered and initial offering price;

·                                          voting rights and other protective provisions;

·                                          any dividend rate(s), payment period(s) and/or payment date(s) or method(s) of calculation of any of those terms that apply to those shares;

·                                          date from which dividends will accumulate, if applicable;

·                                          terms and amount of a sinking fund, if any, for purchase or redemption;

·                                          redemption rights, including conditions and the redemption price(s), if applicable;

·                                          listing on any securities exchange;

·                                          terms and conditions, upon which shares will be convertible into common stock or any other securities, including the conversion price, rate or other manner of calculation, conversion period and anti-dilution provisions, if applicable;

·                                          terms and conditions upon which shares will be exchangeable into debt securities or any other securities, including the exchange price, rate or other manner of calculation, exchange period and any anti-dilution provisions, if applicable;

·                                          the relative ranking and preference as to dividend rights and rights upon liquidation, dissolution or the winding up of our affairs, including liquidation preference amount;

·                                          any limitation on issuance of any series of preferred stock ranking senior to or on a parity with that series of preferred stock as to dividend rights and rights upon liquidation, dissolution or the winding up of our affairs;

·                                          any other specific terms, preferences, rights, privileges, limitations or restrictions; and

·                                          a discussion of applicable material U.S. federal income tax consequences.

Ranking

Unless we provide otherwise in a prospectus supplement, the preferred stock offered through that supplement will, with respect to dividend rights and rights upon our liquidation, dissolution or winding up, rank:

·                                          senior to all classes or series of our common stock, and to all other equity securities ranking junior to the offered preferred stock;

·                                          on a parity with all of our equity securities ranking on a parity with the offered preferred stock; and

·                                          junior to all of our equity securities ranking senior to the offered preferred stock.

The term “equity securities” does not include convertible debt securities.

Voting Rights

Unless otherwise indicated in the applicable prospectus supplement, holders of our preferred stock will not have any voting rights, except as may be required by applicable law.

Dividends

Subject to any preferential rights of any outstanding shares or series of shares, our preferred shareholders are entitled to receive dividends, when and as authorized by our board of directors, out of legally available funds, as specified in the applicable prospectus supplement.

Redemption

If we provide for a redemption right in a prospectus supplement, the preferred stock offered through that supplement will be subject to mandatory redemption or redemption at our option, in whole or in part, in each case upon the terms, at the times and at the redemption prices set forth in that prospectus supplement.

Liquidation Preference

In the event of our voluntary or involuntary dissolution, liquidation, or winding up, the holders of any series of our preferred stock will be entitled to receive, after distributions to holders of any series or class of our capital shares ranking senior, an amount equal to the stated or liquidation value of the series plus, if applicable, an amount equal to accrued and unpaid dividends. If the assets and funds to be distributed among the holders of our preferred stock will be insufficient to permit full payment to the holders, then the holders of our preferred stock will share ratably in any distribution of our assets in proportion to the amounts that they otherwise would receive on their preferred stock if the shares were paid in full.

Conversion Rights

The terms and conditions, if any, upon which any series of preferred stock is convertible into common stock or other securities will be set forth in the prospectus supplement relating to the offering of those preferred stock. These terms typically will include number of common stock or other securities into which the preferred stock is convertible; conversion price (or manner of calculation); conversion period; provisions as to whether conversion will be at the option of the holders of the preferred stock or at our option; events, if any, requiring an adjustment of the conversion price; and provisions affecting conversion in the event of the redemption of that series of preferred stock.

Transfer Agent and Registrar

We will identify in a prospectus supplement the transfer agent and registrar for any series of preferred stock offered by this prospectus.

DESCRIPTION OF DEBT SECURITIES

The complete terms of the debt securities will be contained in the indenture and indenture supplement applicable to the debt securities. These documents have been or will be included or incorporated by reference as exhibits to the registration statement of which this prospectus is a part. You should read the indenture and indenture supplement. You should also read the prospectus supplement, which will contain additional information and which may update or change some of the information below.

General

We may issue debt securities, in one or more series, as either senior or subordinated debt or as senior or subordinated convertible or exchangeable debt. The senior debt securities will rank equally with any other unsubordinated debt that we may have and may be secured or unsecured. The subordinated debt securities will be subordinate and junior in right of payment, to the extent and in the manner described in the instrument governing the debt, to all or some portion of our senior indebtedness. Any convertible debt securities that we may issue will be convertible into or exchangeable for common stock or other securities of ours or of a third party. Conversion may be mandatory or at your option and would be at prescribed conversion rates.

The debt securities will be issued under one or more indentures, which are contracts between us and an eligible banking institution or other eligible party, as trustee. While the terms we have summarized below will apply generally to any debt securities that we may offer under this prospectus, we will describe the particular terms of any debt securities that we may offer in more detail in a prospectus supplement (and any free writing prospectus).

We will issue the senior notes under the senior indenture that we will enter into with the trustee named in the senior indenture. We will issue the subordinated notes under the subordinated indenture that we will enter into with the trustee named in the subordinated indenture. We have filed forms of these documents as exhibits to the registration statement of which this prospectus is a part. We use the term “indentures” to refer to both the senior indenture and the subordinated indenture.

The indentures will be qualified under the Trust Indenture Act of 1939, as amended. We use the term “indenture trustee” to refer to either the senior trustee or the subordinated trustee, as applicable.

The following summaries of the material provisions of the senior notes, the subordinated notes and the indentures are not complete and are qualified in their entirety by reference to all of the provisions of the indenture applicable to a particular series of debt securities. You should read the applicable prospectus supplement (and any free writing prospectus that we may authorize to be provided to you) related to the series of debt securities being offered, as well as the complete indentures that contain the terms of the debt securities. Forms of indentures have been filed as exhibits to the registration statement of which this prospectus is a part, and we will file supplemental indentures and forms of debt securities containing the terms of the debt securities being offered as exhibits to the registration statement of which this prospectus is a part or they will be incorporated by reference.reference to reports that we file with the SEC. Except as we may otherwise indicate, the terms of the senior indenture and the subordinated indenture are identical.

The following are some of the terms relating to a series of debt securities that could be described in a prospectus supplement:

·                                          title;

·                                          principal amount being offered, and, if a series, the total amount authorized and the total amount outstanding;

·                                          any limit on the amount that may be issued;

·                                          whether we will issue the series of debt securities in global form and, if so, the terms and who the depositary will be;

·                                          maturity date;

·                                          principal amount due at maturity, and whether the debt securities will be issued with any original issue discount;

·                                          whether and under what circumstances, if any, we will pay additional amounts on any debt securities held by a person who is not a United States person for tax purposes, and whether we can redeem the debt securities if we have to pay such additional amounts;

·                                          annual interest rate, which may be fixed or variable, or the method for determining the rate, the date interest will begin to accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for determining such dates;

·                                          whether the debt securities will be secured or unsecured, and the terms of any secured debt;

·                                          terms of the subordination of any series of subordinated debt;

·                        ��                 place where payments will be payable;

·                                          restrictions on transfer, sale or other assignment, if any;

·                                          our right, if any, to defer payment of interest and the maximum length of any such deferral period;

·                                          date, if any, after which, the conditions upon which, and the price at which we may, at our option, redeem the series of debt securities pursuant to any optional or provisional redemption provisions, and any other applicable terms of those redemption provisions;

·                                          provisions for a sinking fund, purchase or other analogous fund, if any;

·                                          date, if any, on which, and the price at which we are obligated, pursuant to any mandatory sinking fund or analogous fund provisions or otherwise, to redeem, or at the holder’s option to purchase, the series of debt securities;

·                                          whether the indenture will restrict our ability or the ability of our subsidiaries to:

·                                          incur additional indebtedness;

·                                          issue additional securities;

·                                          create liens;

·                                          pay dividends or make distributions in respect of our capital shares or the capital shares of our subsidiaries;

·                                          redeem capital shares;

·                                          place restrictions on our subsidiaries’ ability to pay dividends, make distributions or transfer assets;

·                                          make investments or other restricted payments;

·                                          sell or otherwise dispose of assets;

·                                          enter into sale-leaseback transactions;

·                                          engage in transactions with shareholders or affiliates;

·                                          issue or sell shares of our subsidiaries; or

·                                          effect a consolidation or merger;

·                                          whether the indenture will require us to maintain any interest coverage, fixed charge, cash flow-based, asset-based or other financial ratios;

·                                          a discussion of any material or special United States federal income tax considerations applicable to the debt securities;

·                                          information describing any book-entry features;

·                                          procedures for any auction or remarketing, if any;

·                                          whether the debt securities are to be offered at a price such that they will be deemed to be offered at an “original issue discount” as defined in paragraph (a) of Section 1273 of the Internal Revenue Code of 1986, as amended;

·                                          denominations in which we will issue the series of debt securities, if other than denominations of $1,000 and any integral multiple thereof; and

·                                          any other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities, including any events of default that are in addition to those described in this prospectus or any covenants provided with respect to the debt securities that are in addition to those described above, and any terms that may be required by us or advisable under applicable laws or regulations or advisable in connection with the marketing of the debt securities.

Conversion or Exchange Rights

We will set forth in the applicable prospectus supplement or free writing prospectus the terms on which a series of debt securities may be convertible into or exchangeable for common stock or other securities of ours or of a third party, including the conversion or exchange rate, as applicable, or how it will be calculated, and the applicable conversion or exchange period. We will include provisions as to whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of our securities or the securities of a third party that the holders of the series of debt securities receive upon conversion or exchange would, under the circumstances described in those provisions, be subject to adjustment, or pursuant to which those holders would, under those circumstances, receive other property upon conversion or exchange, for example in the event of our merger or consolidation with another entity.

Consolidation, Merger or Sale

The indentures in the forms initially filed as exhibits to the registration statement of which this prospectus is a part do not contain any covenant that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of all or substantially all of our assets, except that any successor of ours or acquiror of such assets must be a corporation organized and existing under the laws of the United States and must assume all of our obligations under the indentures and the debt securities, as appropriate. In addition, the terms of any securities that we may offer pursuant to this prospectus may limit our ability to merge or consolidate or otherwise sell, convey, transfer or otherwise dispose of all or substantially all of our assets, which terms would be set forth in the applicable prospectus supplement and supplemental indenture.

If the debt securities are convertible for our other securities or securities of other entities, the person with whom we consolidate or merge or to whom we sell all of our property would have to make provisions for the conversion of the debt securities into securities that the holders of the debt securities would have received if they had converted the debt securities before the consolidation, merger or sale.

 

USEEvents of Default Under the Indenture

The events of default under the indentures, subject to modification or deletion as provided in a supplemental indenture with respect to any specific series of debt securities, include the following events:

·                                          if we fail to pay interest when due and payable and our failure continues for 90 days and the time for payment has not been extended or deferred;

·                                          if we fail to pay the principal, premium or sinking fund payment, if any, when due and payable and the time for payment has not been extended or deferred;

·                                          if we fail to observe or perform any other covenant contained in the debt securities or the indentures, other than a covenant specifically relating to another series of debt securities, and our failure continues for 90 days after we (and the indenture trustee in the event of notice from security holders) receive notice from the indenture trustee or holders of at least 25% in aggregate principal amount of the outstanding debt securities of the applicable series; and

·                                          if specified events of bankruptcy, insolvency or reorganization occur.

If an event of default with respect to debt securities of any series occurs and is continuing, the indenture trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series, by notice to us in writing, and to the indenture trustee if notice is given by such holders, may declare the unpaid principal of, premium, if any, and accrued interest, if any, due and payable immediately.

The holders of a majority in aggregate principal amount of the outstanding debt securities of an affected series may waive any default or event of default with respect to such series and its consequences, except defaults or events of default regarding payment of principal, premium, if any, or interest, and in the event of a waiver after

acceleration as described in the immediately preceding paragraph, we have received written notice of such waiver and have remedied such default or event of default. Any waiver shall cure the default or event of default.

Subject to the terms of the indentures, if an event of default under an indenture occurs and continues, the indenture trustee would be under no obligation to exercise any of its rights or powers under such indenture at the request or direction of any of the holders of the applicable series of debt securities, unless such holders have offered the indenture trustee reasonable indemnity. The holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the indenture trustee, or exercising any trust or power conferred on the indenture trustee, with respect to the debt securities of that series, provided that:

·                                          the direction so given by the holder is not in conflict with any law or the applicable indenture; and

·                                          subject to its duties under the Trust Indenture Act of 1939, the indenture trustee need not take any action that might involve it in personal liability or might be unduly prejudicial to the holders not involved in the proceeding.

A holder of the debt securities of any series will have the right to institute a proceeding under the indentures or to appoint a receiver or trustee, or to seek other remedies only if:

·                                          the holder has given written notice to the indenture trustee of a continuing event of default with respect to that series;

·                                          the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series have made written request to the indenture trustee, and such holders have offered reasonable indemnity to the indenture trustee to institute the proceeding as trustee; and

·                                          for 60 days after receipt of written notice of such event of default, request to institute the proceeding and offer of indemnity, the indenture trustee does not institute such proceeding, and does not receive from the holders of a majority in aggregate principal amount of the outstanding debt securities of that series other conflicting directions.

These limitations do not apply to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest on the debt securities.

We will periodically file statements with the indenture trustee regarding our compliance with specified covenants in the indentures.

Modification of Indenture; Waiver

By entering into supplemental indentures, we and the indenture trustee may modify the terms of an indenture without the consent of any holders with respect to specific matters, including:

·                                          to fix any ambiguity, defect or inconsistency in the indentures;

·                                          to evidence the assumption by a successor corporation of our obligations in compliance with the provisions described above under “Consolidation, Merger or Sale”;

·                                          to comply with any requirements of the SEC in connection with the qualification of any indenture under the Trust Indenture Act of 1939, as amended;

·                                          to provide for the issuance of and establish the form and terms and conditions of the debt securities of any series as provided under “Description of Debt Securities — General,” to establish the form of any certifications required to be furnished pursuant to the terms of the indenture or any series of debt securities, or to add to the rights of the holders of any series of debt securities;

·                                          to evidence and provide for the acceptance of appointment by a successor trustee;

·                                          to provide for uncertificated debt securities and to make all appropriate changes for such purpose;

·                                          to secure any series of debt securities;

·                                          to add to our covenants such new covenants, restrictions, conditions or provisions for the protection of the holders, to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions or provisions an event of default; or

·                                          to make such other provisions in regard to matters or questions arising under the indentures or supplemental indentures that do not materially adversely affect the interests of any holder of debt securities of any series.

In addition, under the indentures or supplemental indentures, the rights of holders of a series of debt securities may be changed by us and the indenture trustee with the written consent of the holders of at least 66 2/3% in aggregate principal amount of the outstanding debt securities of each series that is affected. However, we and the indenture trustee may make the following changes only with the consent of each holder of any outstanding debt securities affected:

·                                          extending the fixed maturity of the series of debt securities;

·                                          reducing the principal amount of, reducing the rate of or extending the time of payment of interest on, or reducing any premium payable upon the redemption of, any debt securities;

·                                          reducing the 66 2/3% requirement described above for the written consent of the holders of affected securities; or

·                                          modifying any of the three bullet points above.

Discharge, Defeasance and Covenant Defeasance

We may elect to have our obligations under the indenture discharged with respect to the outstanding debt securities of any series, known as defeasance. Defeasance means that we will be deemed to have paid and discharged the entire indebtedness represented by the outstanding debt securities of such series under the indenture, except for:

·                                          the rights of holders of the debt securities to receive principal, interest and any premium when due;

·                                          our obligations with respect to the debt securities concerning issuing temporary debt securities, registration of transfer of debt securities, mutilated, destroyed, lost or stolen debt securities and the maintenance of an office or agency for payment for security payments held in trust;

·                                          the rights, powers, trusts, duties and immunities of the trustee; and

·                                          the defeasance provisions of the indenture.

In addition, we may elect to have our obligations released with respect to certain covenants applicable to any series of outstanding debt securities established by and set forth in a supplemental indenture, known as covenant defeasance. If we so elect, any failure to comply with such obligations will not constitute a default or an event of default with respect to the debt securities of such series.

In order to exercise either defeasance or covenant defeasance with respect to outstanding debt securities of any series:

·                                          we must irrevocably have deposited or caused to be deposited with the indenture trustee as trust funds for the purpose of making the following payments, specifically pledged as security for, and dedicated solely to the benefit of, the holders of the debt securities of such series:

·                                          money; or

·                                          U.S. government obligations that will provide, not later than one day before the due date of any payment, money in an amount; or

·                                          a combination of money and U.S. government obligations;

in each case sufficient, in the written opinion (with respect to U.S. obligations or a combination of money and U.S. obligations, as applicable) of a nationally recognized firm of independent public accountants to pay and discharge, and which shall be applied by the trustee to pay and discharge, all of the principal (including mandatory sinking fund payments), interest and any premium at due date or maturity;

·                                          in the case of defeasance, we must have delivered to the indenture trustee an opinion of counsel stating that, under then applicable Federal income tax law, the holders of the debt securities of that series will not recognize income, gain or loss for Federal income tax purposes as a result of the defeasance to be effected and will be subject to the same Federal income tax as would be the case if the defeasance did not occur;

·                                          in the case of covenant defeasance, we must have delivered to the indenture trustee an opinion of counsel to the effect that the holders of the debt securities of that series will not recognize income, gain or loss for Federal income tax purposes as a result of the covenant defeasance to be effected and will be subject to the same Federal income tax as would be the case if the covenant defeasance did not occur;

·                                          no event of default or default with respect to the outstanding debt securities of that series may have occurred and be continuing at the time of such deposit, or at any time during the period ending on the 123rd day after the date of such deposit, or, if longer, the period ending the day following the expiration of the longest preference period applicable to us with respect to such deposit;

·                                          the defeasance or covenant defeasance must not cause the indenture trustee to have a conflicting interest within the meaning of the Trust Indenture Act of 1939, as amended, with respect to any securities of the Company;

·                                          the defeasance or covenant defeasance must not result in a breach or violation of, or constitute a default under, any other agreement or instrument to which we are a party;

·                                          the defeasance or covenant defeasance must be effected in compliance with the applicable provisions set forth in any supplemental indenture;

·                                          the defeasance or covenant defeasance must not result in the trust arising from such deposit constituting an investment company within the meaning of the Investment Company Act of 1940, as amended, unless the trust is registered under such Act; and

·                                          we must have delivered to the trustee an officer’s certificate and an opinion of counsel stating that all conditions precedent with respect to the defeasance or covenant defeasance have been satisfied.

Form, Exchange and Transfer

We will issue the debt securities of each series in registered form without coupons and, unless we otherwise specify in the applicable prospectus supplement or free writing prospectus, in denominations of $1,000 and any integral multiple thereof. The indentures provide that we may issue debt securities of a series in temporary or permanent global form and as book-entry securities that will be deposited with, or on behalf of, The Depository Trust Company or another depositary named by us and identified in a prospectus supplement or free writing prospectus with respect to that series.

At the option of the holder, subject to the terms of the indentures and the limitations applicable to global securities described in the applicable prospectus supplement or free writing prospectus, the holder of the debt securities of any series can exchange the debt securities for other debt securities of the same series, in any authorized denomination and of like tenor and aggregate principal amount.

Subject to the terms of the indentures and the limitations applicable to global securities set forth in the applicable prospectus supplement or free writing prospectus, holders of the debt securities may present the debt securities for exchange or for registration of transfer, duly endorsed or with the form of transfer endorsed thereon duly executed if so required by us or the security registrar, at the office of the security registrar or at the office of any transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that the holder presents for transfer or exchange, we will make no service charge for any registration of transfer or exchange, but we may require payment of any taxes or other governmental charges.

We will name in the applicable prospectus supplement or free writing prospectus the security registrar, and any transfer agent in addition to the security registrar, that we initially designate for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place of payment for the debt securities of each series.

If we elect to redeem the debt securities of any series, we will not be required to:

·                                          issue, register the transfer or exchange of any debt securities of any series being redeemed in part during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption of any debt securities that may be selected for redemption and ending at the close of business on the day of the mailing; or

·                                          register the transfer of or exchange any debt securities so selected for redemption, in whole or in part, except the unredeemed portion of any debt securities we are redeeming in part.

Information Concerning the Indenture Trustee

The indenture trustee, other than during the occurrence and continuance of an event of default under an indenture, undertakes to perform only those duties as are specifically set forth in the applicable indenture. Upon an event of default under an indenture, the indenture trustee must use the same degree of care as a prudent person would exercise or use in the conduct of his or her own affairs.

Payment and Paying Agents

Unless we otherwise indicate in the applicable prospectus supplement or free writing prospectus, we will make payment of the interest on any debt securities on any interest payment date to the person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the regular record date for the interest.

All money we pay to a paying agent or the indenture trustee for the payment of the principal of or any premium or interest on any debt securities which remains unclaimed at the end of two years after such principal,

premium or interest has become due and payable will be repaid to us, and the holder of the debt security thereafter may look only to us for payment thereof.

Governing Law

Unless otherwise provided in the applicable prospectus supplement, the indentures and the debt securities will be governed by and construed in accordance with the laws of the State of Michigan, except to the extent that the Trust Indenture Act of 1939 is applicable.

Subordination of Subordinated Debt Securities

The subordinated debt securities will be subordinate and junior in priority of payment to certain of our other indebtedness to the extent described in a supplemental indenture and applicable prospectus supplement or free writing prospectus. The indentures in the forms initially filed as exhibits to the registration statement of which this prospectus is a part do not limit the amount of indebtedness which we may incur, including senior indebtedness or subordinated indebtedness, and do not limit us from issuing any other debt, including secured debt or unsecured debt.

DESCRIPTION OF PROCEEDSWARRANTS

 

Assuming allThe complete terms of the warrants will be contained in the applicable warrant agreement and warrant. These documents have been or will be included or incorporated by reference as exhibits to the registration statement of which this prospectus is a part. You should read the warrant and warrant agreement. You should also read the prospectus supplement, which will contain additional information and which may update or change some of the information below.

Warrants We May Offer

We may issue warrants for the purchase of common stock, preferred stock and/or debt securities in one or more series. If we offer warrants, we will describe the terms in a prospectus supplement (and any free writing prospectus). Warrants may be offered independently, together with other securities offered by any prospectus supplement, or through a dividend or other distribution to shareholders and may be attached to or separate from other securities. Warrants may be issued under a written warrant agreement to be entered into between us and the holder or beneficial owner, or under a written warrant agreement with a warrant agent specified in a prospectus supplement. A warrant agent would act solely as our agent in connection with the warrants of a particular series and would not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of those warrants.

The following are some of the terms relating to a series of warrants that could be described in a prospectus supplement:

·                                          title of the warrants;

·                                          aggregate number of warrants;

·                                          price or prices at which the warrants will be issued;

·                                          designation, number, aggregate principal amount, denominations and terms of the securities that may be purchased on exercise of the warrants;

·                                          date, if any, on and after which the warrants and the debt securities offered with the warrants, if any, will be separately transferable;

·                                          purchase price for each security purchasable on exercise of the warrants;

·                                          dates on which the right to purchase certain securities upon exercise of the warrants will begin and end;

·                                          minimum or maximum number of securities that may be purchased at any one time upon exercise of the warrants;

·                                          anti-dilution provisions or other adjustments to the exercise price of the warrants;

·                                          terms of any right that we may have to redeem the warrants;

·                                          effect of any merger, consolidation, sale or other transfer of our business on the warrants and the applicable warrant agreement;

·                                          name and address of the warrant agent, if any;

·                                          information with respect to book-entry procedures;

·                                          a discussion of material U.S. federal income tax considerations; and

·                                          other material terms, including terms relating to transferability, exchange, exercise or amendments of the warrants.

Until any warrants to purchase our securities are exercised, holders of the warrants will not have any rights of holders of the underlying securities.

DESCRIPTION OF RIGHTS

The complete terms of the rights will be contained in the rights agreements we enter into with rights agents. These documents will be included or incorporated by reference as exhibits to the registration statement of which this prospectus is a part. You should read the rights agreements and any related documents. You also should read the prospectus supplement, which will contain additional information and which may update or change some of the information below.

This section describes the general terms of the rights to purchase common stock or other securities that we may offer to shareholders using this prospectus. Further terms of the rights will be stated in the applicable prospectus supplement. The following description and any description of the rights in the offering are subscribed, we estimate that the net proceedsa prospectus supplement may not be complete and is subject to us from the sale of our Common Shares offeredand qualified in the rights offering, after deducting estimated offering expenses, will be approximately $6.7 million. We are conducting the rights offering and engaging in the SCI Investment to repurchase the Corporation’s TARP Securities that were issuedits entirety by the Corporationreference to the Treasury by participating in the Capital Purchase Program under TARP.  The preferred share portionterms of the TARP Securities that were issuedany agreement relating to the Treasury were previously authorized preferred shares with a 5% annual dividend rate to the Treasury. The Corporation also, as a required part of the Corporation’s participation in the Capital Purchase Program under TARP, issued 379,310 Common Share warrants with an exercise price of $4.35 per share. The TARP Securities were issued on April 24, 2009.rights.

 

DETERMINATION OF OFFERING PRICE

In determining the Subscription Price, we considered a number of factors, including: the price at which our shareholders mightRights may be willing to participate in the rights offering, the price at which SCI was willing to participate in the SCI Investment, historical and current trading prices for our Common Shares and the desire to provide an opportunity to our shareholders to participate in the rights offering on a pro rata basis.  The Subscription Price was established at a price of $5.75 per full share, which equals the price to be paid by SCI for our Common Shares in the SCI Investment. The Subscription Price is not necessarily related to our book value, net worthissued independently or together with any other established criteria of valuesecurity and may or may not be considered the fair value of our Common Shares to be offered in the rights offering.

We retained River Branch Capital LLC to advise us with respect to an appropriate per share price range for the Subscription Price of our shares in this rights offering. River Branch Capital LLC delivered its analysis, which was prepared using customary methodologies in the investment banking industry, to our board of directors prior to the meeting of our board of directors, and then met with our board of directors on March 9, 2012.transferable. As part of its analysis, River Branch Capital LLC, amongany rights offering, we may enter into a standby underwriting or other things, reviewed financialarrangement under which the underwriters or any other person would purchase any securities that are not purchased in such rights offering. If we issue rights, each series of rights will be issued under a separate rights agreement to be entered into between us and market conditions generally anda bank or trust company, as rights agent, that will be named in Michigan, reviewed the trading multiples of our Common Shares relative to comparable companies, with a focus on multiples of tangible book value, reviewed pricing of precedent stock offerings by bank and thrift institutions including rights offerings, reviewed the current and recent historical trading prices and volume of our Common Shares, reviewed valuation considerations, including tangible book value per share estimates in respect to our current asset quality metrics based on various methodologies used by investors to estimate potential losses in our loan portfolio, discussed the implications of our existing capital structure as it pertains to investor perception and valuation and performed an analysis of our shareholders’ equity and tangible book value per share, both under our existing capital structure and on a pro forma basis under various potential outcomesapplicable prospectus supplement. Further terms of the rights offering.In addition, River Branch Capital LLC had discussions with managementwill be stated in the applicable prospectus supplement. The rights agent will act solely as our agent and other representativeswill not assume any obligation to any holders of rights certificates or beneficial owners of rights. The rights agreements and advisors of the Corporation concerning the business, financial condition, results of operations and forecasts.

In connectionrights certificates will be filed with the rights offering, River Branch Capital LLCisservingSEC as our financial advisor,an exhibit to the registration statement of which this prospectus is a part or as an exhibit to a filing incorporated by reference in the registration statement. See “Where You Can Find Additional Information” for which we will pay River Branch Capital LLC a fee of $100,000 (with half already paid and half payable at year-end) and reimburse them for their reasonable out-of-pocket expenses. No portion of the fee was contingent upon approval or completioninformation on how to obtain copies of the rights offering.

We cannot assure you that the market price of our Common Shares will not decline during or after theagreements and rights offering. We also cannot assure you that you will be able to sell our Common Shares purchased during the rights offering at a price equal to or greater than the Subscription Price. We urge you to obtain a current quote for our Common Shares before exercising your subscription rights.certificates.

 

The Subscription Price does not necessarily bear any relationshipprospectus supplement relating to any other established criteria for value. You should not considerrights we offer will describe the Subscription Price as an indication of valuespecific terms of the Corporation or our Common Shares. You should not assume or expect that, afteroffering and the rights, offering, our Common Shares will trade at or aboveincluding the Subscription Price in any given time period. The marketrecord date for shareholders entitled to the rights distribution, the number of rights issued and the number of shares of common stock that may be purchased upon exercise of the rights, the exercise

22



Table of Contents

price of our Common Shares may decline during or after the rights, offering, and you may not be able to sell the Common Shares purchased during the rights offering at a price equal to or greater than the Subscription Price. You should obtain a current quote for our Common Shares before exercising your subscription rights and make your own assessment of our business and financial condition, our prospects for the future and the terms of this rights offering. On [    ·    ], 2012, the closing sale price of our Common Shares on the NASDAQ Capital Market was $[    ·    ] per share.

MARKET FOR OUR COMMON SHARES AND DIVIDEND INFORMATION

Our Common Shares are traded on the NASDAQ Capital Market under the symbol “MFNC.”

The following table sets forth the quarterly high and low sales prices of our Common Shares on the NASDAQ Capital Market for the periods indicated:

 

 

High

 

Low

 

2012

 

 

 

 

 

First Quarter

 

$

7.43

 

$

5.00

 

 

 

 

 

 

 

2011

 

 

 

 

 

Fourth Quarter

 

$

5.94

 

$

4.63

 

Third Quarter

 

$

7.01

 

$

4.96

 

Second Quarter

 

$

6.20

 

$

4.85

 

First Quarter

 

$

6.52

 

$

4.58

 

 

 

 

 

 

 

2010

 

 

 

 

 

Fourth Quarter

 

$

5.28

 

$

3.95

 

Third Quarter

 

$

6.95

 

$

4.74

 

Second Quarter

 

$

7.39

 

$

4.51

 

First Quarter

 

$

5.20

 

$

4.09

 

 

 

 

 

 

 

2009

 

 

 

 

 

Fourth Quarter

 

$

5.85

 

$

4.00

 

Third Quarter

 

$

6.37

 

$

4.00

 

Second Quarter

 

$

4.50

 

$

3.76

 

First Quarter

 

$

4.72

 

$

2.45

 

On [    ·    ], 2012, the last closing sale price reported on the NASDAQ Capital Market for our Common Shares was $[    ·    ] per share.

Holders

As of the Record Date for this rights offering, there were 3,419,736 common shareholders of record.

Dividends

The Corporation is organized under the Michigan Business Corporation Act which provides that distributions may be made only if, after giving the distribution effect, a corporation is able to pay its debts as they become due in the usual course of business and the corporation’s total assets equal or exceed the sum of its total liabilities plus the amount that would be needed to satisfy the preferential rights of any shareholder whose preferential rights are superior to those receiving the distribution if the corporation were to be dissolved at the time of the distribution.

Additionally, the Federal Reserve has issued a policy statement with regard to the payment of cash dividends by bank holding companies. The policy statement provides that a bank holding company should not pay cash dividends which exceed its net income or which can only be funded in ways that weaken the bank holding company’s financial health, such as by borrowing. The Federal Reserve also possesses enforcement powers over bank holding companies and their non-bank subsidiaries to prevent or remedy actions that represent unsafe or unsound practices or violations of applicable statutes and regulations. Among these powers is the ability to proscribe the payment of dividends by banks and bank holding companies.

As a result of the Corporation’s issuance of the TARP Securities to the Treasury pursuant to the Capital Purchase Program under TARP, the Corporation is restricted in the payment of dividends and, without the Treasury’s consent, may not declare or pay any dividend on the Corporation’s Common Shares. This restriction no longer applies on the earlier to occur of April 24, 2012 (the third anniversary of the issuance of the preferred shares to the Treasury), or the date on which the Corporation has redeemed all of the TARP Securities issued, orrights will become effective and the date on which the Treasury has transferred all of the TARP Securities to third parties not affiliated with

23



Table of Contents

the Treasury. In addition, as long as the TARP Securities are outstanding, dividend payments are prohibited until all accruedrights will expire, and unpaid dividends are paid on such preferred shares, subject to certain limited exceptions.  The purpose of the Rights Offering and the SCI Investment is to secure the capital required to redeem the TARP Securities.  See “Use of Proceeds.”

The principal source of the Corporation’s revenue and cash flow is dividends from the Bank. The Bank is subject to various statutory and regulatory restrictions on its ability to pay dividends or otherwise make distributions or supply funds to the Corporation. In addition, bank regulators may have authority to prohibit a bank subsidiary from paying dividends, depending on the Bank’s financial condition, if such payment is deemed to constitute an unsafe or unsound practice.

Earnings appropriated to bad debt reserves for losses and deducted forany applicable U.S. federal income tax purposesconsiderations.

In general, a right entitles the holder to purchase for cash a specific number of shares of common stock or other securities at a specified exercise price. The rights are normally issued to shareholders as of a specific record date, may be exercised only for a limited period of time and become void following the expiration of such period. If we determine to issue rights, we will accompany this prospectus with a prospectus supplement that will describe, among other things:

·                                          the record date for shareholders entitled to receive the rights;

·                                          the number of shares of common stock or other securities that may be purchased upon exercise of each right;

·                                          the exercise price of the rights;

·                                          whether the rights are transferable;

·                                          the period during which the rights may be exercised and when they will expire;

·                                          the steps required to exercise the rights;

·                                          whether the rights include “oversubscription rights” so that the holder may purchase more securities if other holders do not purchase their full allotments;

·                                          whether we intend to sell the shares of common stock or other securities that are not available for dividends withoutpurchased in the payment of taxes atrights offering to an underwriter or other purchaser under a contractual “standby” commitment or other arrangement;

·                                          our ability to withdraw or terminate the currentrights offering; and

·                                          any material U.S. Federal income tax ratesconsequences.

If fewer than all of the rights issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than shareholders, to or through agents, underwriters or dealers or through a combination of such methods, including pursuant to standby arrangements, as described in the applicable prospectus supplement. After the close of business on the amount used.expiration date, all unexercised rights will become void.

Prior to the exercise of a holder’s rights, the holder will not have any of the rights of holders of the securities issuable upon the exercise of the rights and will not be entitled to, among other things, vote or receive dividend payments or other distributions on the securities purchasable upon exercise.

 

CAPITALIZATIONDESCRIPTION OF UNITS

 

The complete terms of the units will be contained in the unit agreement and any related document applicable to any units. These documents have been or will be included or incorporated by reference as exhibits to the registration statement of which this prospectus is a part. You should read the unit agreement and any related documents. You also should read the prospectus supplement, which will contain additional information and which may update or change some of the information below.

We may issue units, in one or more series, consisting of any combination of one or more of the other securities described in this prospectus. If we offer units, we will describe the terms in a prospectus supplement (and any free writing prospectus). Units may be issued under a written unit agreement to be entered into between us and the holder or beneficial owner, or we could issue units under a written unit agreement with a unit agent specified in a prospectus supplement. A unit agent would act solely as our agent in connection with the units of a particular series

and would not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of those units.

Each unit will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security.

The following table sets forth the Corporation’s actual (see Column A) and pro forma capitalization as of December 31, 2011 after completion of various levelsare some of the SCI Investment and the rights offering, as if the noted level of the SCI Investment and the rights offering and the exercise of all such rights to purchase the underlying Common Shares had been completed onunit terms that date.  The Corporation’s pro forma capitalization gives effect to (i) the exercise by the current shareholders of 100% of their basic subscription privileges or over-subscription privileges with SCI purchasing the maximum amount of Common Shares it is able to purchase without exceeding the 19.9% threshold (see Column B), (ii) the exercise by the current shareholders of none of their basic subscription privilege or over-subscription privilege, with SCI purchasing the maximum amount of Common Shares it is able to purchase without exceeding the 9.9% threshold (see Column C) and (iii) the exercise by the current shareholders of none of their basic subscription privileges or over-subscription privileges, with SCI purchasing the maximum amount of Common Shares it is able to purchase without exceeding the 19.9% threshold (see Column D).could be described in a prospectus supplement:

 

 

Actual
(as of 12-31-
30-2011)
(A)

 

100% Current
Shareholder
Subscription Rights
Exercised and
Maximum SCI
Purchase up to
19.9%
(B)

 

No Current
Shareholder
Subscription
Rights Exercised
and Maximum SCI
Purchase up to
9.9%
(C)

 

No Current
Shareholder
Subscription
Rights Exercised
and Maximum
SCI Purchase up
to 19.9%
(D)

 

Capital Structure

 

 

 

 

 

 

 

 

 

Common shareholders’ equity

 

$

44,342

 

$

55,454

 

$

44,054

 

$

46,704

 

Preferred stock

 

10,921

 

 

2,650

 

0

 

Total shareholders’ equity

 

$

55,263

 

$

55,454

 

$

46,704

 

$

46,704

 

Total capitalization

 

$

55,263

 

$

55,454

 

$

46,704

 

$

46,704

 

Tangible capital

 

$

55,223

 

$

55,414

 

$

46,664

 

$

46,664

 

 

 

 

 

 

 

 

 

 

 

Intangible assets

 

 

 

 

 

 

 

 

 

Subsidiaries:

 

 

 

 

 

 

 

 

 

Core deposit premium

 

$

 

$

 

 

 

Other identifiable intangibles - MSR’s

 

400

 

400

 

400

 

400

 

Total intangibles

 

400

 

400

 

400

 

400

 

 

 

 

 

 

 

 

 

 

 

Risk-Based Capital

 

 

 

 

 

 

 

 

 

Tier 1 Capital:

 

 

 

 

 

 

 

 

 

Total shareholders’ equity

 

$

55,263

 

$

55,454

 

$

46,704

 

$

46,704

 

Net unrealized (gains) losses on available for sale securities

 

(325

)

(325

)

(325

)

(325

)

Less: disallowed deferred tax asset

 

(6,500

)

(6,500

)

(6,500

)

(6,500

)

 

24·



Table                                          title of Contentsthe units;

 

Less: intangibles

 

(40

)

(40

)

(40

)

(40

)

Total Tier 1 Capital

 

$

48,398

 

$

48,589

 

$

39,839

 

$

39,839

 

Tier 2 Capital:

 

 

 

 

 

 

 

 

 

Allowable reserve for loan losses (limited to 1.25% of risk-weighted assets)

 

$

5,206

 

$

5,206

 

$

5,206

 

$

5,206

 

Qualifying long-term debt

 

 

 

 

 

Total Tier 2 capital

 

$

5,206

 

$

5,206

 

$

5,206

 

$

5,206

 

Total risk-based capital

 

$

53,604

 

$

53,795

 

$

45,045

 

$

45,045

 

 

 

 

 

 

 

 

 

 

 

Risk-weighted assets

 

$

416,423

 

$

416,423

 

$

416,423

 

$

416,423

 

 

 

 

 

 

 

 

 

 

 

Capital Ratios:

 

 

 

 

 

 

 

 

 

Tier 1 Capital to average assets

 

10.08

%

10.12

%

8.30

%

8.30

%

Tier 1 Capital to risk-weighted assets

 

11.62

%

11.67

%

9.57

%

9.57

%

Total Capital to risk-weighted assets

 

12.87

%

12.92

%

10.82

%

10.82

%

 

 

 

 

 

 

 

 

 

 

Average Assets (4th quarter)

 

$

486,672

 

$

486,672

 

$

486,672

 

$

486,672

 

Total Tier 1 Average Assets (excluding Deferred Tax Asset)

 

$

480,172

 

$

480,172

 

$

480,172

 

$

480,172

 

·                                          aggregate number of units;

·                                          price or prices at which the units will be issued;

·                                          designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;

·                                          effect of any merger, consolidation, sale or other transfer of our business on the units and the applicable unit agreement;

·                                          name and address of the unit agent;

·                                          information with respect to book-entry procedures;

·                                          a discussion of material U.S. federal income tax considerations; and

·                                          other material terms, including terms relating to transferability, exchange, exercise or amendments of the units.

The provisions described in this section, as well as those described under “Description of Common Stock,” “Description of Preferred Stock,” “Description of Debt Securities,” “Description of Warrants,” and “Description of Rights” will apply to each unit and to any common stock, preferred stock, debt security, warrant, or right included in each unit, respectively.

Unless otherwise provided in the applicable prospectus supplement, the unit agreements will be governed by the laws of the State of Michigan. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date. We will file as an exhibit to a filing with the SEC that is incorporated by reference into this prospectus the forms of the unit agreements containing the terms of the units being offered. The description of units in any prospectus supplement will not necessarily describe all of the terms of the units in detail. You should read the applicable unit agreements for a complete description of all of the terms.

 

PLAN OF DISTRIBUTION

 

As soon as practicable afterWe may sell the Record Date forsecurities from time to time pursuant to public offerings, negotiated transactions, block trades or a combination of these methods. We may sell the rights offering, we willsecurities to or through an underwriter or group of underwriters managed or co-managed by one or more underwriters, or to or through dealers, through agents, directly to one or more investors or through a combination of such methods of sale.

We may distribute the subscription rights and rights certificatessecurities from time to individuals who owned our Common Shares at 5:00 p.m., Eastern Time, on April 6, 2012. If you wish to exercise your subscription rights and purchase shares of our Common Shares, you should complete the rights certificate and return it with payment for the shares as follows:time in one or more transactions:

 

·                                          If your shares are held in the name ofat a broker, dealerfixed price or other nominee, then you should send your subscription documents, rights certificate and subscription payment to that record holder.prices which may be changed;

 

·                                          If you areat market prices prevailing at the record holder, then you should send your subscription documents, rights certificate and subscription payment by hand delivery, first class mailtime of sale;

·                                          at prices related to such prevailing market prices; or courier service toRegistrar and Transfer Company, the subscription agent for the rights offering, as follows:

 

·                                          at negotiated prices.

By Hand or Overnight Courier

(Until 5:00 p.m. Eastern Time on

By First Class Mail:

the expiration date of the rights offering):

Registrar and Transfer Company

Registrar and Transfer Company

P.O. Box 645

10 Commerce Drive

Cranford, NJ 07016

Cranford, NJ 07016

Attn: Reorg/Exchange Dept.

Attn: Reorg/Exchange Dept.

 

You should direct any questions, requests for assistance concerningEach time we sell securities a prospectus supplement will describe the method of subscribing for our Common Sharesdistribution of the securities and any applicable restrictions.

The prospectus supplement or requests forsupplements will describe the terms of the offering of the securities, including:

·                                          the name or names of the underwriters, placement agents or dealers, if any;

·                                          the purchase price of the securities and the proceeds we will receive from the sale;

·                                          any over-allotment options under which underwriters may purchase additional copies ofsecurities from us;

·                                          any agency fees or underwriting discounts and other items constituting agents’ or underwriters’ compensation;

·                                          any discounts or concessions allowed or reallowed to be paid to dealers (which may be changed at any time); and

·                                          any securities exchange or market on which the securities may be listed or quoted.

In addition, we may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to our Executive Vice President/Chief Financial Officer, Ernie R. Krueger, at: Mackinac Financial Corporation, 130 South Cedar Street, Manistique, Michigan 49854, (906) 341-7158.

You are solely responsible for completing deliverythird parties in privately negotiated transactions. In connection with such a transaction, the third parties may sell securities covered by and pursuant to this prospectus and an applicable prospectus supplement. If so, the subscription agent of your subscription documents, rights certificatethird party may use securities borrowed from us or others to settle such sales and payment. We urge youmay use securities received from us to allow sufficient time for delivery of your subscription materials to the subscription agent. See “The Rights Offering—Method of Exercising Subscription Rights” on page [    ·    ].

25



Table of Contentsclose out any related short positions.

 

We do not knowmay determine the price or other terms of the securities offered under this prospectus by use of an electronic auction. We will describe in the applicable prospectus supplement how any auction will be conducted to determine the price or any other terms of the securities, how potential investors may participate in the auction and, where applicable, the nature of the underwriters’ obligations with respect to the auction.

Unless stated otherwise in the applicable prospectus supplement, the obligations of any existing agreements betweenunderwriters to purchase securities will be subject to certain conditions set forth in the applicable underwriting agreement, and generally the underwriters will be obligated to purchase all of the securities if they purchase any of the securities. If underwriters are used in the sale of any securities, the securities will be acquired by the underwriters for their own account and may be resold from time to time in one or amongmore transactions described above. The securities may be either offered to the public through underwriting syndicates represented by managing underwriters, or directly by underwriters. Generally, the underwriters’ obligations to purchase the securities will be subject to certain conditions precedent. If a dealer is used in a sale, we may sell the securities to the dealer as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale.

We or our agents may solicit offers to purchase securities from time to time. Unless stated otherwise in the applicable prospectus supplement, any shareholder, broker, dealer,agent will be acting on a best efforts basis for the period of its appointment.

In connection with the sale of securities, underwriters or agents may receive compensation (in the form of fees, discounts, concessions or commissions) from us or from purchasers of securities for whom they may act as agents. Underwriters may sell securities to or through dealers, and such dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers for whom they may act as agents. Underwriters, dealers and agents that participate in the distribution of securities may be deemed to be “underwriters,” as that term is defined in the Securities Act, and any discounts or commissions received by them from us and any profits on the resale of the securities by them may be deemed to be underwriting

discounts and commissions under the Securities Act. We will identify any such underwriter or agent, relatingand we will describe any compensation paid to them, in the sale or distribution of the underlying Common Shares.related prospectus supplement.

 

Financial Advisor

We have engaged River Branch Capital LLC, a broker-dealer registeredUnderwriters, dealers and agents may be entitled under agreements with the Financial Industry Regulatory Authority, as our financial advisor in connection with the rights offering. River Branch Capital LLC is an investment banking firm specializing in the financial services industry. As part of its investment banking business, River Branch Capital LLC is engaged in the valuation of bankus to indemnification against and bank holding company securities in connection with mergers and acquisitions, private placements and valuations for various other purposes. River Branch Capital LLC has not prepared any report or opinion constituting a recommendation to any subscriber for our Common Shares.

We will pay the fees and all of our expenses related to the rights offering. We have engaged River Branch Capital LLC connection with the rights offering. We will pay River Branch Capital LLC a fee of $100,000, of which $50,000 has been paid and $50,000 is payable January 1, 2013, and reimburse their reasonable out-of-pocket expenses for serving as our financial advisor.

River Branch Capital LLC does not have any obligation or commitment to sell any Common Shares in the rights offering or to acquire any shares for its own account or with a view to their distribution.

We have agreed to indemnify River Branch Capital LLC againstcontribution toward certain civil liabilities, including liabilities under the Securities Act, of 1933, as amended, and to contributeor contribution with respect to payments that River Branch Capital LLCthe underwriters, dealers or agents may be requiredmake with respect to make in respect of these liabilities.

 

DESCRIPTION OF OUR CAPITAL STOCK

The Corporation’s authorized capital stock consists of 18,000,000 Common Shares, with no par value per share, and 500,000 preferred shares, with no par value per share. As of March 30, 2012, 3,419,736 Common Shares were issued and outstanding, and 11,000 preferred shares, comprised solely of our Fixed Rate Cumulative Perpetual Preferred Shares, Series A were issued and outstanding.  In addition,If stated in the Treasury holds a warrantapplicable prospectus supplement, we may authorize underwriters, dealers or agents to solicit offers by certain investors to purchase 379,310 Common Shares.  The Corporation is authorized under its Articles of Incorporation to issue additional shares of authorized capital stock, and our board of directors is authorized to setsecurities from us at the terms of preferred shares, generally without shareholder approval. An amendment to the Corporation’s Articles of Incorporation to change the authorized capital stock requires the approval of the Corporation’s board of directors and shareholders.  If SCI does not receive the Federal Reserve Approval by the completion of the rightspublic offering then the Corporation will file a Certificate of Designation setting forth the rights and preferences of our Series B Preferred Shares with the State of Michigan’s Department of Licensing and Regulatory Affairs to enable the Corporation to issue the No Approval Preferred Shares in connection with the SCI Investment.  See “Description of the Subscription Rights—The SCI Securities Purchase Transaction—Mandatorily Convertible Cumulative Participating Series B Preferred” on page [    ·    ].

This description of our capital stock is only a summary and is qualified by applicable law and by the provisions of our Articles of Incorporation and Bylaws, copies of which are available as set forth under “Where You Can Find More Information” on page [    ·    ].

Description of Common Shares

The following summary describes the material features and rights of our Common Shares. This summary does not purport to be exhaustive and is qualified in its entirety by reference to our Articles of Incorporation, our Bylaws and the Michigan Business Corporation Act (the “MBCA”). The Corporation’s Articles of Incorporation and Bylaws are, and any amendments to them will be, incorporated by reference into this registration statement.

Voting Rights

Holders of our Common Shares are entitled to one (1) vote for each share that they hold and are vested with all of the voting power except as our board of directors has provided, or may provide in the future, with respect to preferred shares or any other class or series of preferred shares that the board of directors may hereafter authorize.

26



Table of Contents

Dividend Rights

Subject to the prior rights of holders of our preferred shares and the informationprice set forth in “Market For Our Common Sharesthe prospectus supplement under delayed delivery contracts providing for payment and Dividend Policy—Dividends,” holders of our Common Shares are entitleddelivery on a specified date in the future. These contracts will be subject only to receive dividends if and when declared by our board of directors or any duly authorized committee ofthose conditions set forth in the board of directors, out of assets legally available for dividends. We expect to pay dividends on our Common Shares only if we have paid or provided for all dividends on our outstanding series of preferred shares for the then current period and all prior periods and are in compliance with all applicable regulations.

Liquidation and Dissolution

In the event of the liquidation, dissolution and winding up of the Corporation, the holders of our Common Shares are entitled, upon our liquidation, and after claims of creditorsprospectus supplement, and the preferencesapplicable prospectus supplement will set forth the commission payable for solicitation of any class or series of preferred shares outstanding at the time of liquidation, to receive a pro rata share of our net assets.

Shareholder Approval of a Merger, Share Exchange, Sale of Assets or Dissolution

Subject to the provisions of Michigan law, a merger or share exchange, sale of all or substantially all of the Corporation’s assets not in the regular course of business or dissolution must be approved by a majority of the shareholder votes entitled to be cast thereon.

Special Meetings of Shareholders

Special meetings of shareholders may be called by the Chairman of the Board, the President or the Secretary and shall be called by either of them pursuant to resolution therefor by the board of directors. The Corporation’s Bylaws require that notice of a special shareholders’ meeting generally be given not less than ten (10) nor more than sixty (60) days before the date of the meeting, by mailing such notice to the shareholder at the address appearing on the stock transfer books of the Corporation or by delivery in person to such shareholder.

Other Rights

Holders of our Common Shares generally have no right to purchase or subscribe for any shares of the Corporation authorized but unissued at this time, or for any shares or other certificates of indebtedness of whatever kind and nature which may hereafter be authorized and issued, except as specifically provided by this offering or as authorized in the future pursuant to the Articles of Incorporation, the Bylaws and Michigan law.

Description of Preferred Shares

Subject to Michigan law and the terms of our Articles of Incorporation, our board of directors, in accordance with the MBCA, may authorize the issuance of preferred shares. The board of directors is authorized to fix and determine the powers, rights, designations, preferences, qualifications, limitations, voting rights and restrictions on any such series of preferred shares.

The Corporation currently has one (1) designated series of preferred shares: Fixed Rate Cumulative Perpetual Preferred Stock, Series A (the “TARP Preferred”).

The TARP Preferredthese contracts.

 

The following is a brief descriptionsecurities we may offer, other than common stock, may be new issues of securities with no established trading market. No assurance can be given as to the liquidity of the TARP Preferred series that was issuedtrading market for any of our securities. Any underwriter may make a market in these securities. However, no underwriter will be obligated to do so, and any underwriter may discontinue any market making at any time, without prior notice. Therefore, we cannot give any assurances to you concerning the Treasury on April 24, 2009.  The descriptionliquidity of the TARP Preferred contained herein is qualified in its entiretyany security offered by the actual terms of the TARP Preferred, the description of which is attached as an exhibit to our Current Report on Form 8-K filed on April 24, 2009, and incorporated by reference into this prospectus.

 

Outstanding Shares

AsIn connection with an offering of securities, underwriters may purchase and sell these securities in the open market. Any underwriter may engage in over-allotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation M under the Exchange Act. Over-allotment involves sales in excess of the date hereof, there are 11,000 shares of TARP Preferred issued and outstanding, withoffering size, which create a liquidation amount $1,000 per share.  The TARP Preferred series was issued on April 24, 2009, as part of the Capital Purchase Program under TARP, and, in connection therewith, the Corporation entered into a Letter Agreement that incorporated an attached Securities Purchase Agreement-Standard Terms (collectively, the “Purchase Agreement”) with the Treasury. Under the Purchase Agreement, the Corporation agreed to issue and sell to the U.S. Treasury (i) 11,000 shares of the TARP Preferred and (ii) a warrant (the “TARP Warrant”)short position. Stabilizing transactions permit bids to purchase 379,310 Common Shares.  The terms of the TARP Warrant are described under “Description of Warrants” below.

27



Table of Contents

Dividends

Holders of shares of the TARP Preferred are entitled, if and when declared by our board of directors or any duly authorized committee of the board of directors, to cumulative cash dividends out of assets legally available for dividends, at a rate of 5% per annum for the first five (5) years and 9% per annum thereafter.

Priority of Dividends

The TARP Preferred rankssenior to the Common Shares and senior to or pari passu with all other series or classes of preferred shares with respect to dividends and distributions and amounts payable upon liquidation, dissolution and winding up of the Corporation.

Sounderlying security so long as the TARP Preferred remains outstanding, westabilizing bids do not exceed a specified maximum price. Syndicate-covering or other short-covering transactions involve purchases of the securities, either through exercise of the over-allotment option or in the open market after the distribution is completed, to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are generally not permittedpurchased in a stabilizing or covering transaction to declare or pay dividends or distributionscover short positions. Those activities may cause the price of the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of the activities at any time.

Any underwriters who are qualified market makers on the Common Shares or any other shares of juniorNASDAQ Stock Market LLC may engage in passive market making transactions in our common stock, (other than dividends payable solely in Common Shares) or paritypreferred stock and no Common Shares, junior stockwarrants, as applicable, on the NASDAQ Stock Market LLC in accordance with Rule 103 of Regulation M, during the business day prior to the pricing of the offering, before the commencement of offers or parity stock shallsales of the securities. Passive market makers must comply with applicable volume and price limitations and must be directlyidentified as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest independent bid for such security; if all independent bids are lowered below the passive market maker’s bid, however, the passive market maker’s bid must then be lowered when certain purchase limits are exceeded. Passive market making may stabilize the market price of the securities at a level above that which might otherwise prevail in the open market and, if commenced, may be discontinued at any time.

Underwriters, dealers and agents and their affiliates may be customers of, engage in transactions with, or indirectly, purchased, redeemed or otherwise acquiredperform services for consideration by us or our subsidiary unless all accrued and unpaid dividends for all past dividend periods, including the latest completed dividend period, on all outstanding shares of TARP Preferred have been or are contemporaneously declared and paid in full. The following exceptions, however, are permissible:

·Purchases, redemptions or other acquisitions of our Common Shares or other junior stock in connection with the administration of our employee benefit planssubsidiaries in the ordinary course of business and consistent with past practice;

·acquisitions by the Corporation or any of its subsidiaries or record ownership in junior stock or parity stock for the beneficial ownership of any other person (other than the Corporation or any of its subsidiaries), including as trustees or custodians; and

·the exchange or conversion of junior stock for or into other junior stock or of parity stock for or into other parity stock (with the same or lesser aggregate liquidation amount) or junior stock, in each case, solely to the extent required pursuant to binding contractual agreements entered into before April 24, 2009, or any subsequent agreement for the accelerated exercise, settlement or exchange thereof for Common Shares.

Redemption

The TARP Preferred may not be redeemed prior to May 5, 2012, unless we have received aggregate gross proceeds from one or more qualified equity offerings (as described below) equal to $550,000, which equals 5% of the aggregate liquidation amount of the TARP Preferred on the date of issuance.their businesses. In such a case, we may redeem the TARP Preferred, subject to the approval of the Federal Reserve Board and the FDIC, in whole or in part, upon notice as described below, up to a maximum amount equal to the aggregate net cash proceeds received by us from such qualified equity offerings. A “qualified equity offering” is a sale and issuance for cash by us, to persons other than the Corporation or its subsidiaries after April 24, 2009, of perpetual preferred shares, common shares or a combination thereof, that in each case qualify as “tier 1 capital” of the Corporation at the time of issuance under the applicable risk-based capital guidelines of the FDIC. Qualified equity offerings do not include issuances made in connection with any such sales or issuances made pursuant to agreements or arrangements entered into, or pursuant to financing plans that were publicly announced, on or prior toOctober 18, 2008.

Notwithstanding the foregoing, the American Recovery and Reinvestment Act of 2009 (“ARRA”), which was signed into law on February 17, 2009, provides that the Secretary of the U.S. Treasury shall permit, subject to consultation with the recipient’s appropriate federal banking agency, a recipient of funds under the Capital Purchase Program to repay such assistance previously provided under the Capital Purchase Program, without regard to whether the recipient has replaced such funds from any other source or to any waiting period. It appears that ARRA will permit us, if we so elect and following consultation with the Federal Reserve Board and the FDIC, to redeem the TARP Preferred at any time without restriction.

After May 15, 2012, the TARP Preferred may be redeemed at any time, subject to the approval of the Federal Reserve Board and the FDIC, in whole or in part, subject to notice as described below.

In any redemption, the redemption price is an amount equal to the per share liquidation amount of $1,000 per share plus accrued and unpaid dividends up to, but excluding the date of, redemption.

The TARP Preferred will not be subject to any mandatory redemption, sinking fund or similar provisions. Holders of shares of the TARP Preferred have no right to require the redemption or repurchase of the TARP Preferred.

28



Table of Contents

If fewer than all of the outstanding shares of the TARP Preferred are to be redeemed, the shares to be redeemed will be selected either pro rata from the holders of record of shares of the TARP Preferred in proportion to the number of shares held by those holders or in such other manner as our board of directors or a committee thereof may determine to be fair and equitable.

We must mail notice of any redemption of the TARP Preferred by first class mail, postage prepaid, addressed to the holders of record of the shares of the TARP Preferred to be redeemed at their respective last addresses appearing on our books. This mailing must be at least thirty (30) days and not more than sixty (60) days before the date fixed for redemption. Any notice mailed or otherwise given as described in this paragraph will be conclusively presumed to have been duly given, whether or not the holder receives the notice, and failure duly to give the notice by mail or otherwise, or any defect in the notice or in the mailing or provision of the notice, to any holder of the TARP Preferred designated for redemption will not affect the redemption of any other holder of the TARP Preferred. Each notice of redemption must set forth the applicable redemption date, the redemption price, the place where shares of the TARP Preferred are to be redeemed and the number of shares of the TARP Preferred to be redeemed (and, if less than all shares of the TARP Preferred held by the applicable holder, the number of shares to be redeemed from the holder).

Shares of the TARP Preferred that are redeemed, repurchased or otherwise acquired by us will revert to authorized but unissued shares of our preferred shares.

Liquidation Rights

In the event that we voluntarily or involuntarily liquidate, dissolve or wind up our affairs, holders of the TARP Preferred will be entitled to receive an amount per share, referred to as the total liquidation amount, equal to the fixed liquidation preference of $1,000per share, plus any accrued and unpaid dividends, whether or not declared, to the date of payment. Holders of the TARP Preferred will be entitled to receive the total liquidation amount out of our assets that are available for distribution to shareholders, after payment or provision for payment of our debts and other liabilities, but before any distribution of assets is made to holders of our Common Shares or any other shares ranking, as to that distribution, junior to the TARP Preferred.

If our assets are not sufficient to pay the total liquidation amount in full to all holders of the TARP Preferred and all holders of any shares of outstanding parity stock, the amounts paid to the holders of the TARP Preferred and other shares of parity stock will be paid  pro rata  in accordance with the respective total liquidation amount for those holders. If the total liquidation amount per share of the TARP Preferred has been paid in full to all holders of the TARP Preferred and other shares of parity stock, the holders of our Common Shares or any other shares ranking, as to such distribution, junior to the TARP Preferred, will be entitled to receive all of our remaining assets according to their respective rights and preferences.

For purposes of the liquidation rights, neither the sale, conveyance, exchange or transfer of all or substantially all of our property and assets, nor the consolidation or merger by us with or into any other corporation or by another corporation with or into us, will constitute a liquidation, dissolution or winding-up of our affairs.

Voting Rights

Except as indicated below or otherwise required by law, the holders of TARP Preferred do not have any voting rights.

Election of Two (2) Directors upon Non-Payment of Dividends.  In the event that dividends payable on the shares of TARP Preferred have not been paid for an aggregate of six (6) or more quarterly dividend periods, whether or not consecutive, the authorized number of directors then constituting our board would be automatically increased by two (2), and the holders of TARP Preferred, together with the holders of any outstanding parity stock with like voting rights, referred to as voting parity stock, voting as a single class, would be entitled to elect the two (2) additional members of our board of directors, referred to as the “Preferred Stock Directors,” at the next annual meeting (or at a special meeting called for the purpose of electing the Preferred Stock Directors prior to the next annual meeting) and at each subsequent annual meeting until all accrued and unpaid dividends for all past dividend periods have been paid in full. The election of any Preferred Stock Directors is subject to the condition that the election would not cause us to violate any corporate governance requirements relating to board independence of any securities exchange or other trading facility on which our securities may then be listed or traded.

Upon the termination of the right of the holders of TARP Preferred and voting parity stock to vote for Preferred Stock Directors, as described above, the Preferred Stock Directors would immediately cease to be qualified as directors, their term of office would terminate immediately and the number of authorized directors of the Corporation would be reduced by the number of Preferred Stock Directors that the holders of TARP Preferred and voting parity stock had been entitled to elect. The holders of a majority of the TARP Preferred and voting parity stock shares, voting as a class, may remove any Preferred Stock Director, with or without cause, and the holders of a majority of the TARP Preferred and voting parity stock shares, voting as a class, may fill any vacancy created by

29



Table of Contents

the removal of a Preferred Stock Director. If the office of a Preferred Stock Director becomes vacant for any other reason, the remaining Preferred Stock Director may choose a successor to fill such vacancy for the remainder of the unexpired term.

Other Voting Rights. So long as any shares of TARP Preferred are outstanding, the vote or consent of the holders of at least 66 2/3 % of the shares of TARP Preferred at the time outstanding, voting as a separate class, shall be necessary for effecting or validating:

·Any amendment or alteration of the Articles of Incorporation, as amended, to authorize or create or increase the authorized amount of, or any issuance of, any shares of, or any securities convertible into or exchangeable or exercisable for shares of, any class or series of our capital stock ranking senior to TARP Preferred with respect to either or both the payment of dividends and/or the distribution of assets on any liquidation, dissolution or winding up of the Corporation;

·Any amendment, alteration or repeal of any provision of the Articles of Incorporation, as amended, for the TARP Preferred so as to adversely affect the rights, preferences, privileges or voting powers of the TARP Preferred; or

·Any consummation of a binding share exchange or reclassification involving the TARP Preferred, or of a merger or consolidation of the Corporation with another entity, unless the shares of TARP Preferred remain outstanding following any such transaction or, if the Corporation is not the surviving entity, are converted into or exchanged for preference securities and such remaining outstanding shares of TARP Preferred or preference securities have rights, preferences, privileges and voting powers that are not materially less favorable than the rights, preferences, privileges or voting powers of the TARP Preferred immediately prior to such consummation, taken as a whole.

The foregoing voting provisions would not apply if, at or prior to the time when the vote or consent would otherwise be required, all outstanding shares of TARP Preferred have been redeemed or called for redemption upon proper notice and sufficient funds have been set aside by us for the benefit of the holders of TARP Preferred to effect the redemption.

Conversion

Holders of TARP Preferred shares have no right to exchange or convert such shares into any other securities.

No Preemptive Rights

No share of TARP Preferred shall have any rights of preemption whatsoever as to any securities of the Corporation, or any warrants, rights or options issued or granted with respect thereto, regardless of how such securities, or such warrants, rights or options may be designated, issued or granted.

Other Rights

The shares of TARP Preferred do not have any rights, preferences, privileges or voting powers or relative, participating, optional or other special rights or qualifications, limitations or restrictions thereof, other than as set forth in the Articles of Incorporation or as provided by applicable law.

More Information

More information regarding TARP Preferred can be found in our Current Report on Form 8-K and the exhibits attached thereto, filed with the SEC on April 24, 2009, which is incorporated into the registration statement of which this prospectus is a part by reference.

Description of Warrants

The following is a brief description of the TARP Warrant that was issued to the Treasury on April 24, 2009. The description of the TARP Warrant contained in this section is qualified in its entirety by the actual terms of the TARP Warrant, a form of which is attached as an exhibit to our Current Report on Form 8-K filed on April 24, 2009, and incorporated by reference into this prospectus.

Common Shares Subject to the TARP Warrant

The Warrant is initially exercisable for 379,310 Common Shares.

30



Table of Contents

Exercise of the TARP Warrant

The initial exercise price applicable to the TARP Warrant is $4.35per Common Share. The TARP Warrant may be exercised at any time on or before April 24, 2019, by surrender of the TARP Warrant and a completed notice of exercise attached as an annex to the TARP Warrant and the payment of the exercise price for the Common Shares for which the TARP Warrant is being exercised. The exercise price may be paid either by the withholding by the Corporation of such number of Common Shares issuable upon exercise of the TARP Warrant equal to the value of the aggregate exercise price of the TARP Warrant determined by reference to the market price of our Common Shares on the trading day on which the TARP Warrant is exercised or, if agreed to by us and the holder of the TARP Warrant, by the payment of cash equal to the aggregate exercise price. The exercise price applicable to the TARP Warrant is subject to the further adjustments described belowoffered under the heading “Adjustments to the TARP Warrant.”

Upon exercise of the TARP Warrant, certificates for the Common Shares issuable therefor will be issued to the holder of the TARP Warrant. We will not issue fractional shares upon any exercise of the TARP Warrant. Instead, the holder of the TARP Warrant will be entitled to a cash payment equal to the market price of our Common Shares on the last trading day preceding the exercise of the TARP Warrant (less the pro-rated exercise price of the TARP Warrant) for any fractional shares that would have otherwise been issuable upon exercise of the TARP Warrant. We must at all times reserve the aggregate number of Common Shares for which the TARP Warrant may be exercised.

Rights as a Shareholder

The holder of the TARP Warrant has no rights or privileges of the holders of our Common Shares, including any voting rights, until (and then only to the extent) the TARP Warrant has been exercised.

Transferability and Assignability

The TARP Warrant, and all rights under the TARP Warrant, are transferable and assignable.

Adjustments to the TARP Warrant

Adjustments in Connection with Stock Dividends, Stock Splits, Subdivisions, Reclassifications and Combinations.  The number of shares for which the TARP Warrant may be exercised and the exercise price applicable to the TARP Warrant will be proportionately adjusted in the event we pay stock dividends or make distributions of our Common Shares, subdivide, combine or reclassify outstanding Common Shares.

Certain Issuances.  Until the earlier of April 24, 2012, and the date the Treasury no longer holds the TARP Warrant (and other than in certain permitted transactions described below), if we issue any Common Shares (or securities convertible or exercisable into Common Shares) at a price per share less than the applicable per share warrant exercise price, then the exercise price under the TARP Warrant shall be adjusted to equal the consideration per Common Share received by the Corporation in connection with such issuance, and the number of Common Shares into which the TARP Warrant is exercisable will be adjusted. Permitted transactions include issuances:

·as consideration for or to fund the acquisition of businesses and/or related assets at fair market value;

·in connection with employee benefit plans and compensation related arrangements in the ordinary course and consistent with past practice approved by our board of directors;

·in connection with public or broadly marketed offerings and sales of Common Shares or convertible securities for cash conducted by us or our affiliates pursuant to registration under the Securities Act, or Rule 144A thereunder, on a basis consistent with capital-raising transactions by comparable financial institutions; and

·in connection with the exercise of preemptive rights on terms existing as of the TARP Warrant issue date.

Other Distributions

If we declare any dividends or distributions other than stock dividends, the exercise price of the TARP Warrant will be adjusted to reflect such distribution.

31



Table of Contents

Certain Repurchases

If we effect a pro rata repurchase of Common Shares, both the number of shares issuable upon exercise of the TARP Warrant and the exercise price will be adjusted.

Business Combinations

In the event of a merger, consolidation or similar transaction involving the Corporation and requiring shareholder approval, the TARP Warrant holder’s right to receive Common Shares upon exercise of the TARP Warrant shall be converted into the right to exercise the TARP Warrant for the consideration that would have been payable to the TARP Warrant holder with respect to the Common Shares for which the TARP Warrant may be exercised, as if the TARP Warrant had been exercised prior to such merger, consolidation or similar transaction.

More Information

More information regarding the TARP Warrant can be found in our Current Report on Form 8-K and the exhibits attached thereto, filed with the SEC on April 24, 2009, which is incorporated into the registration statement of which this prospectus is a part by reference.

DESCRIPTION OF THE SUBSCRIPTION RIGHTS

The Subscription Rights

We are distributing to holders of our Common Shares as of 5:00 p.m., Eastern Time, on April 6, 2012, which is the Record Date for this rights offering, at no charge, non-transferable subscription rights to purchase our Common Shares. You will receive approximately three hundred fifty-six thousandths (0.356) of a subscription right for each Common Share you owned at the close of business on the Record Date. The subscription rights will be evidenced by subscription rights certificates. Subscription rights may only be exercised in whole numbers; we will not issue fractional shares and will round all of the subscription rights down to the nearest whole number, but may round up to the nearest whole number with respect to the over-subscription privilege.  As a result, we may not issue the full number of shares authorized for issuance in connection with the rights offering. Any excess subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable.

Basic Subscription Privilege

Each whole subscription right that you own will entitle you to purchase one (1) Common Share at a Subscription Price of $5.75 per share. You may exercise your basic subscription privilege for some or all of your subscription rights, or you may choose not to exercise any subscription rights.

For example, if you owned one thousand (1,000) Common Shares as of 5:00 p.m., Eastern Time, on the Record Date, you would receive three hundred fifty-six (356) whole subscription rights and would have the right to purchase three hundred fifty-six (356) Common Shares for $5.75 per share with your basic subscription privilege.

We determined the number of Common Shares to be offered and the fractional subscription right to attach to each whole Common Share based on the total Common Shares outstanding on the Record Date and the number of Common Shares underlying this rights offering. Because we are offering subscription rights to purchase $7.0 million of Common Shares at $5.75 per Common Share, the subscription rights must be exercisable for 1,217,391 Common Shares ($7.0 million divided by $5.75). To determine the number of subscription rights to attach to each outstanding Common Share, we divided the number of Common Shares that we are offering (1,217,391) by the 3,419,736 currently outstanding Common Shares eligible to participate. The result, to the third decimal place, is that each shareholder will receive three hundred fifty-six thousandths (.356) of a subscription right for each whole Common Share owned by such shareholder.  Accordingly, you will need to own at least three (3) Common Shares in order to exercise a full subscription right for one (1) Common Share in this rights offering.

Over-Subscription Privilege

If you exercise your basic subscription privilege in full, you will also have an over-subscription privilege to subscribe for any shares that our other subscription rights holders do not purchase under their basic subscription privilege. The Subscription Price for shares purchased pursuant to the over-subscription privilege will be the same as the Subscription Price for the basic subscription privilege.

You may exercise your over-subscription privilege only if you exercise your basic subscription privilege in full. To determine if you have fully exercised your basic subscription privilege, we will consider only the basic subscription privileges held by you in the

32



Table of Contents

same capacity. For example, if you are granted subscription rights for our Common Shares that you own individually and our Common Shares that you own jointly with your spouse, you may exercise your over-subscription privilege with respect to the subscription rights you own individually, as long as you fully exercise your basic subscription privilege with respect to your individually owned subscription rights. You will not, however, be able to exercise the over-subscription privilege you have collectively with your spouse unless the basic subscription privilege collectively held by you and your spouse is fully exercised. You do not have to subscribe for any shares under the basic subscription privilege owned jointly with your spouse to exercise your individual over-subscription privilege.

When you complete the portion of your subscription rights certificate to exercise your over-subscription privilege, you will be representing and certifying that you have fully exercised your subscription privileges as to Common Shares that you hold in that capacity. You must exercise your over-subscription privilege at the same time you exercise your basic subscription privilege in full.  Because we will not know the total number of unsubscribed Common Shares before the rights offering expires, if you wish to maximize the number of Common Shares you may purchase pursuant to your over-subscription privilege, you will need to deliver payment in an amount equal to the aggregate subscription price for the maximum number of Common Shares that may be available to you (i.e., the aggregate payment for both your basic subscription rights and for any additional shares you desire to purchase pursuant to your over-subscription privileges).  To properly exercise your over-subscription privilege, you must deliver the subscription payment related to your over-subscription privilege before the rights offering expires.

We reserve the right to reject in whole or in part any over-subscription requests, regardless of the availability of shares to satisfy these requests.

Common Shares available to our shareholders pursuant to the over-subscription privilege will be allocated pursuant to a two-step process. The maximum number of Common Shares purchasable by a shareholder in the first step of the allocation process will be limited to the result of: (x) the total number of unsubscribed Common Shares multiplied by (y) the number of subscription rights that were distributed to such shareholder divided by (z) the number of subscription rights distributed to all holders of Common Shares as of the Record Date. Shareholders whose over-subscription requests exceed the Common Share limitation of the first step of the allocation process will proceed to the second step, where we will seek to honor over-subscription requests in full if sufficient Common Shares are available. If over-subscription requests for Common Shares in the second step of the allocation process exceed the number of Common Shares available, however, we will allocate the available Common Shares pro rata among the shareholders participating in the second step of the allocation process in proportion to the number of subscription rights that were distributed to each of those shareholders relative to the number of subscription rights distributed to all holders of Common Shares participating in the second step of the allocation, with the number of Common Shares rounded up or down, as applicable, to result in the allocation of whole Common Shares. If this pro rata allocation results in any shareholder receiving a greater number of Common Shares than for which the shareholder subscribed pursuant to the exercise of the over-subscription privilege, then such shareholder will be allocated only that number of Common Shares for which the shareholder oversubscribed, and the remaining Common Shares will be allocated among all other shareholders exercising the over-subscription privilege on the same pro rata basis described above. The proration process will be repeated until all Common Shares have been allocated.

For example, if: (i) there are one hundred (100) excess Common Shares available for purchase by three (3) shareholders who have timely and fully exercised their basic subscription privileges with respect to all the subscription rights they hold and (ii) shareholder A, who received 15% of the subscription rights distributed to all holders of Common Shares as of the Record Date, requests the purchase of one hundred (100) Common Shares pursuant to shareholder A’s over-subscription privilege, shareholder B, who received 10% of the subscription rights distributed to all holders of Common Shares as of the Record Date, requests the purchase of fifty (50) Common Shares pursuant to shareholder B’s over-subscription privilege, and shareholder C, who received 5% of the subscription rights distributed to all holders of Common Shares as of the Record Date, requests the purchase of twenty (20) Common Shares pursuant to shareholder C’s over-subscription privilege, then, assuming the valid exercise of each of these shareholder’s basic subscription privileges and receipt of sufficient payment for the Common Shares requested pursuant to the over-subscription request, in the first step of the allocation process of the over-subscription privilege: shareholder A would receive fifteen (15) Common Shares, shareholder B would receive ten (10) Common Shares and shareholder C would receive five (5) Common Shares. In the second step of the allocation process: shareholder A would receive thirty-five (35) Common Shares, shareholder B would receive twenty-three and thirty-three hundredths (23.33) Common Shares (rounded down to twenty-three (23) Common Shares, with the total subscription payment being adjusted accordingly) and shareholder C would receive eleven and sixty-seven  hundredths (11.67) Common Shares (rounded up to twelve (12) Common Shares, with the total subscription payment being adjusted accordingly).

Registrar & Transfer Company, our subscription agent for the rights offering, will determine the over-subscription allocation based on the formula described above. Any excess subscription payments received by the subscription agent will be returned as soon as practicable, without interest or penalty.

33



Table of Contents

Limitation on the Purchase of Common Shares

As a bank holding company, we are subject to regulation by the Federal Reserve Board. The Federal Reserve Board has the authority to prevent individuals and entities from acquiring control of us. Under Federal Reserve Board rules and regulations, if you, directly or indirectly, or through one or more subsidiaries or acting in concert with one or more persons or entities will own 10% or more of our voting stock after giving effect to the rights offering and the SCI Investment, then you will be presumed to control us. This presumption of control is rebuttable; however, it is likely that you will need to submit materials to the Federal Reserve Board or enter into what is referred to as a passivity commitment, to successfully rebut this presumption. If, after giving effect to the rights offering and the SCI Investment, you will hold 25% or more of our voting stock, you will be conclusively presumed to control us, and the Federal Reserve Board will require that an application or other documentation be filed prior to obtaining this level of control.

We will not issue Common Shares pursuant to the exercise of basic subscription privileges or over-subscription privileges to any shareholder who, in our sole opinion, could be required to obtain prior clearance or approval from or submit a notice to any state or federal bank regulatory authority, including the Federal Reserve Board, to acquire, own or control such Common Shares if, as of the closing of the rights offering, such clearance or approval has not already been obtained or any applicable waiting period has not expired. If we elect not to issue Common Shares in such a case, the unissued Common Shares will become available to satisfy over-subscriptions by other shareholders.

You are urged to consult your own legal counsel regarding whether you are required to seek the prior approval of the Federal Reserve Board or any other bank regulatory authority in connection with your exercise of the subscription rights issued to you.

Effects of Rights Offering on Ownership of Certain Beneficial Owners and Management

The following table sets forth information regarding the beneficial ownership of our Common Shares as of March 30, 2012 by our directors, executive officers and 5% beneficial owners, and the potential effects of the rights offering.

The information provided in the table below is based on our records, information filed with the SEC and information provided to us, except where otherwise noted.

Name of Beneficial Owner Directors and Executive
Officers

 

Amount and
Nature of
Beneficial
Ownership(1) (2)

 

Percent
of
Class(1) (2)

 

Percentage of Class if
all Holders Exercise

Subscription
Rights(1)(2)

 

Paul D. Tobias, Chairman and Chief Executive Officer (3)

 

152,586

 

4.35

%

3.21

%

 

 

 

 

 

 

 

 

Kelly W. George, President

 

20,716

 

0.59

%

0.45

%

 

 

 

 

 

 

 

 

Ernie R. Krueger, Executive Vice President/CFO

 

19,166

 

0.55

%

0.43

%

 

 

 

 

 

 

 

 

Walter J. Aspatore, Director

 

13,264

 

0.38

%

0.30

%

 

 

 

 

 

 

 

 

Dennis B. Bittner, Director

 

5,016

 

0.14

%

0.11

%

 

 

 

 

 

 

 

 

Joseph D. Garea, Director

 

52,228

 

1.49

%

1.25

%

 

 

 

 

 

 

 

 

Robert E. Mahaney, Director

 

7,261

 

0.21

%

0.17

%

 

 

 

 

 

 

 

 

Robert H. Orley, Director

 

27,641

 

0.79

%

0.65

%

 

 

 

 

 

 

 

 

Randolph C. Paschke, Director

 

16,165

 

0.46

%

0.37

%

 

 

 

 

 

 

 

 

L. Brooks Patterson, Director

 

2,000

 

0.06

%

0.04

%

 

 

 

 

 

 

 

 

All current executive officers and directors as a group (10) persons

 

316,368

 

9.01

%

6.99

%

 

 

 

 

 

 

 

 

Financial Stocks Capital
Partners III LP
441 Vine Street,
Suite 507 Cincinnati, OH 45202

 

340,000

 

9.68

%

8.13

%

 

 

 

 

 

 

 

 

Gerlach & Co.
FBO Banc Fund V LP
208 LaSalle Street, Suite 1680
Chicago, IL 60604

 

300,000

 

8.54

%

7.18

%

 

 

 

 

 

 

 

 

Raymond Garea
31 Claremont Avenue
Maplewood, NJ 07040

 

231,137

 

6.58

%

5.53

%

 

 

 

 

 

 

 

 

Wellington Management Company LLP
75 State Street
Boston, MA 02109

 

212,380

 

6.05

%

5.08

%

 

 

 

 

 

 

 

 

PRB Advisors, LLC
600 Third Avenue, 17
th Floor
New York, NY 10016

 

290,496

 

8.27

%

6.95

%

 

 

 

 

 

 

 

 

Hillsdale Hourly Pension Plan
2424 John Daly Road
Inkster, MI 48141

 

235,911

 

6.72

%

5.64

%

34



Table of Contents


(1)This table is based upon information supplied by officers and directors. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, the Corporation believes that each of the shareholders named in this table has sole voting and investment power with respect to the shares indicated as beneficially owned. Applicable percentages are based on shares outstanding on March 30, 2012, adjusted as required by rules promulgated by the SEC.

(2)Includes the following shares subject to options exercisable within 60 days of April 19, 2011: Mr. Aspatore — 2,000, Mr. Bittner — 2,000, Mr. George — 7,000, Mr. Krueger — 4,000, Mr. Orley — 2,000, Mr. Paschke — 2,000, Mr. Patterson — 2,000, Mr. Tobias — 70,502, all current Directors and Executive Officers as a group — 91,827.

(3)Includes 10,256 shares owned by Tobias Capital LLC, which is 35% owned by Mr. Tobias and his wife.

Method of Exercising Subscription Rights

The exercise of subscription rights is irrevocable and may not be cancelled or modified. You may exercise your subscription rights as follows:

Subscription by Registered Holders

You may exercise your subscription rights by properly completing and executing the rights certificate together with any required signature guarantees and forwarding it, together with your full subscription payment, to the subscription agent prior to the expiration of the rights offering.

Subscription by Beneficial Owners

If you are a beneficial owner of our Common Shares that are registered in the name of a broker, custodian bank or other nominee, or if you hold our Common Share certificates and would prefer to have an institution conduct the transaction relating to the subscription rights on your behalf, you should instruct your broker, custodian bank or other nominee or institution to exercise your subscription rights and deliver all documents and payment on your behalf prior to 5:00 p.m., Eastern Time, on [    ·    ], 2012, which is the expiration of the rights offering. Your subscription rights will not be considered exercised unless the subscription agent receives from you, your broker, custodian bank, nominee or institution, as the case may be, all of the required documents and your full subscription payment prior to 5:00 p.m., Eastern Time, on [    ·    ], 2012.

35



Table of Contents

Payment Method

Your payment of the Subscription Price must be made in U.S. dollars for the full number of Common Shares you wish to acquire under the basic subscription privilege and the over-subscription privilege. Your payment must be delivered in one of the following ways:

·uncertified check drawn upon a U.S. bank and payable to Mackinac Financial Corporation; or

·certified check drawn upon a U.S. bank and payable to Mackinac Financial Corporation.

Receipt of Payment

Your payment will be considered received by the subscription agent only upon:

·clearance of any uncertified personal check deposited by the subscription agent; or

·receipt by the subscription agent of any certified check drawn upon a U.S. bank.

Clearance of Uncertified Personal Checks

If you are paying by uncertified personal check, please note that payment will not be deemed to have been received by the subscription agent until the check has cleared, which could take at least five (5) or more business days. If you wish to pay the Subscription Price by uncertified personal check, we urge you to make payment sufficiently in advance of the time the rights offering expires to ensure that your payment is received by the subscription agent and clears by the rights offering expiration date. We urge you to consider using a certified check made payable to Mackinac Financial Corporation.

Instructions for Completing Your Subscription Rights Certificate

You should read the instruction letter accompanying the subscription rights certificate carefully and strictly follow it. Do not send subscription rights certificates or payments to us.  We will not consider your subscription received until the subscription agent has received delivery of a properly completed and duly executed subscription rights certificate and payment of the full subscription amount. The risk of delivery of all documents and payments is on you or your nominee, not us or the subscription agent.

The method of delivery of subscription rights certificates and payment of the subscription amount to the subscription agent will be at the risk of the holders of subscription rights. If sent by mail, we recommend that you send those certificates and payments by overnight courier or by registered mail, properly insured, with return receipt requested, and that a sufficient number of days be allowed to ensure delivery to the subscription agent and clearance of payment before the expiration of the subscription period for the rights offering. Because uncertified personal checks may take at least five (5) or more business days to clear, we urge you to pay or arrange for payment by means of certified check made payable to Mackinac Financial Corporation to avoid missing the opportunity to exercise your subscription rights should you decide to exercise your subscription rights.

Missing or Incomplete Subscription Information

If you do not indicate the number of subscription rights being exercised or do not forward full payment of the total Subscription Price payment for the number of subscription rights that you indicate are being exercised, then you will be deemed to have exercised your subscription rights with respect to the maximum number of whole subscription rights that may be exercised with the aggregate Subscription Price payment you delivered to the subscription agent. If your aggregate Subscription Price payment is greater than the amount you owe for exercise of your basic subscription privilege in full, you will be deemed to have exercised your over-subscription privilege to purchase the maximum number of our Common Shares with your over-payment. If we do not apply your full Subscription Price payment to your purchase of our Common Shares, the subscription agent will return the excess amount to you by mail, without interest or penalty, as soon as practicable after the expiration date of the rights offering.

Expiration Date and Amendments

The subscription period, during which you may exercise your subscription rights, expires at 5:00 p.m., Eastern Time, on [    ·    ], 2012, which is the expiration of the rights offering. If you do not exercise your subscription rights prior to that time, your subscription rights will expire and will no longer be exercisable. We will not be required to issue shares of our Common Shares to you if the subscription agent receives your rights certificate or your subscription payment after that time, regardless of when the rights certificate and subscription payment were sent. We have the option to extend the rights offering in our discretion and the period for exercising your subscription rights, although we do not presently intend to do so. We may extend the expiration of the rights offering by giving oral or written notice to you prior to the expiration of the rights offering. If we elect to extend the expiration of the rights

36



Table of Contents

offering, we will issue a press release announcing such extension no later than 9:00 a.m., Eastern Time, on the next business day after the most recently announced expiration of the rights offering. We reserve the right to amend or modify the terms of the rights offering, including increasing the size of the offering.

Subscription Price

In determining the Subscription Price, the board of directors considered a number of factors, including: the price at which our shareholders might be willing to participate in the rights offering, the price at which SCI was willing to participate in the SCI Investment, historical and current trading prices for our Common Shares and the desire to provide an opportunity to our shareholders to participate in the rights offering on a pro rata basis.  The Subscription Price was established at a price of $5.75 per full share, which equals the price to be paid by SCI for our Common Shares in the SCI Investment. The Subscription Price is not necessarily related to our book value, net worth or any other established criteria of value and may or may not be considered the fair value of our Common Shares to be offered in the rights offering.

We have also retained River Branch Capital LLC to advise us with respect to an appropriate per share price rage for the Subscription Price of our shares in this rights offering.  Please see “Determination of Offering Price” on page [    ·    ] for more information regarding our retention of River Branch Capital LLC.

We cannot assure you that the market price of our Common Shares will not decline during or after the rights offering. We also cannot assure you that you will be able to sell our Common Shares purchased during the rights offering at a price equal to or greater than the Subscription Price. We urge you to obtain a current quote for our Common Shares before exercising your subscription rights.

Conditions, Withdrawal and Termination

We reserve the right to withdraw the rights offering prior to the expiration of the rights offering for any reason. We may terminate the rights offering, in whole or in part, if at any time before completion of the rights offering there is any judgment, order, decree, injunction, statute, law or regulation entered, enacted, amended or held to be applicable to the rights offering that in the sole judgment of our board of directors would or might make the rights offering or its completion, whether in whole or in part, illegal or otherwise restrict or prohibit completion of the rights offering. We may waive any of these conditions and choose to proceed with the rights offering even if one or more of these events occurs. If we terminate the rights offering, in whole or in part, all affected subscription rights will expire without value, and all excess subscription payments received by the subscription agent will be returned, without interest, as soon as practicable.

Cancellation Rights

Our board of directors may cancel the rights offering at any time prior to the time the rights offering expires for any reason. If we cancel the rights offering, we will issue a press release notifying shareholders of the cancellation and all subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable.

Subscription Agent

Registrar and Transfer Company is acting as the subscription agent for the rights offering under an agreement with us. All subscription rights certificates, payments of the Subscription Price and nominee holder certifications, to the extent applicable to your exercise of rights, must be delivered to Registrar and Transfer Company as follows:

By Hand or Overnight Courier

(Until 5:00 p.m. Eastern Time on

By First Class Mail:

the expiration date of the rights offering):

Registrar and Transfer Company

Registrar and Transfer Company

P.O. Box 645

10 Commerce Drive

Cranford, NJ 07016

Cranford, NJ 07016

Attn: Reorg/Exchange Dept.

Attn: Reorg/Exchange Dept.

You should direct any questions, requests for assistance concerning the method of subscribing for our Common Shares or requests for additional copies of this prospectus to our Executive Vice President/Chief Financial Officer, Ernie R. Krueger, at: Mackinac Financial Corporation, 130 South Cedar Street, Manistique, Michigan 49854, (906) 341-7158.

37



Table of Contents

We will pay the fees and expenses of Registrar and Transfer Company. We have also agreed to indemnify Registrar and Transfer Company against certain liabilities in connection with the rights offering.

If you deliver subscription documents or subscription rights certificates in a manner different than that described in this prospectus, we may not honor the exercise of your subscription privileges.enter into swap or other hedging transactions with, or arranged by, underwriters or agents or their affiliates. These underwriters or agents or their affiliates may receive compensation, trading gain or other benefits from these transactions.

 

Fees and Expenses

We will pay all fees charged by the subscription agent. You are responsible for paying any other commissions, fees, taxes or other expenses incurred in connectionIn compliance with the exercise of the subscription rights. Neither the subscription agent nor the Corporation will pay such expenses.

No Fractional Shares

We will not issue fractional shares. Any excess subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable.

Medallion Guarantee May Be Required

Your signature on each subscription rights certificate must be guaranteed by an eligible institution, such as a member firm of a registered national securities exchange or a memberguidelines of the Financial Industry Regulatory Authority, Inc., or a commercial bankFINRA, the maximum consideration or trust company having an office or correspondent in the United States, subject to standards and procedures adopted by us, unless:

·your subscription rights certificate provides that shares arediscount to be delivered to you as record holder of those subscription rights; or

·you are an eligible institution.

Notice to Nominees

If you are a broker, custodian bank or other nominee holder that holds our Common Shares for the account of others on the Record Date, you should notify the beneficial owners of the shares for whom you are the nominee of the rights offering as soon as possible to learn their intentions with respect to exercising their subscription rights. You should obtain instructions from the beneficial owner, as set forth in the instructions we have provided to you for your distribution to beneficial owners. If the beneficial owner so instructs, you should complete the appropriate rights certificate and submit it to the subscription agent with the proper subscription payment. If you hold our Common Shares for the account(s) of more than one beneficial owner, you may exercise the number of subscription rights to which all beneficial owners in the aggregate otherwise would have been entitled had they been direct holders of our Common Shares on the Record Date, provided that you, as a nominee record holder, make a proper showing to the subscription agent by submitting the form entitled “Nominee Holder Certification,” which is provided with your rights offering materials. If you did not receive this form, you should contact the subscription agent to request a copy.

Beneficial Owners

If you are a beneficial owner of our Common Shares or will receive your subscription rights through a broker, custodian bank or other nominee, we will ask your broker, custodian bank or other nominee to notify you of the rights offering. If you wish to exercise your subscription rights, you will need to have your broker, custodian bank or other nominee act for you. If you hold certificates of our Common Shares directly and would prefer to have your broker, custodian bank or other nominee act for you, you should contact your nominee and request it to effect the transactions for you. To indicate your decision with respect to your subscription rights, you should complete and return to your broker, custodian bank or other nominee the form entitled “Beneficial Owner Election Form.” You should receive this form from your broker, custodian bank or other nominee with the other rights offering materials. If you wish to obtain a separate subscription rights certificate, you should contact the nominee as soon as possible and request that a separate subscription rights certificate be issued to you. You should contact your broker, custodian bank or other nominee if you do not receive this form, but you believe you are entitled to participate in the rights offering. We are not responsible if you do not receive the form from your broker, custodian bank or other nominee or if you receive it without sufficient time to respond.

Transferability of Subscription Rights

The subscription rights granted to you are non-transferable and, therefore, you may not sell, transfer or assign your subscription rights to anyone.

38



Table of Contents

Validity of Subscriptions

We will resolve all questions regarding the validity and form of the exercise of your subscription rights, including time of receipt and eligibility to participate in the rights offering. Our determination will be final and binding. Once made, subscriptions and directions are irrevocable, and we will not accept any alternative, conditional or contingent subscriptions or directions. We reserve the absolute right to reject any subscriptions or directions not properly submitted or the acceptance of which would be unlawful. You must resolve any irregularities in connection with your subscriptions before the subscription period expires, unless waived by us in our sole discretion. Neither the subscription agent nor we shall be under any duty to notify you or your representative of defects in your subscriptions. A subscription will be considered accepted, subject to our right to withdraw or terminate the rights offering, only when a properly completed and duly executed rights certificate and any other required documents and the full subscription payment have been received by the subscription agent. Our interpretations of the termsany FINRA member or independent broker dealer must be fair and conditions of the rights offering will be final and binding.

Segregated Account; Return of Funds

The subscription agent will hold funds received in payment for our Common Shares in a segregated account pending completion of the rights offering. We will hold this money in escrow until the rights offering is completed or is withdrawn and canceled. If the rights offering is canceled for any reason, all subscription payments received by the subscription agent will be returned, without interest or penalties, as soon as practicable.

Certificates for our Common Shares

As soon as practicable after the expiration of the rights offering period, the subscription agent will arrange for issuance, to each subscription rights holder of record that has validly exercised its basic subscription privilege, the Common Shares purchased pursuant to the basic subscription privilege. Any shares purchased pursuant to the over-subscription privilege will be issued as soon as practicable after the expiration date of the rights offering and following the completion of any prorations as may be necessary in the event the over-subscription requests exceed the number of shares available to satisfy such requests.

Shareholder Rights

If you purchase our Common Shares in the rights offering, you will have no rights as a holder until certificates representing the Common Shares are issued to you or credited to your account with your holder of record.  You will have no right to revoke your subscription after your rights certificate or the “Beneficial Owner Election Form,” the full subscription payment and any other required documents have been delivered to the subscription agent.

Foreign Shareholders

We will not mail this prospectus or rights certificates to shareholders with addresses that are outside the United States or that have an army post office or foreign post office address. The subscription agent will hold these rights certificates for their account. To exercise subscription rights, our foreign shareholders must notify us prior to 11:00 a.m., Eastern Time, at least three (3) business days prior to the expiration of the rights offering, and demonstrate to our satisfaction that the exercise of such subscription rights does not violate the laws of the jurisdiction of such shareholder.

No Revocation or Change

Once you submit the form of rights certificate to exercise any subscription rights, you are not allowed to revoke or change the exercise or request a refund of monies paid. All exercises of subscription rights are irrevocable, even if you learn information about us that you consider to be unfavorable. You should not exercise your subscription rights unless you are certain that you wish to purchase additional Common Shares at the Subscription Price.

Regulatory Limitation

We will not be required to issue to you our Common Shares pursuant to the rights offering if, in our opinion, you are required to obtain prior clearance or approval from any state or federal regulatory authorities to own or control such shares and if, at the time the rights offering expires, you have not obtained such clearance or approval.

39



Table of Contents

No Recommendation to Rights Holders

Our board of directors is making no recommendation regarding your exercise of the subscription rights. You are urged to make your decision based on your own assessment of our business and the rights offering. Please see “Risk Factors” for a discussion of some of the risks involved in investing in our Common Shares.

Listing

The subscription rights will not be listed for trading on the NASDAQ Capital Market or any stock exchange or market or any over-the-counter or bulletin board market. Our Common Shares are currently listed for quotation on the NASDAQ Capital Market under the ticker symbol “MFNC,” and the shares to be issued in connection with the rights offering will also be listed on the NASDAQ Capital Market under the same symbol

Our Common Shares Outstanding After the Rights Offering

Assuming no options are exercised, all subscription rights are exercised prior to the expiration of the rights offering and giving effect to the maximum number of Common Shares issuable pursuant to the SCI Investment, we expect approximately 5,668,073 Common Shares will be outstanding immediately after completion of the rights offering.

The SCI Investment Transaction

We have separately entered into a securities purchase agreement with SCI in connection with the rights offering. In connection with the SCI Investment and pursuant to the securities purchase agreement, SCI has agreed to purchase, upon completion of the rights offering, between $5,000,000 and $11,000,000 of varying types and amounts of our securities depending on (i) the outcome of the rights offering and (ii) SCI receiving the Federal Reserve Approval.

If SCI receives the Federal Reserve Approval by the completion of the rights offering, then SCI has agreed to purchase:

·the Approval Common Shares, which equals an amount of our Common Shares (including some or all of the Unsubscribed Shares) that SCI can purchase without SCI owning more than 19.9% of our Common Shares then issued and outstanding, at a per share price equal to the Subscription Price (with the amount of Approval Common Shares multiplied by the Subscription Price being equal to the Approval Aggregate Common Purchase Price); and

·the Approval Note, which is a senior promissory note in the principal amount to be determined based upon the number of Unsubscribed Shares remaining after the issuance to SCI of the Approval Common Shares.

If SCI does not receive the Federal Reserve Approval by the completion of the rights offering, then SCI has agreed to purchase:

·the No Approval Common Shares, which equals an amount of our Common Shares (including some or all of the Unsubscribed Shares) that SCI can purchase without SCI owning more than 9.9% of our Common Shares then issued and outstanding, at a per share price equal to the Subscription Price (with the amount of No Approval Common Shares multiplied by the Subscription Price being equal to the No Approval Aggregate Common Purchase Price);

·the No Approval Preferred Shares, which equals an amount of our Series B Preferred Shares determined by dividing (1) the difference between (x) the Approval Aggregate Common Purchase Price that SCI would have paid if it had received the Federal Reserve Approval by the completion of the rights offering and (y) the No Approval Aggregate Common Purchase Price (such difference being the No Approval Aggregate Preferred Purchase Price) by (2) the Series B Preferred Per Share Price; and

·the No Approval Note, which is a senior promissory note in the principal amount to be determined based upon the number of Unsubscribed Shares remaining after the issuance to SCI of the No Approval Common Shares and the No Approval Preferred Shares.

The proceeds from the sale of securities derived from the SCI Investment and the rights offering would be used exclusively to repurchase the Corporation’s outstanding TARP Securities that were issued by the Corporation to the Treasury under the Troubled Asset Relief Capital Purchase Program.  The aggregate maximum number of Common Shares that may be sold to SCI, if no current shareholder exercises its subscription rights or over-subscription rights and assuming regulatory approval, is 728,498.

40



Table of Contents

For so long as SCI and its affiliates own 5% or more of our Common Shares, we have agreed to take all action necessary to cause one (1) person designated by SCI to be elected to our board of directors and, so long as such person is appropriately qualified, to recommend to our shareholders that they elect such designee to our board of directors.  SCI has indicated that its designee to our board of directors will initially be David R. Steinhardt.

More information regarding the SCI Investment can be found in our Current Report on Form 8-K, filed with the SEC on March 28, 2012, which is incorporated into the registration statement of which this prospectus is a part by reference.

The Securities Purchase Agreement

Prior to making its commitment to purchase our Common Shares, SCI executed a non-disclosure agreement and accordingly gained access to nonpublic information about the Corporation and the Bank. Subsequently, we negotiated and entered into the securities purchase agreement with SCI. The following summarizes the material terms of the securities purchase agreement. A form of the securities purchase agreement and the promissory note has been filed as an exhibit to our Current Report on Form 8-K, filed with the SEC on March 28, 2012, which is incorporated into the registration statement of which this prospectus is a part by reference. We urge you to carefully read the entire document.

Representations Made by the Corporation in the Securities Purchase Agreement.  The Corporation has made representations and warranties to SCI including with respect to its corporate organization and authority, subsidiaries, capitalization, authorization of the securities purchase agreement and ancillary documents thereto (collectively, the “Transaction Documents”) and related transactions, knowledge of conditions relating to regulatory approvals, financial statements, corporate reporting and government correspondence, properties and leases, taxes, absence of certain changes since December 31, 2010, commitments and contracts, securities offerings, litigation and other proceedings, undisclosed liabilities, compliance with laws, insurance, labor, benefit plans, investment company status, risk management, derivatives, environmental liability, anti-takeover provisions, intellectual property, agreements with regulatory agencies, loan portfolio, directors’ and officers’ insurance, Section 16 items, adequate capitalization, changes in control and brokers and finders.  Pursuant to the terms of the Transaction Documents, the Corporation will be liable to SCI for any breaches of these representations and warranties.

Representations Made by SCI in the Securities Purchase Agreement.  SCI has made representations and warranties to SCI including with respect to its corporate organization and authority, authorization of the Transaction Documents and related transactions, its residence, economic status, knowledge, information, investment intent and brokers and finders.

Covenants of the Corporation Under the Securities Purchase Agreement.  The securities purchase agreement contains covenants of the Corporation to take or refrain from taking certain actions, including the following:

·file all necessary and customary documentation to effect all necessary and customary applications, notices, petitions, filings and other documents and obtain all necessary and customary permits, consents, orders, approvals and authorizations of, or any exemption by, all third parties and governmental entities and in connection with the expiration or termination of any applicable waiting periods;

·use its commercially reasonable, efforts to help SCI promptly obtain or submit, as the case may be, as promptly as practicable, the approvals and authorizations of, filings and registrations with and notifications to or expiration or termination of any applicable waiting period, all notices to, and, to the extent required by applicable law or regulation, consents, approvals or exemptions from bank regulatory authorities, for the transactions contemplated by the securities purchase agreement;

·use its, and cause its affiliates to use, commercially reasonable efforts to obtain all approvals required to be obtained by the Corporation in connection with the transactions contemplated by the Transaction Documents, including responding fully to all requests for additional information from the Federal Reserve, the FDIC and OFIR;

·furnish SCI with all information concerning itself, its subsidiaries, affiliates, directors, officers, partners and shareholders and such other matters as may be reasonably necessary or advisable in connection with any statement, filing, notice or application made by or on behalf of such other party or any of its subsidiaries to any governmental entity in connection with the securities purchase agreement;

·from the date of the securities purchase agreement until the Closing, the Corporation must refrain from, directly or indirectly, amending, modifying or waiving, and our board of directors must refrain from recommending approval of any proposal to the Corporation’s shareholders having the effect of amending, modifying or waiving, any provision in our Articles of Incorporation or Bylaws in any manner adverse to SCI;

41



Table of Contents

·use the proceeds of the rights offering and the SCI Investment exclusively to repurchase the Corporation’s TARP Securities that were issued by the Corporation to the Treasury;

·pay (i) the reasonable legal fees and expenses of SCI’s counsel and (ii) all other reasonable and documented costs and expenses incurred by SCI (other than any legal fees) in connection with the transactions contemplated by the Transaction Documents; provided, however, in no event shall such fees, costs and expenses exceed $75,000 in the aggregate;

·upon reasonable notice, and in such a manner as not to interfere unreasonably with the conduct of the business of the Corporation, the Corporation and its subsidiaries must afford to SCI and its representatives (including employees of SCI and counsel, accountants, financial and investment banking advisors and other professionals retained by the Investor) (i) such access during normal business hours to its books, records, properties and personnel and to such other information as SCI may reasonably request and (ii) reasonable opportunities to routinely consult with the management of the Corporation and its subsidiaries, which shall not be more frequently than once per calendar quarter, on matters relating to the operation of the Corporation;

·hold, and cause its respective subsidiaries and their directors, officers, employees, agents, consultants and advisors to hold in strict confidence, unless disclosure is specifically permitted by the securities purchase agreement, all nonpublic records, books, contracts, instruments, computer data and other data and information concerning SCI furnished to the Corporation by SCI or its representatives pursuant to this Agreement;

·cooperate, in accordance with reasonable and customary business practices, with any and all transfers by SCI of the Corporation’s securities as permitted by the securities purchase agreement;

·use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, and to assist and cooperate with SCI in doing, all things necessary, proper or advisable to consummate and make effective, in the most expeditious manner practicable, the transactions contemplated by the Transaction Documents;

·promptly inform SCI of, and consult SCI regarding, any claim, action, suit, arbitration, mediation, demand, hearing, investigation or proceeding against the Corporation, any of its subsidiaries or any of the past or present executive officers or directors of the Corporation or any of its subsidiaries that is threatened or initiated by or on behalf of any shareholder of the Corporation in connection with or relating to the transactions contemplated by the Transaction Documents;

·during the period from the date of the securities purchase agreement though the Closing, the Corporation and its subsidiaries must refrain from entering into any additional or modifying any existing agreements with any existing or future investors in the Corporation or any of its subsidiaries that have the effect of establishing rights or otherwise benefiting such investor in a manner more favorable in any material respect to such investor than the rights and benefits established in favor of SCI by the Transaction Documents, unless, in any such case, SCI has been offered such rights and benefits;

·provide prompt notice to SCI of any event, condition, fact, circumstance, occurrence, transaction or other item that would constitute a violation or breach of any Transaction Document or that would have been required to be disclosed to SCI in connection with the execution of the securities purchase agreement had such event occurred prior to the date of the securities purchase agreement;

·use commercially reasonable efforts to carry on its business in the ordinary course of business and use commercially reasonable efforts to maintain and preserve its and its subsidiaries’ businesses (including their organization, assets, properties, goodwill and insurance coverage) and preserve business relationships with customers, vendors, strategic partners and others having business dealings with them;

·unless otherwise contemplated by the securities purchase agreement, refrain from (i) declaring, setting aside or paying any distributions or dividends on, or making any other distributions (whether in cash, securities or other property) in respect of, any of its capital stock; (ii) splitting, combining or reclassifying any of its capital stock or issuing or authorizing the issuance of any other securities in respect of, in lieu of or in substitution for capital stock or any of its other securities; (iii) purchasing, redeeming or otherwise acquiring any capital stock or any of its other securities or any rights, warrants or options to acquire any such capital stock or other securities; (iv) issuing, delivering, selling, granting, pledging or otherwise disposing of or encumbering any capital stock, any other voting

42



Table of Contents

securities or any securities convertible into or exchangeable for, or any rights, warrants or options to acquire, any such capital stock, voting securities or convertible or exchangeable securities, other than any issuance of Common Shares on exercise of any compensatory stock options outstanding on the date of the securities purchase agreement; or (v) entering into any contract with respect to, or otherwise agreeing or committing to do, any for the foregoing;

·to the extent reasonably practicable, consult with SCI prior to taking any material action outside of the ordinary course of business; provided that the Corporation shall refrain from consulting with SCI with respect to such material action or providing any material non-public information to SCI unless the Corporation first seeks and obtains SCI’s prior consent to be so consulted or to receive such information; and

·except as provided in the securities purchase agreement, refrain from (i) granting or providing any severance or termination payments or benefits to any director, officer or employee of the Corporation or any of its subsidiaries; (ii) increase the compensation, bonus or pension, welfare, severance or other benefits of, pay any bonus to or make any new equity awards to any director, officer or employee of the Corporation or any of its subsidiaries; (iii) establish, adopt, amend or terminate any benefit plan or amend the terms of any outstanding equity-based awards; (iv) take any action to accelerate the vesting or payment or fund or in any other way secure the payment of compensation or benefits under any benefit plan to the extent not already provided in any such benefit plan; (v) change any actuarial or other assumptions used to calculate funding obligations with respect to any benefit plan or to change the manner in which contributions to such plans are made or the basis on which such contributions are determined, except as may be required by generally accepted accounting principals (as further defined by the securities purchase agreement); or (vi) forgive any loans to directors, officers or employees of the Corporation or any of its subsidiaries.

Conditions to Closing Obligations of SCI. The securities purchase agreement provides that the obligations of SCI to consummate the transactions contemplated by the securities purchase agreement are subject to satisfaction or waiver of the following conditions:

·that no provision of applicable law or judgment, injunction, order or decree prohibits the closing or restricts SCI from holding or voting any capital stock of the Corporation;

·that no lawsuit has been commenced in any court or other governmental authority or agency seeking to prohibit the closing or to restrict SCI from holding or voting any capital stock of the Corporation;

·that all of the representations and warranties made by the Corporation in the securities purchase agreement are true and correct as provided by the securities purchase agreement;

·that between the date of the securities purchase agreement and the consummation of the transactions contemplated by the securities purchase agreement, neither the Corporation nor the Bank shall have experienced any material adverse effect;

·that the Corporation has performed all of its obligations required to be performed by it under the securities purchase agreement;

·that certain employees of the Corporation have entered into amended and restated employment agreements in forms reasonably acceptable to SCI;

·that our board of directors has adopted, approved and recommended to the Corporation’s shareholders for approval at the Corporation’s 2012 annual meeting of shareholders, a new equity incentive plan in a form reasonably acceptable to SCI;

·that counsel to the Corporation has delivered a written legal opinion to SCI satisfactory to SCI;

·that the Corporation has obtained all third party approvals and consents necessary to consummate the transactions contemplated by the securities purchase agreement;

·that SCI has received the requisite approvals, consents, non-objections, written confirmations or other correspondence regarding SCI’s investment in the Corporation by the Federal Reserve Board, the FDIC, OFIR and all other applicable governmental or regulatory approvals or authorizations of and, to the extent required by

43



Table of Contents

applicable law or regulation, consents, approvals or exemptions from bank regulatory authorities required in connection with the transactions contemplated by the Transaction Documents;

·that, following the date of the securities purchase agreement, the Corporation shall not have agreed to enter into a transaction that resulted in, or would result in if consummated, a change in control of the Corporation;

·that the Corporation delivers to SCI certain certificates, resolutions and other ancillary document deliverables and has made certain filings contemplated by the securities purchase agreement;

·that the Corporation shall have implemented, effective subject to the occurrence of the Closing, the governance matters contemplated by the securities purchase agreement with respect to the appointment to the board of a representative of SCI;

·that the Corporation shall have caused the Common Shares issued to SCI under the securities purchase agreement to be approved for listing on the NASDAQ Capital Market, subject to official notice of issuance;

·that the Corporation shall have closed the rights offering or the rights offering shall have expired;

·that, since the date of the securities purchase agreement, there shall not have been any action taken or any law enacted, entered, enforced or deemed applicable by any governmental entity, whether in connection with the consent of any governmental entity specified in the securities purchase agreement or otherwise, which imposes any new restriction or condition on the Corporation or its subsidiaries or SCI or any of its affiliates (other than as specifically permitted by the securities purchase agreement) which is materially and unreasonably burdensome on the Corporation’s business following the Closing or on SCI (or any of its affiliates) related to the SCI Investment, as applicable, or would reduce the economic benefits of the transactions contemplated by the securities purchase agreement to SCI to such a degree that SCI would not have entered into the securities purchase agreement had such condition or restriction been known to it on the date of the securities purchase agreement;

·that the Corporation shall have filed with the State of Michigan’s Department of Licensing and Regulatory Affairs (and such department shall have accepted) the certificate of designations setting forth the terms of the Series B Preferred Stock; and

·the Corporation shall have entered into a definitive agreement with the Treasury to redeem all of the TARP Securities.

Conditions to Closing Obligations of the Corporation. The securities purchase agreement provides that the obligations of the Corporation to consummate the transactions contemplated by the securities purchase agreement are subject to satisfaction or waiver of the following conditions:

·that all of the representations and warranties made by SCI in the securities purchase agreement are true and correct as provided by the securities purchase agreement;

·that no provision of applicable law or judgment, injunction, order or decree prohibits the Closing;

·that no lawsuit has been commenced in any court or other governmental authority or agency seeking to prohibit the Closing;

·that SCI has obtained all third party approvals and consents necessary to consummate the transactions contemplated by the securities purchase agreement;

·that SCI has performed all of its obligations required to be performed by it under the securities purchase agreement;

·that SCI delivers to the Corporation certain certificates, resolutions and other ancillary document deliverables and has made certain filings contemplated by the securities purchase agreement; and

·that the State of Michigan’s Department of Licensing and Regulatory Affairs accepts the certificate of designations setting forth the terms of the Series B Preferred shares.

44



Table of Contents

Termination Provisions in the Securities Purchase Agreement. The securities purchase agreement contains certain termination rights for the Corporation and SIC, as the case may be, which may be triggered:

·by mutual written agreement of the Corporation and SCI;

·by any party, upon written notice to the other party, if the consummation of the transaction does not occur by June 30, 2012; provided, however, that the right to terminate the securities purchase agreement pursuant to this provision will not be available to any party whose failure to fulfill any obligation under the securities purchase agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to occur on or prior to such date;

·by any party, upon written notice to the other party, if such other party has breached any of its representations, warranties, covenants or agreements made in the securities purchase agreement and such breach is not curable by the date that would be the transaction consummation date;

·by any party, upon written notice to the other party, if any governmental authority issues any order, decree or injunction or takes any other type of restraining action to prohibit the consummation of the transactions consummated by the securities purchase agreement; and

·by any party, upon written notice to the other party, in the event that any governmental entity shall have issued any order, decree or injunction or taken any other action restraining, enjoining or prohibiting any of the transactions contemplated by the securities purchase agreement, and such order, decree, injunction or other action shall have become final and nonappealable;

·by SCI, upon written notice to the Corporation, if SCI or any of its affiliates receives written notice from or is otherwise advised by the Federal Reserve Board, OFIR or the FDIC that the Federal Reserve Board, OFIR or the FDIC, as applicable, will not grant (or intends to rescind or revoke if previously granted) any of the written confirmations or determinations as set forth in the securities purchase agreement; or

·by the Corporation, upon written notice to SCI, if the Corporation receives written notice from or is otherwise advised by the Federal Reserve Board, OFIR or the FDIC that the Federal Reserve Board, OFIR or the FDIC will not grant (or intends to rescind or revoke if previously granted) any approvals required to be obtained to consummate the transactions contemplated by the Transaction Documents.

In the event of any termination of the securities purchase agreement, the securities purchase agreement (other than certain sections specified in the securities purchase agreement) becomes wholly void and of no further force and effect; provided, that this termination provision does not relieve any party from liability for willful breach of the securities purchase agreement.

Additional Agreements with SCI.  Pursuant to the securities purchase agreement, the following additional agreements apply to the SCI Transaction:

·From the date of the securities purchase agreement through such time during which SCI, together with its affiliates, in the aggregate own 5% or more of all of the outstanding Common Shares (including any securities owned by SCI that are directly or indirectly convertible or exercisable into Common Shares on an as-converted basis, as further specified in the securities purchase agreement (the “Qualifying Ownership Interest”), the Corporation shall not enter into any poison pill agreement, shareholders’ rights plan or similar agreement that shall limit the rights of SCI and its affiliates and associates to hold any Common Shares or acquire additional securities of the Corporation, unless such poison pill agreement, shareholders’ rights plan or similar agreement grants an exemption or waiver to SCI and its affiliates and associates and any group in which SCI may become a member, immediately effective upon execution of such plan or agreement, that would allow SCI and its affiliates and associates to acquire such additional securities of the Corporation.

·SCI has agreed to enter into a four (4) year standstill provision.

·SCI has agreed that any securities it purchases in connection with the SCI Investment may be disposed of only pursuant to an effective registration statement under, and in compliance with the requirements of, the Securities Act of 1933, as amended (the “Securities Act”) or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state, federal or foreign securities laws.

45



Table of Contents

·SCI has agreed that all certificates or other instruments representing the securities it purchases in connection with the SCI Investment will bear a specific legend as set forth in the securities purchase agreement.

·The Corporation has agreed that prior to the Closing, notwithstanding anything in the securities purchase agreement to the contrary, the Corporation shall not directly or indirectly effect or cause to be effected any transaction with a third party that would reasonably be expected to result in a change in control (as specified in the securities purchase agreement) unless such third party shall have provided prior assurance in writing to the Corporation that the terms of the securities purchase agreement will be fully performed (i) by the Corporation or (ii) by such third party if it is the successor of the Corporation or if the Corporation is its direct or indirect subsidiary, and to promptly provide copies of such assurances to SCI.

·The Corporation has agreed to indemnify and hold harmless SCI and its affiliates and each of their respective officers, directors, direct or indirect partners or members, employees and agents and each person who controls SCI within the meaning of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder, to the fullest extent lawful, from and against any and all actions, suits, claims, proceedings, costs, losses, liabilities, damages, expenses (including attorneys’ fees and disbursements), amounts paid in settlement and other costs (collectively, “Losses”) arising out of or resulting from (1) any inaccuracy in or breach of the Corporation’s representations or warranties contained in the securities purchase agreement, (2) the Corporation’s breach of agreements or covenants made by the Corporation in the securities purchase agreement or (3) any Losses arising out of or resulting from any legal, administrative or other proceedings instituted by any governmental entity, shareholder of the Corporation or any other person (other than SCI and its affiliates and the Corporation and its subsidiaries) arising out of the transactions contemplated by the securities purchase agreement and the terms of the securities SCI purchases in connection with the SCI Investment (other than any Losses attributable to the acts, errors or omissions on the part of SCI, but not including the transactions contemplated by the securities purchase agreement).

·Subject to the terms and conditions of the securities purchase agreement, the Corporation has covenanted and agreed that as promptly as practicable after the Closing (and in any event no later than the registration deadline as set forth in the securities purchase agreement), the Corporation shall have prepared and filed with the Securities and Exchange Commission (the “SEC”) a shelf registration statement (pursuant to the terms of the securities purchase agreement) covering, for the benefit of SCI, the resale of all registrable securities (as defined in the securities purchase agreement), and, to the extent the shelf registration statement has not theretofore been declared effective, the Corporation has agreed to use commercially reasonable efforts to cause such shelf registration statement to be declared or become effective not later than the effectiveness deadline (as defined in the securities purchase agreement) and to keep such shelf registration statement continuously effective and in compliance with the Securities Act and usable for resale of such registrable securities for a period from the date of its initial effectiveness until such time as there are no registrable securities remaining (including by re-filing such shelf registration statement (or a new shelf registration statement) if the initial shelf registration statement expires).  The Corporation has also agreed to various other terms, conditions and covenants in connection with SCI’s registration rights, including giving SCI piggyback registration rights, bearing expenses incurred in connection with any such registration rights (including up to $30,000 of SCI’s attorneys fees for each registration), indemnifying any holder of such registration rights in connection with the registration rights provisions and related Corporation actions, as set forth in the securities purchase agreement and using its commercially reasonable efforts to comply with various Rule 144 reporting requirements as set forth in the securities purchase agreement.

·The Corporation has agreed to cause one (1) person designated by SCI (the “Board Representative”) to be elected or appointed, as the case may be, subject to all legal and governance requirements and approvals regarding service and election or appointment as a director of the Corporation (including any required approvals of the Federal Reserve Board), and subject to the approval of the Corporation’s Nominating/Corporate Governance Committee (the “Governance Committee”), to our board of directors, as well as the board of directors of the Bank (the “Bank Board”) for as long as SCI, together with its affiliates, has a Qualifying Ownership Interest.  The Corporation has agreed to recommend the election of the Board Representative to our board of directors and the Bank Board to its shareholders at the Corporation’s annual meeting of shareholders, subject to satisfaction of all legal and governance requirements regarding service as a director of the Corporation (including those of the Federal Reserve Board) and subject to the approval of the Governance Committee.  At the option of the Board Representative, our board of directors must cause the Board Representative to be appointed to any two (2) of the following three (3) committees of our board of directors, and/or any equivalent committees of the Bank, as agreed by the Corporation and SCI prior to the Closing: the Compensation Committee, the Governance Committee and the Risk Management Committee, in each case so long as the Board Representative qualifies to serve on such committees under the Corporation’s or the Bank’s corporate governance guidelines and committee charters currently in effect, as applicable, and rules

46



Table of Contents

applicable to the Corporation by any exchange on which the Common Shares are then listed.  Furthermore, the Corporation has agreed that, from and after the Closing, for so long as SCI and its affiliates in the aggregate have a Qualifying Ownership Interest and do not have a Board Representative currently serving on our board of directors and the Bank Board (or have a Board Representative whose appointment is subject to receipt of regulatory approvals), the Corporation will, subject to applicable law, invite a person designated by SCI and reasonably acceptable to the Corporation (the “Board Observer”) to attend meetings of our board of directors and the Bank Board (including any meetings of committees thereof) in a nonvoting observer capacity.  The Board Observer will be entitled to attend such meetings only in the event SCI does not have a Board Representative on our board of directors and the Bank Board.  The Board Observer will not have any right to vote on any matter presented to our board of directors or the Bank Board or any committee thereof.  The Corporation has agreed that the Board Representative shall be entitled to compensation and indemnification in connection with his or her role as a director to the same extent as other directors on our board of directors or the Bank Board, as applicable, and the Board Representative shall be entitled to reimbursement for reasonable documented, out-of-pocket expenses incurred in attending meetings of our board of directors and the Bank Board or any committee thereof in accordance with Corporation policy.

·If any control share acquisition, business combination, poison pill (including any distribution under a rights agreement), any other similar “moratorium,” “control share,” “fair price,” “takeover” or “interested stockholder” law (each, a “Takeover Law”) may become, or may purport to be, applicable to the transactions contemplated or permitted by the securities purchase agreement, the Corporation has agreed that it and our board of directors will grant such approvals and take such actions as are necessary so that the transactions contemplated or permitted by the Transaction Documents may be consummated, as promptly as practicable, on the terms contemplated by the Transaction Documents, as the case may be, and otherwise act to eliminate or minimize the effects of any Takeover Law on any of the transactions contemplated or permitted by the Transaction Documents.

·The Corporation has agreed to cooperate with SCI and use its commercially reasonable efforts to ensure that neither SCI nor any of SCI’s affiliates will become or control a “bank holding company” within the meaning of the BHCA Act and the Change in Bank Control Act of 1978, as amended.

·The Corporation has agreed to timely file a Form D and any applicable blue sky law filings and make any securities laws disclosures required by the securities purchase agreement.

·The Corporation has agreed that, between the date of the securities purchase agreement and the Closing, except as specifically permitted by the securities purchase agreement, the Common Shares issued in connection with the rights offering and the securities being issued pursuant to the Transaction Documents, the Corporation will not issue or agree to issue any additional Common Shares, Series B Preferred Shares or other securities which provide the holder thereof the right to convert such securities into Common Shares.

Mandatorily Convertible Cumulative Participating Series B Preferred

If SCI does not receive the Federal Reserve Approval by the completion of the rights offering, then SCI has agreed to purchase the No Approval Preferred Shares.  The No Approval Preferred Shares are a certain amount of our currently undesignated Mandatorily Convertible Cumulative Participating Series B Preferred Stock calculated in accordance with the details set forth in “The SCI Investment Transaction” on page [    ·    ].  In order to issue the No Approval Preferred Shares to SCI, the Corporation will be required to file a Certificate of Designations setting forth the rights and preferences of our Mandatorily Convertible Cumulative Participating Series B Preferred Stock (or Series B Preferred Shares, as used in this prospectus) with the State of Michigan’s Department of Licensing and Regulatory Affairs.  The following is a brief description of the Series B Preferred Shares to be designated by the Corporation if SCI does not receive the Federal Reserve Approval by the completion of the rights offering.  The description of the Series B Preferred Shares contained herein is qualified in its entirety by the actual terms of the Series B Preferred Shares, the description of which is attached as an exhibit to our Current Report on Form 8-K filed on March 28, 2012, and incorporated by reference into this prospectus.

Dividends. Upon issuance of the Series B Preferred Shares, if the Board of Directors declares and pays a dividend or other distribution in respect of Common Shares (other than with respect to a the Rights Offering), then the Board of Directors shall declare and pay to the holders of the Series B Preferred Shares, on the same dates on which such dividend or other distribution is declared and paid on the Common Shares, a dividend or other distribution in an amount per Series B Preferred Share equal to the product of (i) the per share dividend or other distribution declared and paid in respect of each share of Common Shares and (ii) the number of Common Shares into which such Series B Preferred Shares are convertible as of the record date for such dividend or distribution.

47



Table of Contents

In the event that, at any time, the Federal Reserve Board informs SCI that it will not issue a written non-objection (a “No Approval Notice”) to the notice SCI filed in connection with its purchase of Common Shares pursuant to the Change in Bank Control Act of 1978, as amended (the “CBCA”), the holders shall be entitled to receive, out of the funds legally available therefor, quarterly cumulative cash dividends at an annual rate equal to 8%, calculated with respect to the base value of $1,000.00 of each Series B Preferred Share (the “Non Approval Dividends”).  The Non Approval Dividends shall accumulate beginning as of the date of issuance of the Series B Preferred Shares, but shall only be paid in the event of a Non Approval and on each quarterly dividend date thereafter.

Priority of Dividends.  The Series B Preferred Shares will, with respect to dividend rights and rights on liquidation, winding-up and dissolution, rank (i) on parity with each other class or series of equity securities of the Corporation, if any, the terms of which do not expressly provide that such class or series will rank senior or junior to the Series B Preferred Shares as to dividend rights and rights on liquidation, winding-up and dissolution of the Corporation (collectively referred to as “Parity Securities”) and (ii) senior to the Corporation’s Common Shares and each other class or series of capital stock outstanding or established after the date of issuance of the Series B Preferred Shares, the terms of which expressly provide that each ranks junior to the Series B Preferred Shares as to dividend rights and/or as to rights on liquidation, winding-up and dissolution of the Corporation.

Redemption.  The Series B Preferred Shares are not redeemable by the Corporation.

Liquidation Rights.In the event the Corporation voluntarily or involuntarily is liquidated, dissolved or wound up, the holders at the time shall be entitled to receive, for each Series B Preferred Share, the sum of (i) liquidating distributions in an amount equal to the liquidation preference of $0.01 per Series B Preferred Share, plus any accrued but unpaid dividends thereon to and including the date of such liquidation, out of assets legally available for distribution to the Corporation’s shareholders, before any distribution of assets is made to the holders of the Common Shares or any other junior securities and (ii) after all distributions have been made to the holders pursuant to clause (i) above, liquidating distributions, as determined by the Corporation (or the trustee or other person or persons administering its liquidation, dissolution or winding-up in accordance with applicable law) as of a date that is at least ten (10) business days before the first liquidating distribution is made on Series B Preferred Shares, in the amount that would be made on the number of shares of Common Shares equal to $1,000 divided by the then-applicable conversion price as if all of the outstanding Series B Preferred Shares had been converted into Common Shares on such date of determination, out of assets legally available for distribution to the Corporation’s shareholders, simultaneous with any distribution of assets made to the holders of the Common Shares.

In the event the assets of the Corporation available for distribution to shareholders upon any liquidation, dissolution or winding-up of the affairs of the Corporation, whether voluntary or involuntary, shall be insufficient to pay in full the amounts payable with respect to all outstanding Series B Preferred Shares and the corresponding amounts payable on any parity securities, the holders of the Series B Preferred Shares and the holders of such parity securities shall share ratably in any distribution of assets of the Corporation in proportion to the full respective liquidating distributions to which they would otherwise be respectively entitled.

Voting Rights.  Except as indicated below or otherwise required by law, the holders of Series B Preferred Shares do not have any voting rights.

So long as any Series B Preferred Shares are outstanding, the vote or consent of the holders of 80% of the Series B Preferred Shares at the time outstanding, voting as a single class, shall be necessary for effecting or validating:

(i) any amendment or alteration of the Corporation’s Articles of Incorporation to authorize or create, or increase the authorized amount of, any shares of, or any securities convertible into shares of, any class or series of the Corporation’s capital stock ranking senior to the Series B Preferred Shares in the payment of dividends or in the distribution of assets on any liquidation, dissolution or winding-up of the Corporation; and

(ii) any amendment, alteration or repeal of any provision of the Corporation’s Articles of Incorporation or Bylaws that would significantly and adversely alter or change the terms, rights, preferences or privileges of the Series B Preferred Shares;

provided, that the holders of Series B Preferred Shares will have no voting rights if such voting rights arise due to a merger or consolidation of the Corporation with another entity, a share exchange, a reclassification of Common Shares or a sale of all or substantially all of the Corporation’s assets not in the regular course of business, if the Series B Preferred Shares remain outstanding following any such transaction or, if the Corporation is not the surviving entity, are converted into or exchanged for preference securities and such remaining outstanding Series B Preferred Shares or preference securities have rights, preferences, privileges and voting powers that are not materially less favorable than the rights, preferences, privileges and voting powers of the Series B Preferred Shares immediately prior to such consummation, taken as a whole.

48



Table of Contents

Conversion.  Effective as of the close of business on the date on which SCI receives Regulatory Approval (the “Mandatory Conversion Date”), the Series B Preferred Shares shall automatically convert into Common Shares as set forth below.  The initial conversion price applicable to the Series B Preferred Shares will be $5.75 (the “Conversion Price”).  The Conversion Price will be proportionately adjusted in the event the Corporation pays stock dividends or makes distributions of its Common Shares or subdivides, combines or reclassifies outstanding Common Shares. The number of Common Shares into which Series B Preferred Shares shall be convertible is the result of dividing the base value of $1,000 by the then applicable Conversion Price on the Mandatory Conversion Date.

The automatic conversion of the Series B Preferred Shares is limited such that if the conversion results in any holder holding more than 24.9% of all outstanding Common Shares (in the case of SCI) or 9.9% of all outstanding Common Shares (in the case of any other holder of Series B Preferred Shares) without such holder having obtained prior approval from the Federal Reserve Board under the CBCA, then only the maximum allowable number of Series B Preferred Shares will convert into Common Shares.

More Information.  More information regarding our Series B Preferred Shares can be found in our Current Report on Form 8-K, filed with the SEC on March 28, 2012, which is incorporated into the registration statement of which this prospectus is a part by reference.

The Note

As part of the SCI Investment, SCI has agreed to issue to the Corporation an 8% senior unsecured promissory note in the principal amount to be determined based upon the number of Unsubscribed Shares remaining after the issuance to SCI, as the case may be, either (a) the Approval Common Shares or (b) the No Approval Common Shares and the No Approval Preferred Shares.

General Terms.  The Approval Note or the No Approval Note (as applicable, the “Note”) would (i) be senior to all current and future indebtedness of the Corporation, (ii) bear interest at a per annum rate of 8% calculated on the basis of a 360-day year consisting of twelve (12) thirty (30)-day months, (iii) be unsecured, (iv) require monthly interest only payments, (v) mature on the third anniversary of the Closing and (vi) permit prepayment without penalty.

More Information.  More information regarding the Note can be found in our Current Report on Form 8-K, filed with the SEC on March 28, 2012, which is incorporated into the registration statement of which this prospectus is a part by reference.

More Information Regarding the SCI Investment

More information regarding our transaction with SCI can be found in our Current Report on Form 8-K, filed with the SEC on March 28, 2012, which is incorporated into the registration statement of which this prospectus is a part by reference.

CERTAIN U.S. FEDERAL INCOME TAX CONSIDERATIONS

The following is a discussion of certain U.S. federal income tax considerations for U.S. holders (as defined below) of the receipt and ownership of the subscription rights acquired in the rights offering and certain tax considerations for U.S. holders of the ownership of Common Shares received upon exercise of the rights or, if applicable, upon exercise of the over-subscription privilege.

You are a U.S. holder if you are a beneficial owner of rights or Common Shares and you are:

·an individual citizen or resident of the United States;

·a corporation (or any other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia;

·an estate whose income is subject to U.S. federal income tax regardless of its source; or

·a trust if it (1) is subject to the primary supervision of a court within the United States and one or more “United States persons,” as defined in the Code, have the authority to control all substantial decisions of the trust or (2) has a valid election in effect under applicable Treasury Department regulations to be treated as a United States person.

49



Table of Contents

The following discussion is based upon the provisions of the Code, regulations promulgated by the Treasury thereunder and administrative rulings and judicial decisions, in each case as of the date hereof. These authorities are subject to differing interpretations and may be changed, perhaps retroactively, resulting in U.S. federal income tax consequences different from those discussed below. We have not sought any ruling from the IRS with respect to the statements made and the conclusions reached in this discussion, and there can be no assurance that the IRS will agree with such statements and conclusions. This discussion applies only to U.S. holders who acquire the subscription rights in the rights offering. Further, this discussion assumes that the rights or Common Shares issued upon exercise of the rights or, if applicable, the over-subscription privilege, will be held as capital assets within the meaning of Section 1221 of the Code. In addition, this summary does not address all tax considerations that may be applicable to your particular circumstances or to you if you are a U.S. holder that may be subject to special tax rules, including, without limitation:

·banks, insurance companies or other financial institutions;

·regulated investment companies;

·real estate investment trusts;

·dealers in securities or commodities;

·traders in securities that elect to use a mark-to-market method of accounting for securities holdings;

·tax-exempt organizations;

·partnerships or other pass-through entities;

·persons liable for alternative minimum tax;

·expatriates;

·persons that hold Common Shares as part of a straddle or a hedging or conversion transaction; or

·persons whose “functional currency” is not the United States dollar.

If a partnership (including any entity treated as a partnership for U.S. federal income tax purposes) receives the rights or holds Common Shares received upon exercise of the rights or the over-subscription privilege, the tax treatment of a partner in such partnership generally will depend upon the status of the partner and the activities of the partnership. Such a partner or partnership should consult its own tax advisor as to the U.S. federal income tax consequences of the receipt and ownership of the rights or the ownership of Common Shares received upon exercise of the rights or, if applicable, upon exercise of the over-subscription privilege.

This discussion addresses only certain aspects of U.S. federal income taxation. You should consult your own tax advisor regarding the U.S. federal, state, local, non-U.S. and other tax consequences of the receipt and ownership of the rights acquired in the rights offering and the ownership of Common Shares received upon exercise of the rights or, if applicable, upon exercise of the over-subscription privilege.

THIS IS ONLY A GENERAL DISCUSSION AND IS NOT INTENDED TO BE, AND SHOULD NOT BE CONSTRUED TO BE, LEGAL, OR TAX ADVICE. ACCORDINGLY, EACH U.S. HOLDER WHO ACQUIRES RIGHTS IS STRONGLY URGED TO CONSULT HIS, HER OR ITS OWN TAX ADVISER WITH RESPECT TO THE U.S. FEDERAL, STATE, LOCAL AND FOREIGN INCOME, ESTATE AND OTHER TAX CONSEQUENCES OF THE ACQUISITION OF THE RIGHTS, WITH SPECIFIC REFERENCE TO SUCH PERSON’S PARTICULAR FACTS AND CIRCUMSTANCES.

Taxation of Rights

Receipt of Rights

Provided that the rights offering is not part of a “disproportionate distribution” within the meaning of Section 305 of the Code, we believe that your receipt of rights in the rights offering should generally be treated as a nontaxable distribution for U.S. federal income tax purposes.  If this position is finally determined by the IRS or a court to be incorrect, the fair market value of the rights would be taxable to you as a dividend to the extent of your pro rata share of our current and accumulated earnings and profits, if

50



Table of Contents

any, with any excess being treated as a return of capital to the extent of your adjusted tax basis in your shares of Common Stock and thereafter as capital gain.

The distribution of the rights in the rights offering would be taxable to you under Section 305(b) of the Code if it were a distribution or part of a series of distributions, including deemed distributions, that have the effect of the receipt of cash or other property by some of our stockholders and an increase in the proportionate interest of other stockholders in our assets or earnings and profits, if any.

The discussion below assumes that the receipt of subscription rights will be treated as a nontaxable distribution.

Tax Basis and Holding Period of Rights

Your tax basis of the rights for U.S. federal income tax purposes will depend on the fair market value of the rights you receive and the fair market value of your existing Common Shares on the date you receive the rights.

If the fair market value of the rights you receive is 15% or more of the fair market value of your existing Common Shares on the date you receive the rights, then you must allocate the tax basis of your existing Common Shares between the existing Common Shares and the rights you receive in proportion to their respective fair market values determined on the date you receive the rights. If the fair market value of the rights you receive is less than 15% of the fair market value of your existing Common Shares on the date you receive the rights, the rights will be allocated a zero tax basis, unless you elect pursuant to Section 307 of the Code and the Treasury regulations promulgated thereunder to allocate the tax basis of your existing Common Shares between the existing Common Shares and the rights you receive in proportion to their respective fair market values determined on the date you receive the rights. If you choose to allocate the tax basis between your existing Common Shares and the rights, you must make this election on a statement included with your U.S. federal income tax return for the taxable year in which you receive the rights. Such an election is irrevocable. The fair market value of the rights on the date the rights are distributed is uncertain, and we have not obtained, and do not intend to obtain, an appraisal of the fair market value of the rights on that date. In determining the fair market value of the rights, you should considerconsidering all relevant factsrisks, factors and circumstances, including any difference between the subscription price of the rights and the trading price of our Common Shares on the date that the rights are distributed, the length of the period during which the rights may be exercised and the fact that the rights are transferable.circumstances.

Your holding period of the rights will include your holding period of the Common Shares with respect to which the rights were distributed.

Exercise of Rights

You generally will not recognize gain or loss upon exercise of the rights. The tax basis of the Common Shares you receive upon exercise of the rights or, if applicable, upon exercise of the over-subscription privilege, generally will equal the sum of (i) the subscription price and (ii) the tax basis, if any, of the rights as determined above. Your holding period of the Common Shares you receive upon exercise of the rights or, if applicable, upon exercise of the over-subscription privilege, will begin on the date the subscriptions rights are exercised.

Expiration of Rights

If you do not exercise the rights, you should not recognize a capital loss for U.S. federal income tax purposes, and any portion of the tax basis of your existing Common Shares previously allocated to the rights not exercised will be re-allocated to the existing shares.

Ownership of Common Shares

Dividends

In general, distributions of money, securities and any other property (other than our stock or rights to acquire such stock) with respect to Common Shares will constitute dividends to the extent made out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current and accumulated earnings and profits, the excess will be treated as a non-taxable return of capital to the extent of your adjusted tax basis in Common Shares and thereafter as capital gain from the sale or exchange of such Common Shares. Dividends received by a corporate U.S. holder may qualify for a dividends-received deduction, and dividends received by non-corporate U.S. holders, including individuals, may qualify for preferential rates of taxation; however, in each case, certain holding period and other limitations apply.

51



Table of Contents

Gain on Disposition of Common Stock.  Upon the sale or other disposition of Common Shares, you will generally recognize capital gain or loss for U.S. federal income tax purposes equal to the difference between your amount realized on the sale and your adjusted tax basis in such Common Shares.  Capital gain of a noncorporate U.S. holder is generally taxed at preferential rates where the holder has a holding period greater than one (1) year.  The deductibility of capital losses is subject to limitations.

Information Reporting and Backup Withholding.  Payments made to you of proceeds from the sale or other disposition of Common Shares may be subject to information reporting to the IRS and possible U.S. federal backup withholding. Backup withholding will not apply if you furnish a correct taxpayer identification number (certified on the IRS Form W-9) or otherwise establish that you are exempt from backup withholding. Backup withholding is not an additional tax. Amounts withheld as backup withholding may be credited against your U.S. federal income tax liability. You may obtain a refund of any excess amounts withheld under the backup withholding rules by filing the appropriate claim for refund with the IRS and furnishing any required information.

THE FOREGOING SUMMARY IS INCLUDED FOR GENERAL INFORMATION ONLY.  ACCORDINGLY, HOLDERS OF OUR COMMON STOCK ARE URGED TO CONSULT WITH THEIR OWN TAX ADVISORS WITH RESPECT TO THE PARTICULAR FEDERAL, STATE, LOCAL AND FOREIGN TAX CONSEQUENCES OF THE RECEIPT OF SUBSCRIPTION RIGHTS IN THIS OFFERING AND THE OWNERSHIP, EXERCISE AND DISPOSITION OF THE SUBSCRIPTION RIGHTS APPLICABLE TO THEIR OWN PARTICULAR TAX SITUATIONS.

LEGAL MATTERS

 

Unless otherwise indicated in the applicable prospectus supplement, the validity of the securities offered hereby will be passed upon for us by Honigman Miller Schwartz and Cohn LLP will render an opinion regarding whether the Common Shares into which the rights are exercisable will be validly issued.LLP.

 

EXPERTS

 

The audited consolidated financial statements of Mackinac Financial Corporation as of December 31, 2011 and 2010 and for the years then ended have beensubsidiaries incorporated in this prospectus as of and infor the registration statement by reference andyear ended December 31, 2017 have been so incorporatedincluded in reliance upon the reportsreport of Plante & Moran, PLLC, an independent registered public accounting firm, givenand upon the authority of said firm as experts in accounting and auditing.

 

WHERE YOU CAN FIND ADDITIONAL INFORMATION

We have filed with the SEC a registration statement on Form S-3 under the Securities Act for the securities being offered under this prospectus. This prospectus, which is part of the registration statement, does not contain all of the information set forth in the registration statement and accompanying exhibits. This prospectus contains descriptions of certain agreements or documents that are exhibits to the registration statement. The statements as to the contents of such exhibits, however, are brief descriptions and are not necessarily complete, and each statement is qualified in all respects by reference to such agreement or document.

In addition, we file annual, quarterly and other reports, proxy statements and other information with the SEC. Our current SEC filings and the registration statement and accompanying exhibits may be inspected without charge at the public reference facilities of the SEC located at 100 F Street, N. E., Washington, D.C. 20549. You may obtain copies of this information at prescribed rates. The SEC also maintains a website that contains reports, proxy statements, registration statements and other information, including our filings with the SEC. The SEC website address is www.sec.gov. You may call the SEC at 1-800-SEC-0330 to obtain further information on the operations of the public reference room.

We make available free of charge through our website our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, Proxy Statement on Schedule 14A and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. Information about us can be found on the Internet at http://www.bankmbank.com. Please note that our website address is provided as inactive textual reference only. Information contained on or accessible through our website is not part of this prospectus or the prospectus supplement, and is therefore not incorporated by reference unless such information is otherwise specifically referenced elsewhere in this prospectus or the prospectus supplement.

INCORPORATION OF CERTAIN INFORMATIONDOCUMENTS BY REFERENCE

 

We are incorporatingThe SEC allows us to “incorporate by referencereference” certain documentsinformation that we file with the Securities and Exchange Commission, which means thatSEC into this prospectus. By incorporating by reference, we can disclose important information to you by referring you to those documents. Anyanother document we have filed separately with the SEC. The information that weincorporated by reference this way is considereddeemed to be part of this prospectus.

We incorporateprospectus, except for information incorporated by reference intothat is superseded by information contained in this prospectus the documents listed below andor any future filingsdocument we makesubsequently file with the SEC under sections 13(a), 13(c), 14that is incorporated or 15(d) of the Securities Exchange Act of 1934 after the date of this prospectus. These additional documents include periodic reports, such as annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K (other than information furnished under Items 2.02 and 7.01, which is deemed not to be incorporated by reference into this prospectus. Likewise, any statement in this prospectus). You should review these filings as they may disclose a changeprospectus or any document which is incorporated or deemed to be incorporated by reference herein will be deemed to have been modified or superseded to the extent that any statement contained in our business, prospects, financial conditionany document that we subsequently file with the SEC that is incorporated or other affairs after the date of this prospectus.

deemed to be incorporated by reference herein modifies or supersedes that statement. This prospectus incorporates by reference the documents listed belowbelow; however, we are not incorporating by reference in this prospectus any material that we have filed“furnished” and did not “file” with the SEC but have not been included or delivered with this document:SEC.

 

·                                          Our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, filed with the Securities and Exchange Commission on March 30, 2012;2017;

·                                          Our Annual Report on Form 11-K for the fiscal year ended December 31, 2010, filed with the Securities and Exchange Commission on June 23, 2011;

·Our Current Reports on Form 8-K filed with the Securitieson January 16, 2018, January 19, 2018, February 13, 2018, March 7, 2018, March 29, 2018 and Exchange Commission on March 28, 2012;May 10, 2018; and

 

·                                          Our Current ReportThe description of our common stock under the caption “Description of Common Shares” found in our Registration Statement on Form 8-K and the exhibits attached thereto,S-1/A (333-18724), filed with the SEC on April 24, 2009; and

·The description of our capital stock contained in the Registration Statement on Form S-2/A (SEC File No. 333 06017) filed with the Securities and Exchange Commission on July 19, 1996,August 21, 2012, and any amendmentamendments or reportreports filed for the purpose of updating such description.

 

52



Table of Contents

Notwithstanding the foregoing, weWe are notalso incorporating any document or information deemed to have been furnished and not filed in accordance with SEC rules.

Information contained in this prospectus supersedes information incorporated by reference that we have filed with the SEC prior to the date of this prospectus, while informationadditional documents that we file with the SEC afterpursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act from the date of the initial registration statement that contains this prospectus (including prior to the effectiveness of the registration statement) and prior to the sale of all the securities covered by this prospectus. Any statement contained in a document that is incorporated by reference will automatically update and supersede this information.

Our filings are available on our website, www.bankmbank.com. Information contained inbe deemed to be modified or linked to our website is not a part of this prospectus. You may also request a copy of these filings, at no cost, by writing or telephoning us at:

MACKINAC FINANCIAL CORPORATION

130 South Cedar Street

Manistique, Michigan 49854

(888) 343-8147

ATTENTION: Ernie R. Krueger

WHERE YOU CAN FIND MORE INFORMATION

This prospectus is part of a Registration Statement on Form S-3 filed by us with the Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended.  This prospectus does not containsuperseded for all of the information set forth in the Registration Statement, certain parts of which are omitted in accordance with the rules and regulations of the SEC.  For further information with respect to us and the securities offered by this prospectus, reference is madepurposes to the Registration Statement, including the exhibits to the Registration Statement and documents incorporated by reference.  Statementsextent that a statement contained in this prospectus concerning the provisions of such documents are summaries only, and each such statementdocument (or in any other document that is qualified in its entirety by reference to the copy of the applicable document filed with the SEC.

We file annual, quarterly and current reports, proxy statements and other information with the Securities and Exchange Commission. You may read and copy materials that we havesubsequently filed with the SEC atand incorporated by reference) modifies or is contrary to that previous statement. Notwithstanding the SEC’s public reference room located at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Please callforegoing, unless specifically stated to the contrary, none of the information we disclose under Items 2.02 or 7.01 of any Current Report on Form 8-K that we may from time to time furnish to the SEC at 1-800-SEC-0330 for further information on the publicwill be incorporated by reference room. Our SEC filings also are available to the public on the SEC’s website at www.sec.gov, which contains reports, proxies and information statements and other information regarding issuers that file electronically. In addition, our filings are available on our website at www.bankmbank.com.into, or otherwise included in, this prospectus.

 

We will provide without charge, upon writtenThese documents may be obtained by you or oralany beneficial owner as explained above (see “Where You Can Find Additional Information”), or you or any beneficial owner may request a free copy of any or all of thethese documents, whichincluding exhibits that are specifically incorporated by reference into this prospectus, excluding any exhibitsthese documents, by writing to those documents unlessor calling us at the exhibit is specifically incorporated by reference as an exhibit tofollowing address or telephone number or via the registration statement of which this prospectus is a part. Requests for documents should be directed to our Executive Vice President/Chief Financial Officer, Ernie R. Krueger,Internet at:

Mackinac Financial Corporation

130 South Cedar Street

Manistique, Michigan 49854 (906) 341-7158.

Attention: Secretary

Telephone: (888) 343-8147

Website: http://www.bankmbank.com

 

COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

Insofar as indemnification for liabilities arising underYou should rely only on the Securities Act of 1933 may be permitted to directors, officers or persons controllinginformation in our prospectus, any applicable prospectus supplement, any related free writing prospectus and the registrant pursuant to the foregoing provisions, the registrant has been informeddocuments that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is therefore unenforceable.

53



Table of Contents

[  ], 2012

Subscription Rights to Purchase up to 1,217,391 Common Shares

at $5.75 per Share

PROSPECTUS

are incorporated by reference. We have not authorized any dealer, salesperson or other personanyone else to giveprovide you written information other than this prospectus or to make representations as to matterswith different information. We are not stated in this prospectus. You must not rely on unauthorized information. This prospectus is not an offer to sell these securities or our solicitation of your offer to buyoffering these securities in any jurisdictionstate where the offer is prohibited by law. You should not assume that would not be permitted or legal. Neither the delivery ofinformation in this prospectus, nor any sales made hereunder afterapplicable prospectus supplement, any related free writing prospectus or any incorporated document is accurate as of any date other than the date of this prospectus shall create an implication that the information contained herein or the affairs of the Corporation have not changed since the date of this prospectus.document.



Table of Contents

PART II
INFORMATION NOT REQUIRED IN THE PROSPECTUS

 

Item 14. Other Expenses Ofof Issuance And Distributionand Distribution.

 

The following table sets forthitemizes the estimated expenses incurred, or expected to be incurred, by the Registrant in connection with the issuanceregistration and distributionissuance of the securities covered bybeing registered hereunder. As indicated below, all amounts shown are estimates except for the SEC registration statement of which this prospectus is a part. We will bear all of these expenses.fee.

 

Registration fee under the Securities Act

 

$

802.20

 

Legal fees and expenses

 

$

*

 

Accounting fees and expenses

 

$

*

 

Printing expenses

 

$

*

 

Other miscellaneous fees and expenses

 

$

100,000

 

 

 

 

 

Total

 

$

 

 

SEC Registration Fee

$

*

Printing Expenses

$

**

Accounting Fees and Expenses

$

**

Legal Fees and Expenses

$

**

Blue Sky Fees and Expenses

$

**

Transfer Agent Fees and Expenses

$

**

Trustee Fees and Expenses

$

**

Miscellaneous

$

**

Total

$

**

 


*                 See footnote 4 to the Calculation of Registration Fee table on the cover page of this registration statement.

Not presently known**          Fees and expenses (other than the SEC Registration Fee to be paid upon filing of this registration statement) will depend on the securities offered, the number of issuances and the nature of offerings, and cannot be estimated at this time.

 

Item 15. Indemnification Of Officers Andof Directors

Michigan Business Corporation Act and Officers.

 

The Corporation is organized underPursuant to Mackinac’s articles of incorporation and bylaws, as well as individual indemnity agreements with each director, Mackinac’s directors and officers are to be indemnified as of right to the fullest extent permitted by the Michigan Business Corporation Act (the“MBCA” “MBCA”) which, in general, empowers Michigan corporations to indemnify a person who was or is a party or is threatened to be made a party to a threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative and whether formal or informal, other than an action by or in the right of the corporation, by reason of the fact that such person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, partner, trustee, employee or agent of another enterprise, against expenses, including attorney’s fees, judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred in connection therewith if the person acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the corporation or its shareholders and, with respect to a criminal action or proceeding, if the person had no reasonable cause to believe his or her conduct was unlawful.

 

The MBCA also empowers Michigan corporations to provide similar indemnity to such a person for expenses, including attorney’s fees, and amounts paid in settlement actually and reasonably incurred by the person in connection with actions or suits by or in the right of the corporation if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the interests of the corporation or its shareholders, except in respect of any claim, issue or matter in which the person has been found liable to the corporation, unless the court determines that the person is fairly and reasonably entitled to indemnification in view of all relevant circumstances, in which case indemnification is limited to reasonable expenses incurred. If a person is successful in defending against a derivative action or third-party action, the MBCA requires that a Michigan corporation indemnify the person against expenses incurred in the action.

 

The MBCA also permits a Michigan corporation to purchase and maintain on behalf of such a person insurance against liabilities incurred in such capacities. The CorporationMackinac has obtained a policy of directors’ and officers’ liability insurance.

II-1



Table of Contents

 

The MBCA further permits Michigan corporations to limit the personal liability of directors for a breach of their fiduciary duty. However, the MBCA does not eliminate or limit the liability of a director for any of the following: (i) the amount of a financial benefit received by a director to which he or she is not entitled; (ii) intentional infliction of harm on the corporation or the shareholders; (iii) a violation of Section 551 of the MBCA; or (iv) an intentional criminal act. If a Michigan corporation adopts such a provision, then the Michigan corporation may indemnify its directors without a determination that they have met the applicable standards for indemnification set forth above, except, in the case of an action or suit by or in the right of the corporation, only against expenses reasonably incurred in the action. The foregoing does not apply if the director’s actions fall into one of the exceptions to the limitation on personal liability discussed above, unless a court determines that the person is fairly and reasonably entitled to indemnification in view of all relevant circumstances.

The Corporation’s Articles of Incorporation and Bylaws

The Corporation’s articles of incorporation limit the personal liability of directors for a breach of their fiduciary duty except under the circumstances required to be excepted under Michigan law described above.

II-1



Table of Contents

Insurance

In addition, the Corporation has purchased insurance policies that provide coverage for its directors and officers in certain situations where the Corporation cannot directly indemnify such directors or officers.

Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.

II-2



Table of Contents

 

Item 16. ExhibitsExhibits.

 

Exhibit
No.Number

 

Description

 

 

 

3.11.1

 

ArticlesForm of Incorporation and all amendments (most recent amendment filed December 14, 2004) (incorporated by reference to Exhibit 3.1 to the Corporation’s Form 10-K filed March 31, 2009)

3.2

Certificate of Designations of Fixed Rate Cumulative Perpetual Preferred Stock, Series A of Mackinac Financial Corporation dated April 21, 2009 (incorporated by reference to Exhibit 3.1 to the Corporation’s Form 8-K filed April 24, 2009)

3.2(a)

Amended and Restated Bylaws as revised June 27, 2001(incorporated by reference to Exhibit 3.2(a) to the Corporation’s Form 10-K filed March 31, 2009)

3.2(b)

Amendment to the Amended and Restated Bylaws adopted August 9, 2004 (incorporated by reference to Exhibit 3.2(b) to the Corporation’s Form 10-K filed March 31, 2009)

3.2(c)

Second Amendment to the Amended and Restated Bylaws adopted December 2007 (incorporated by reference to Exhibit 3.2(c) to the Corporation’s Form 10-K filed March 31, 2009)

3.3

Amendment to the Amended and Restated Bylaws adopted October 6, 2004 (incorporated by reference to Exhibit 3.3 to the Corporation’s Form 10-K filed March 31, 2008)

3.4

Second Amended and Restated Bylaws of Mackinac Financial Corporation Revised April 14, 2009 (incorporated by reference to Exhibit 3.2 to the Corporation’s Form 8-K filed April 24, 2009)Underwriting Agreement*

 

 

 

4.1

 

Rights Agreement dated asArticles of June 21, 2000, between the CorporationIncorporation and Registrar and Transfer Company, as Rights Agent (incorporated by reference to Exhibit 4 to the Corporation’s Form 8-Kall amendments (most recent amendment filed July 31, 2000)December 14, 2004)**

 

 

 

4.2

 

Amendment to Rights Agreement dated August 9, 2004 (incorporated by reference to Exhibit 10.1 to the Corporation’s Form 8-K filed August 13, 2004)Third Amended and Restated Bylaws adopted March 18, 2014**

 

 

 

4.3

 

Form of Amendment No. 2 to Rights Agreement dated December 2004 ( incorporated by reference to Exhibit 4.1 to the Corporation’s Form 8-K filed December 16, 2004)Articles of Incorporation Creating New Series of Preferred Stock*

 

 

 

4.4

 

Warrant to Purchase Common Stock dated April 24, 2009 (incorporated by reference to Exhibit 4.1 to the Corporation’s Form 8-K filed April 24, 2009)Specimen Certificate for Preferred Stock*

 

 

 

4.5**4.5

 

Subscription Agent Agreement, dated April [    ], 2012, between the Corporation and Register and Transfer CompanyForm of Senior Debt Security (included in Exhibit 4.7)

 

 

 

4.6

 

Form of SubscriptionSubordinated Debt Security (included in Exhibit 4.8)

4.7

Form of Indenture for Senior Debt

4.8

Form of Indenture for Subordinated Debt

4.9

Form of Debt Warrant Agreement (including form of Warrant Certificate)*

4.10

Form of Preferred Stock Warrant Agreement (including form of Warrant Certificate)*

4.11

Form of Common Stock Warrant Agreement (including form of Warrant Certificate)*

4.12

Form of Rights Certificate (filed herewith)Agreement*

4.13

Form of Unit Agreement*

4.14

Form of Pledge Agreement*

 

 

 

5.1

 

Opinion of Honigman Miller Schwartz and& Cohn, LLP with respectas to the validity of the Common Shares to be issued hereunder (filed herewith)securities registered hereunder.

12.1

Statement Regarding Computation of Ratios

 

 

 

23.1

 

Consent of Honigman Miller Schwartz and Cohn LLP (included in Exhibit 5.1)Plante & Moran, PLLC

 

 

 

23.2

 

Consent of Plante Moran, PLLC (filed herewith)Honigman Miller Schwartz & Cohn, LLP (included in Exhibit 5.1)

 

 

 

24.1*24.1

 

PowersPower of Attorney (included on signature page hereto)

II-2



Table of Contents

25.1

Form T-1 Statement of Eligibility of Trustee under the Indenture Senior Debt*

 

 

 

99.125.2

 

Form T-1 Statement of Letter to Registered HoldersEligibility of Common Shares (filed herewith)

99.2

Form of InstructionsTrustee under the Indenture for Use of Mackinac Financial Corporation Subscription Rights Certificates (filed herewith)

99.3

Form of Letter to Brokers and other Nominee Holders (filed herewith)

99.4

Form of Letter to Client (filed herewith)

99.5

Form of Beneficial Owner Election Form (filed herewith)

99.6

Form of Nominee Holder Certification (filed herewith)Subordinated Debt*

 


*                 Previously filed.

**ToIf applicable, to be filed by a post-effectivean amendment to this registration statement or as an exhibit toby a Current Report on Form 8-K and incorporated by reference herein.

**   Previously filed and incorporated by reference herein.

Item 17. Undertakings.

The undersigned Registrant hereby undertakes:

 

II-3(1)                                 To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i)                                     To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

(ii)                                  To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

(iii)                               To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

Provided, however, that paragraphs (1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

(2)                                 That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3)                                 To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(4)                                 That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

(i)                                     Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

(ii)                                  Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the

II-3



Table of Contents

 

Item 17.  Undertakingsprospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.

 

A.(5)                                 That, for the purpose of determining liability of the Registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities:

The undersigned registrant herebyRegistrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

(A)                               Any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424;

(B)                               Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant;

(C)                               The portion of any other free writing prospectus relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and

(D)                               Any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser.

(6)                                 That, for purposes of determining any liability under the Securities Act theof 1933, each filing of the registrant’sRegistrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act)1934 that is incorporated by reference in thisthe registration statement shall be deemed to be a new registration statement relating to the securities offered herein,therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

B.(7)                                 That, if any of the securities of the undersigned Registrant are offered pursuant to this registration statement at competitive bidding, the undersigned Registrant undertakes (i) to use its best efforts to distribute prior to the opening of bids, to prospective bidders, underwriters, and dealers, a reasonable number of copies of a prospectus which at that time meets the requirements of section 10(a) of the Act, and relating to the securities offered at competitive bidding, as contained in the registration statement, together with any supplements thereto, and (ii) to file an amendment to the registration statement reflecting the results of bidding, the terms of the reoffering and related matters to the extent required by the applicable form, not later than the first use, authorized by the issuer after the opening of bids, of a prospectus relating to the securities offered at competitive bidding, unless no further public offering of such securities by the issuer and no reoffering of such securities by the purchasers is proposed to be made.

Insofar(8)                                 That, insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrantRegistrant pursuant to the foregoing provisions, described in Item 15 above or otherwise, the registrantRegistrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by a registrantthe Registrant of expenses incurred or paid by a director, officer, or controlling person of the registrantRegistrant in the successful defense of any action, suit or proceeding) is asserted by such

II-4



Table of Contents

director, officer or controlling person in connection with the securities being registered, the registrantRegistrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.

 

D.(9)                                 The undersigned registrant hereby undertakes that:

(1)For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance on Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

(2)ForTo file an application for the purpose of determining any liabilitythe eligibility of the trustee to act under subsection (a) of section 310 of the SecuritiesTrust Indenture Act each post-effective amendment that contains a form(“Act”) in accordance with the rules and regulations prescribed by the Commission under section 305(b)(2) of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.Act.

 

II-4II-5



Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the RegistrantMackinac certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Manistique, State of Michigan, on April 6, 2012.May 11, 2018.

 

MACKINAC FINANCIAL CORPORATION

                                        (Registrant)

 

 

 

/s/ Paul D. Tobias

 

By:

/S/ PAULPaul D. TOBIAS

Tobias

 

Name:

Paul D. Tobias

Title:

Chairman and Chief Executive Officer

By:

/S/ ERNIE R. KRUEGER

Name:

Ernie R. Krueger

Title:

Executive Vice President/Chief Financial Officer

 

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Paul D. Tobias and Ernie R. Krueger, and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to execute any and all amendments (including post-effective amendments) to this registration statement or any registration statement relating to this offering to be effective upon filing pursuant to Rule 462(b) under the Securities Act of 1933 and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute, may lawfully do or cause to be done by virtue thereof.

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below on May 11, 2018, by the following persons on behalf of Mackinac and in the capacities indicated.  Each director of Mackinac, whose signature appears below, hereby appoints Paul D. Tobias and Jesse A. Deering, and each of them severally, as his attorney-in-fact, to sign in his name and on his behalf, as a director of Mackinac, and to file with the dates indicated.Commission any and all Amendments to this registration statement on Form S-3.

 

Signature

 

Title

Date

 

 

 

 

/s/ Paul D. Tobias

 

/s/ Jesse A. Deering

/S/ PAULPaul D. TOBIASTobias — Chairman,
Chief Executive Officer & Director
(principal executive officer)

 

Chairman and Chief Executive Officer (Principal

April 6, 2012

Paul D. Tobias

Executive Officer)

/S/ ERNIE R. KRUEGER

Jesse A. Deering — Executive Vice President/Chief Financial Officer

April 6, 2012

Ernie R. Krueger


(Principal Accountingprincipal financial and Financial Officer)

/S/ WALTER J. ASPATORE

Director

April 6, 2012

Walter J. Aspatore

/S/ DENNIS B. BITTNER

Director

April 6, 2012

Dennis B. Bittner

/S/ JOSEPH D. GAREA

Director

April 6, 2012

Joseph D. Garea

/S/ ROBERT E. MAHANEY

Director

April 6, 2012

Robert E. Mahaney

/S/ ROBERT H. ORLEY

Director

April 6, 2012

Robert H. Orley

/S/ RANDOLPH C. PASCHKE

Director

April 6, 2012

Randolph C. Paschke

/S/ L. BROOKS PATTERSON

Director

April 6, 2012

L. Brooks Patterson



Table of Contents

EXHIBIT INDEX

Exhibit
No.

Description

3.1

Articles of Incorporation and all amendments (most recent amendment filed December 14, 2004) (incorporated by reference to Exhibit 3.1 to the Corporation’s Form 10-K filed March 31, 2009)accounting officer)

 

 

 

3.2/s/ Walter J. Aspatore

 

Certificate of Designations of Fixed Rate Cumulative Perpetual Preferred Stock, Series A of Mackinac Financial Corporation dated April 21, 2009 (incorporated by reference to Exhibit 3.1 to the Corporation’s Form 8-K filed April 24, 2009)/s/ Joseph D. Garea

Walter J. Aspatore - Director

Joseph D. Garea — Director

 

 

 

3.2(a)/s/ Robert E. Mahaney

 

Amended and Restated Bylaws as revised June 27, 2001(incorporated by reference to Exhibit 3.2(a) to the Corporation’s Form 10-K filed March 31, 2009)/s/ Robert H. Orley

Robert E. Mahaney — Director

Robert H. Orley - Director

 

 

 

3.2(b)/s/ Dennis B. Bittner

 

Amendment to the Amended and Restated Bylaws adopted August 9, 2004 (incorporated by reference to Exhibit 3.2(b) to the Corporation’s Form 10-K filed March 31, 2009)/s/ L. Brooks Patterson

Dennis B. Bittner — Director

L. Brooks Patterson — Director

 

 

 

3.2(c)/s/ Kelly W. George

 

Second Amendment to the Amended and Restated Bylaws adopted December 2007 (incorporated by reference to Exhibit 3.2(c) to the Corporation’s Form 10-K filed March 31, 2009)/s/ Randolph C. Paschke

Kelly W. George — President & Director

Randolph C. Paschke — Director

 

 

 

3.3

Amendment to the Amended and Restated Bylaws adopted October 6, 2004 (incorporated by reference to Exhibit 3.3 to the Corporation’s Form 10-K filed March 31, 2008)

/s/ David R. Steinhardt

 

 

3.4

Second Amended and Restated Bylaws of Mackinac Financial Corporation Revised April 14, 2009 (incorporated by reference to Exhibit 3.2 to the Corporation’s Form 8-K filed April 24, 2009)

David R. Steinhardt — Director

 

 

4.1

Rights Agreement dated as of June 21, 2000, between the Corporation and Registrar and Transfer Company, as Rights Agent (incorporated by reference to Exhibit 4 to the Corporation’s Form 8-K filed July 31, 2000)

4.2

Amendment to Rights Agreement dated August 9, 2004 (incorporated by reference to Exhibit 10.1 to the Corporation’s Form 8-K filed August 13, 2004)

4.3

Amendment No. 2 to Rights Agreement dated December 2004 ( incorporated by reference to Exhibit 4.1 to the Corporation’s Form 8-K filed December 16, 2004)

4.4

Warrant to Purchase Common Stock dated April 24, 2009 (incorporated by reference to Exhibit 4.1 to the Corporation’s Form 8-K filed April 24, 2009)

4.5**

Subscription Agent Agreement, dated April [    ], 2012, between the Corporation and Register and Transfer Company

4.6

Form of Subscription Rights Certificate

5.1

Opinion of Honigman Miller Schwartz and Cohn LLP with respect to the validity of the Common Shares to be issued hereunder (filed herewith)

23.1

Consent of Honigman Miller Schwartz and Cohn LLP (included in Exhibit 5.1)

23.2

Consent of Plante Moran, PLLC (filed herewith)

24.1*

Powers of Attorney

99.1

Form of Letter to Registered Holders of Common Shares (filed herewith)

99.2

Form of Instructions for Use of Mackinac Financial Corporation Subscription Rights Certificates (filed herewith)

99.3

Form of Letter to Brokers and other Nominee Holders (filed herewith)

99.4

Form of Letter to Client (filed herewith)

99.5

Form of Beneficial Owner Election Form (filed herewith)

99.6

Form of Nominee Holder Certification (filed herewith)

 


*Previously filed.

**To be filed by a post-effective amendment to this registration statement or as an exhibit to a Current Report on Form 8-K and incorporated by reference herein.